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MODELING OF TLR4 SIGNAL TRANSDUCTION PATHWAY 
SUMMARY 
A principal challenge for life sciences is to understand the organization and 
dynamics of those components that make up a living system. Understanding the 
systems of cellular processes is very similar to solving many body problems 
including complex interactions, in this case among a large number of genes, proteins 
and other molecules.  One way to achieve such an aim is passing through the 
investigation of signaling pathways by computational Modeling approaches.  
Bacterial lipopolysaccharide (LPS) association with their connate receptor TLR4 
triggers Type I interferon signaling cascade through its MyD88 independent 
downstream. Compared to plethora of reported empirical unorganized data on TLR4 
and Type I interferon pathways, there is no known model to decipher crosstalk 
mechanisms between these two crucial innate immune pathogen activated pathways 
regulating vital transcriptional factors such as nuclear factor-"B (NF"B), interferon 
beta (IFN#), the interferon-stimulated gene factor-3 (ISGF3) and an important cancer 
drug target protein kinase-R (PKR).  
Innate immune system is based on a sensitive balance of many interactions. Attempts 
restricted to single pathway resulted in misleading Modeling infrastructures in 
reported models such as introducing conjectural 6 hour delay in single transcription 
step for PKR, in this aspect, in silico combination of immune regulatory systems 
have great potential to unravel elusive regulatory mechanisms.  
In this study we model the NF!B-I!B signaling module by control theory 
approaches and the interactions between two vital pathogen activated pathways, 
namely the TLR4-MyD88 independent and interferon pathways, overall by utilizing 
reaction kinetics ODEs and a statistical approach at the transcriptional level. This is 
the first report joining toll-like receptor-4 (TLR4) and IFN# pathways in a single in 
silico model, analyzing the crosstalk mechanisms, explicitly Modeling the cascade 
through TLR4-IKK, limiting the transcription of IFN and PKR by introducing a 
hybrid method including a statistical physics technique and pinpointing the source of 
delay in PKR late phase activity. The TLR4-IFN# model quite successfully 
recapitulates published interferon regulatory factor-3 (IRF3) and IFN# data from 
mouse macrophages and PKR data from mouse embryonic fibroblast cell lines. The 
simulations end up with an estimate of IRF3, IFN#, ISGF3 profiles for different 
doses of LPS and IFN# ligands. Involvement of concomitant PKR downstream can 
reveal elusive mechanisms in specific profiles like NF"B regulation. 
  xx 
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TLR4 S!NYAL YOLA$ININ MODELLENMES! 
ÖZET 
Tanı ve tedavi yöntemleri belirlemek için, sisteme ait parçalar hakkında ayrı ayrı 
bilgiye sahip olmak yeterli gelmemekte ve bu parçaların nasıl etkile$ti%i bilgisine 
ihtiyaç duyulmaktadır. Bugün halen bilim dünyası en basit organizmaların bile 
sistem olarak tüm i$leyi$ mekanizmasını çözmekten uzaktır. &$te tam bu noktada 
disiplinler arası bir dal olan sistem biyolojisi önemli bir rol üstlenmektedir. Bu 
sebeple ya$am ile ilgilenen bilim alanlarının ba$lıca u%ra$ısı ya$amsal birimi 
olu$turan parçaların düzenini ve dinami%ini anlamaktır. Bu u%ra$  karma$ık 
etkile$imler içeren çok parçacık problemini çözmeye benzer, ki bu durumda 
parçacıkların yerini yüksek sayıda gen, protein ve di%er moleküller alır. &$te tam bu 
noktada disiplinler arası bir dal olan sistem biyolojisi önemli bir rol üstlenmektedir. 
Sistem biyolojisinin temelde DNA, RNA, proteinler ve ya%lar gibi biyomoleküller 
arasındaki dinamik etkile$im mekanizmalarını, metabolik yapının küçük bir 
parçasından, tüm organizma düzeyine kadar pek çok seviyede inceler. Erken te$his 
ve tedavi yöntemleri, önleyici tıbbi yöntemler, enfeksiyona ve enflamasyona kar$ı 
özel yöntemler geli$tirmek sistem biyolojisinin önemli hedefleri arasında yer alır. 
Bütün bu çalı$maların bir geri döngüsü de tanı ve tedavi yöntemlerini her ki$iyi farklı 
yapan özelikleri göz önünde bulundurarak, ki$iye özel bir $ekle dönü$türebilmek 
olacaktır. 
Sistem biyolojisi yinelemeli yöntemler takip eder. &lk a$amada yöntemleri sistem 
bile$enleri ve bunların bir biri ile etkile$imi belirlenir. Bu sonuçlara göre  sistem 
hakkında öngörülerde bunlunmakta kullanılacak modeler geli$tirilir. 
Biyolojik yapıyı olu$turan temelleri anlamanın etkin yolarından biri de bilgisayar 
ortamında hesaplamalı modeller olu$turmaktır. Biyolojik sistemlerin matematiksel 
olarak modellenmesi ve hesaplamalı yöntemlerle çözülmesi mümkün tüm 
molekülleri denemek yerine içlerinden en iyi adayları ve bunlara en uygun hedefleri 
göstermedeki potansiyelleri  açısından sistem biyolojisi icinde büyük bir öneme 
sahiptir. Bir ilaç geli$tirmek için mevcut olası her kimyasal yöntemi denemek ne 
zamansal nede maddi açıdan etkin bir yöntem de%ildir. Biz bu çalısmada vücudun 
do%al ba%ı$ıklık sisteminde önemli rol oynayan NF!B-I!B sinyal modülünü kontrol 
teorisi yöntemleri kullanarak, ve yine hayati açıdan çok onemli TLR4-MyD88, 
interferon beta sinyal yola%ı isimli iki yola%ını reaksiyon kineti%i differansiyel 
denklemleri kullanarak bilgisayar ortamında modelledik. Ba%ı$ıklık sistemini sinyal 
yolaklarının bu tür bilgisayar modelleri ile kombinasyonu, yolaklar tek tek 
incelendi%i zaman açıklamanın mümkün olmadıgı pek çok olaya çözüm getirebilir. 
Bu durum göz önünde bulundurularak bu çalı$madaki modeller literatürdeki ilgili 
yolaklarının modellerine uyumlu olarak geli$tirilmi$tir.  
Moleküler sinyal yola%ı modelleri reaksiyon katsayıları gibi pek çok parametreye 
ba%lıdır. Bu parametrelerin bazıları hassas bir $ekilde belirlenebilse de, di%erleri  
bilinmemekte yada insan genetik farklılıklarının sebep oldu%u bireysel farklarla 
ölçülmesine olanak olmamaktadır. Bu tarz parametrelerin elde edilmesi pek çok 
durumda sadece, yolak modellerinden elde edilen sonuçların deneysel verilerden elde 
  xxii 
edilen sonuçlar ile hesaplamalı yöntemler kullanarak kar$ıla$tırılmasi ile mümkün 
olur. 
NF-!B ba%ı$ıklık sisteminde planlı hücre ölümü, inflamasyon, kanser, sistemin stres 
tepkileri gibi pek çok olayda önemli rolü olan bir traskripsiyon faktörüdür. NF-!B 
ekspresyonu insan ba%ı$ıklık sistemindeki çok sayıda farklı uyarana kar$ı oldukça 
ılımlı bir $ekilde gerçekle$ir. Bu ekspresyondaki ani ve sert de%i$iklikler ölümcül 
sonuçlara sebep olabilir. Ba%ı$ıklık sistemini enfeksiyon durumunda ya$amsal risk 
yaratmayacak $ekilde tepki verir.  
Bu çalı$madaki bir amacımız NF!B’nin bu ılımlı düzenlenme mekanizmasını, 
transfer fonksiyonları kullanarak, NF-!B-I!B sinyal modülü düzeyinde açıklamakdı. 
Bu sebeple olası mekanizmalari içeren farklı modeller, her reaksiyon bile$eninin 
davranı$ını üreten transfer fonksiyonları ile kurulmu$, bu modellerden do%al 
mezkanizmaya uyumlu olanları optimizasyon yöntemleri ve literatürdeki veriler 
kullanılarak belirlenmeye çalı$ılmı$tır. Bu yöntemle biyolojik sistem içindeki geri 
besleme mekanizmalarının nasıl i$lendi%i incelenmi$tir. Çalı$ma sonucunda deneysel 
NF"B  ekpresyonu  üreten bir model geli$tirilip,  yöntemin geçerli oldu%u limitler  
literatürdeki uygulamalarla kar$ıla$tırılarak de%erlendirilmi$tir. Elde edilen model ile 
deneysel NF!B zamana ba%lı konsantrasyon de%isimi verisi, ilk tepenin genli%i 
dı$ında, genel özellikleri açısından aynen elde etmek mümkün olmu$tur. Bu 
modelden yola çıkarak LPS uyaranlı NF!B regülasyonunu, uyaran seviyesinden 
itibaren temsil edecek bir  model öngörülmü$tür. Burada bahsi geçen çalı$mada 
verilen modeller ile sistemin farklı ko$ullarda nasıl davranaca%ını öngörmek için, 
tepkime üyelerinin bu farklı $artlar altında nasıl davranca%ını içeren bir veri 
kütüphanesine ihtiyaç vardır. Zira olu$turulan her transfer fonksiyonu sistemin 
sadece o ko$ul için nasıl davranaca%ını belirten özel bir çözümüdür. Ba%ı$ıklık 
sistemi ço%u zaman  oldukça do%rusal olmayan davranı$lar sergiledi%i için, bu özel 
çözümlerin ba$ka sınır ko$ullarında sistemin gerçek durumunu yansıtmaması ve 
deneysel sonuclarını  yinelememesi kuvetli bir ihtimaldir. Bu davranı$ları lineer 
modelleme yöntemleri ile çözümlemeye çalı$mak ancak yo%un bir deneysel verinin 
varlı%ında etkin olur, yani her durum için do%ru transfer fonksiyonlarının 
belirlenmesi bu durumlarda sistemin davranı$ını tanımlayan bilgi gerektirir. 
Çalı$manın ikinci a$amasında TLR4 ve IFN# yolakları için literatürde yayınlanmı$ 
olan fare makrofaj hücrelerinden elde edilmi$  IRF3 ve IFN# verilerine uyumlu 
$ekilde adi diffransiyel denklemler kullanılarak modeller geli$tirilmi$tir. Elde edilen 
denklemler MATLAB ortamında literatürde yer alan veriler do%rultusunda 
çözülmü$tür. TLR4 modelin çıktısı olan IFN#’nın IFN# yola%ındaki interferon 
reseptörünün tetiklenmesi için kullanılarak bu modeller birle$tirilmi$tir.  Similasyon 
LPS ve interferonun farklı seviyeleri için ISGF3 ve PKR nin zamana ba%lı yo%unluk 
de%i$imlerinin elde edilmesi ile sonuçlanır. PKR önemli bir kanser ilaç hedefi olup, 
literatürde doz tepki e%rileri mevcut olmadı%ı için,  bu çalı$ma bu verilerin elde 
edilmesi açısından da önem arz etmektedir. Ayrıca LPS etkisi ile üretilen NF!B nin 
uygulanması ile deneysel verilere çok yakın bir IFN# davranı$ı elde edilmi$tir. 
Deneysel sonuçlarla uyumlu olarak, olu$turulan model de receptor metabolizmasının 
transkripsiyon faktörü davranı$ını düzenleyen ba$lıca etkenlerden biri oldu%unu 
i$aret etmi$tir.  
Bu çalı$mada hayati açıdan çok önemli iki farklı patojen aracılı%ı ile tetiklenen 
yola%ı literatürde ilk olarak tek bir hesaplamalı model üzerinde birle$tirilerek, 
aralarındaki etkile$im incelenmi$tir. Yine ilk kez bu yolakların di%er modellerinden 
farklı olarak gen transkripsiyonu seviyesinde, üretimi üst sınır sa%layabilmek için 
istatistiksel fizik yöntemlerini içeren melez bir yakla$ım uygulanmı$tır. &laveten PKR 
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geç fazındaki gecikmeyi üretebilmek için literatürde belirtilen transkripyon 
seviyesinde 6 saatlik yapay bir gecikme yaratan fonksiyonun yerine, gene ilk olarak 
iki yola%ın etkilesmesinden kaynaklı do%al süreç kullanılmı$tır. Bu çalı$mada PKR 
üretimine kadar olan a$amalar modellenmi$ olsa da, modelin sonuçlarının 
kullanılarak geni$letilmesi ile NF!B seviyesini düzenleyici di%er mekanizmaların 
aydınlatılması da olasıdır. 
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1. INTRODUCTION 
Biological signaling cannot be totally understood by ignoring the communication 
mechanisms between different pathways and the effect of the many positive or 
negative feedback regulatory mechanisms. Diverse cell response characteristics of 
mammalian species is a result of interaction networks between over 3000 signaling 
proteins and 15 secondary messengers (Brandman and Meyer, 2008; Jordan et al., 
2000).  
The properties of networks such as the World Wide Web, food webs, transportation 
networks, social, email networks, citation networks, software call graphs and 
biochemical signaling networks have been drawing attention within the physics 
community for a while. Interest of physics community to explain life is not only 
restricted with quite recent network analysis. Schrodinger’s discussion about 
dependence of biological events to individual atoms or molecules has great impact on 
foundation of molecular biology and his ideas about treating living organisms as 
purely mechanical systems to explain their behaviour is one of the basis of todays 
system approach to biology (Schrodinger, 1944; Schrodinger, 1967; Wellstead, 2005). 
Despite its great contribution, like the other disciplines, physics alone is not enough to 
resolve whole biological mechanisms. To date, several methods of many disciplines 
are utilized to understand and model the biochemical signaling pathways. While 
Schrodinger’s system approaches, together with electrical engineering system and 
signal analysis methods form the early groundwork ushering in prelude systems 
biology, Wellstead (2005), today broad network of disciplines are integrated under this 
innovative field to understand the life and contemporary system biology has become a 
paramount paradigm for life sciences in the last decade. 
Systems biology is a recently emerging field with higly multi-disciplinary scope and 
bursting very promosing developments in life sciences. The main interest of system 
biology is the dynamics of interactions between bio-molecules like DNA, RNA, 
proteins, lipids and metabolites at various levels ranging from a small part of a 
metabolic  pathway  in  an organelle to an organism level. To perform this, an iterative 
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approach is followed. The first step is the determination of system components and 
their interactions. Consecutively, a predictive model is constructed and its conjectures 
are tested by present or forthcoming data from experiments which in turn lead to the 
refinement of the model and construction of new hypotheses. Among the system 
biology tools, one of the most prominent methods to model cellular dynamics is the 
use of ordinary differential equations (ODEs) that we also applied in this study. 
Developing opportunities for early and accurate diagnosis, preventative strategies, 
specific treatments for infectious and inflammatory diseases are the important 
objectives of system biology. One spin off them in prospect is to personalize diagnoses 
and therapies, by concerning the factors making each individual unique. 
Considering its complexity, abundance of interaction and medical significance, one of 
the ideal application for system biology is immune system. For appropriate immune 
response various complex interactions, feedbacks, and dynamical behavior is essential 
as in the case of the innate immune response, which is highly context dependent and 
according to the context, while pathogen and host factors can be protective, it can also 
be injurious. For example depending on dose of pathogens, Toll-like receptor (TLR)-2 
and myeloid differentiation response gene 88 (MyD88) either defend against spread of 
Group B Streptococcus in the case of low concentrations or can promote lethality for 
high doses (Mancuso et al., 2004). 
The positive and negative feedback mechanisms are very important in regulation of 
biological systems. Blurriness in connection of the signaling input-output behavior by 
known feedback relations can illustrate the presence of missed mechanism (Brandman 
and Meyer, 2008). Even a very small part of innate immune system like the NF!B-I!B 
signaling module can involve many such mechanisms (Kearn et al, 2006; Basak et al., 
2007). 
Innate immune system also includes many examples of other types of complex 
interaction like the ones existing among Toll-like receptors (TLRs: receptors 
recognizing microbial pathogens signaling) and interferon (IFN) pathways. It is known 
that the viral by-product double stranded RNAs are sensed via TLR3 pathway and 
leads production of viral IFNs (Alexopoulou et al., 2001). TLR4 also produces IFN 
through MyD88 independent pathway that is common both in TLR3 and TLR4 
signaling cascade (Kawai et al., 2001; Yamamoto et al., 2003).  
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At the line of contact in between the pathogens and internal milieu, epithelial cells 
secrete Type I IFNs as a first defence mechanism facing invading viruses (Jamaluddin  
et al., 2001). Interferons have important roles in antiviral activities of the cells. It is 
known that lipopolysaccharide (LPS) stimulation results in IFN# transcription via the 
MyD88 independent pathway (Kawai et al., 2001; Yamamoto 2003). Thus, there is a 
close correlation between the responses of the cell in the presence of viral and 
bacterial infection, and presumably being treated with one of them makes the cell 
more vulnerable to the other. 
Computational models are very effective tools in organizing the correlations and 
contradictions among the vast amount of data in the literature, pointing to the missed 
parts and possible other outcomes of the systems. Models of molecular signaling 
pathways in cells include large numbers of parameters, such as reaction rates. While 
some of these parameters are known quite accurately, others are either unknown or 
even impossible to measure, partly because of the fact that human genetic 
polymorphisms may cause individual variability of some of these parameters. For 
these reasons, estimation of such model parameters needs to be accomplished by 
fitting models of pathways involving these parameters to available data. Optimization 
methods are effective tools to attain the proper fit for the system, but in many case 
intuitive methods based on biological data are also indispensable because of large 
search space. 
In this study we had searched for the properties of biochemical signaling network 
regulating the transcription factors such as NF!B, IRF3 and ISGF3 expression having 
a role in many vital biological processes. Throughout the last decade an avalanche of 
research is conducted on these proteins because of their roles in immune response, 
inflammation, and development. Compared to extensive amount of experimental 
studies conducted to understand the mechanisms of LPS and IFN" stimulated 
pathways, at hand only a few comprehensive mathematical or computational models 
exist for TLR4, even less for the IFN" pathways. We utilized system biology tools and 
transfer functions in control theory to model these pathways. 
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1.1 Motivations and Main Achievements 
Immune system needs to defend against an infection without risking the organism 
survival. In immune system NF"B expression to wide range of stimulation is moderate 
and harsh changes could be fatal. One of the main motivations in this study is to 
develop mathematical models explaining such a moderate regulation of NF"B with 
methods relayed on reaction kinetics ODEs, transfer functions of control theory and 
optimization techniques. Still there are many unsolved mechanism for LPS and IFN# 
stimulated pathways and related NF"B expression. My purpose is to suggest models 
illuminating some of these mechanisms and anticipate the illusive parts of stable 
behavior of the LPS mediated NF-"B puzzle. 
Because of the natural cross correlations and concomitant highly linked outcomes, to 
simulate the whole picture, it is very important to integrate the pathways. In this sense 
compatibility in between the models of individual pathways is also very important to 
consider. With this point of view, we developed computational models for the IFN# 
and TLR4-MyD88 independent pathways separately, and linked them on a single 
model that can also be used as part of a more comprehensive structure in combination 
with other pathogen activated pathway (PAMP) models in the literature. In terms of 
modelling aspects, this is the first reported attempt to join TLR4 and Interferon beta 
pathways and to analyze how they communicate with each other.  
The ODE model proposed in this study combines reaction kinetics approach for the 
signal transduction and a probabilistic approach at the transcription level. For TLR4 
and IFN# signaling cascade, in parallel with experimental data available in the 
literature, the results indicated that receptor metabolism like degradation, 
internalization and complex formation is an important factor in determining the trends 
of transcription factors’ expression profiles. This model successfully reproduced the 
experimental interferon IRF3 and IFN# expression levels and profiles. Moreover, we 
propose the possible dose response curves for ISGF3 profiles corresponding to the 
different levels of LPS and test the results with published dependent PKR expression 
data. 
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1.2 Background  
1.2.1 TLR4 pathway 
TLR4 signal transduction pathway forms an important part in the immune system. 
Gram-negative bacteria are detected through their LPS regions by transmembrane 
TLR4 receptors (Carpenter and O’Neill, 2007; Kawai and Akira, 2007). A 
concomitant signaling cascade via both MyD88 dependent and independent pathways, 
Kawai et al. (2001), leads to free nuclear factor kappa-light-chain-enhancer of 
activated B cells (NF"B) and according to the pathway, interferons and cytokines. 
Most of the cell types can produce Type I interferon IFN' and IFN# (Barton and 
Medzhitov, 2003; Meylan et al., 2004; Vivarelli et al., 2004; Katze and He, 2002). 
Despite the 14 different IFN# genes, IFN" is encoded by single gene (Katze et al., 
2002; Kelley and Pitha, 1985; Chen, 2004) and NF"B and IRFs function together in 
the transcription of IFN# gene (Thanos , and Maniatis, 1995; Hu et al., 2007).  
TLR family members consist of more than 13 members and from TLR1 to TLR10, ten 
of them have been identified in humans. In mice total twelve TLRs numbered in 
between 1-9 and 11-13 exist (Takeda, Kaisho, Akira, 2003; Kawai and Akira, 2006). 
They are component of a wide range of cells in immune system, i.e., macrophages, 
dendritic cells, neutrophils, B cells and non-immune cells like keratinocytes fibroblast 
cells and epithelial cells (Kawai and Akira, 2007).  
The interaction in between TLR4 and LPS is mediated by a protein called as 
lymphocyte antigen 96 or MD-2 (Kumar et al, 2009; Kawai and Akira, 2009). The 
sequence of events after this association remained a mystery for a while. In an early 
computational study (Selvarajoo, 2006) on MyD88 independent pathway conducted to 
explain late phase NF"B activity, the number of intermediates acting through the 
downstream was claimed as the source of the phase. The reason behind this suggestion 
was based on the fact that in the models representing MyD88 knockouts, the changes 
neither in the kinetic rates nor the reaction kinetics equations were not enough to 
recapitulate the correct NF"B profile but incorporation of a few unknown 
intermediates and slowing down the reaction kinetics would lead to the desired 
expression profile. However another experimental study, Kagan et al., (2008), 
revealed that the proposed unknown intermediates are not different reaction species 
but rather endocytosis of TLR4, sequential events during this stage and transportation 
of the endosome, which are very important in providing the delay necessary to 
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produce LPS stimulated NFkB profile. The results of the experiment indicate that at 
the initial stage of TLR4 stimulation, toll-interleukin 1 receptor (TIR) domain-
containing adaptor protein (TIRAP)-MyD88 complex interacts with the receptor 
through its TIR domain. This is followed by internalization of TLR4 by endocytosis 
(Kagan et al., 2008). Releasing the TIR domain, TRIP- MyD88 complex is not 
involved in this process, which allows sequential association of TRIF-related adapter 
molecule (TRAM) and TIR domain containing adapter inducing interferon-b (TRIF) 
complex to the remaining empty domain (Kagan et al., 2008). Some in silico results 
indicate a competitive relation between TRAM and the tumour necrosis factor 
associated factor (TRAF) for the TIR domain (Selvarajoo et al., 2008). The 
experiment conducted to validate this competitive behaviour illustrates an increase in 
the early IRF3 expression, Selvarajoo et al. (2008), which is incongruous with the 
experimental study showing the formation of endosomes and sequential binding to 
TLR4 (Kagan et al., 2008). However, other evidences in MyD88 knockouts seems to 
contradict with competitive behaviour and support the sequential binding and 
endocytosis by indicating a decrease in the level of phosphorylation of down stream 
molecules like IRF3 (Kawai et al., 2001). 
TLRs cause recruitment of a set of adaptor proteins due to the homophilic interactions 
between their TIR domains and that of adaptor proteins (O’Neill and Bowie, 2007; 
Kawai and Akira, 2007). Five adaptor proteins contain TIR domain, O’Neill and 
Bowie (2007), and among all TLRs, TLR4 is the only one known as utilizing all these 
adaptor proteins (O’Neill and Bowie, 2007). The adaptor proteins are:  
•Myeloid differentiation primary response gene 88 (MyD88) 
•TIR domain-containing adaptor protein (TIRAP), also named as Mal, MyD88-
adapter- like  
•TRIF-related adaptor molecule (TRAM),  
•TIR domain-containing adaptor inducing IFN-" (TRIF), 
•Sterile Alpha and HEAT-Armadillo motifs-containing protein (SARM) seems to act 
as an inhibitor of TRIF-mediated signaling in the human HEK293 cell line (Peng et 
al., 2010). However, the role of SARM in vivo is still unclear (Peng et al., 2010).  
Several proteins get involved in LPS stimulation of mammalian cells including the 
LPS binding protein CD14, (LBP), TLR4 and MD-2 (Gioannini, Weiss, 2007; 
Miyake, 2007; Lu, Yeh, Ohashi, 2008). LBP is a soluble protein facilitating LPS and 
CD14 association (Tobias and Soldau, 1986; Wright et al., 1989). CD14 helps the LPS 
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to be transferred to the TLR4-MD-2 complex (Wright et al., 1990). TLR4 facilitates 
binding of LPS to MD-2 (Mitsuzawa et al. 2006). In this study, we summurized all of 
these stages in a single step for the sake of modeling simplicity and because of 
restricted knowledge about their exact kinetic mechanisms. 
TLR4 signals mainly through two pathways (Takeda and Akira, 2004): 
• MyD88 Dependent Pathway results in induction of vital proinflammatory cytokines 
like TNF#, IL-6, SOCS3, JNK, NF!B, ERK. (Selvarajoo, 2008). 
• MyD88 Independent or TRIF Dependent Pathway mainly induces chemokines such 
as IP-10, Type I interferons (IFNs) (Takeda and Akira, 2004) and dependent proteins 
through IRF3 and IRF7 in the presence of NF!B (Lu et al., 2008). 
In addition to activate canonical NF!B pathway, both MyD88 and TRIF dependent 
pathway utilizes distinct signaling cascades defining its unique effectors function. 
Despite TLR3, TLR4 additionally triggers MYD88 dependent pathway, which is 
exclusive to the cell surface membrane (Kumar et al., 2009). TRAM serve at the down 
stream of TLR4 (Yamamoto et al. 2003a, Yamamoto et al. 2003b). After the 
association of TLRs with MyD88, the resultant complex recruits death domain of the 
member IL1 receptor associated kinases family (IRAK) through MyD88 death domain 
by homophilic interactions (Barton and Medzhitov, 2003). While the family members 
like IRAK1, IRAK2 and IRAK4 act as TRAF6 activator, IRAK-M blocks this 
activation by preventing the dissociation of IRAK1 and IRAK4 from MyD88 (Barton 
and Medzhitov, 2003; Covert et al., 2005; Keating et al., 2007). TRAF6 leads 
activation of the I"B Kinase complex (IKK) and in turn release of NF-"B transcription 
(Covert  et al., 2005). The receptor-interactor proteins 1 (RIP1) act together with 
TRAF6 to enhance cell survival (Covert et al., 2005; O’Neill and Bowie, 2007; 
Meylan et al., 2004; Vivarelli et al., 2004). 
Both IRF3 and IRF7 function synergistically in LPS and virus induced IFN" 
production (Wathelet et al., 1998; Yang et al., 2004). While this synergistic activity 
brings maximum efficiency, presence of either IRF3 or IRF7 is sufficient and the 
redundant roles of this two-transcription factor can bypass virus defence against the 
immunity (Yang et al., 2004). The effects of IRF3 and IRF7 depend upon the promoter 
context and even very low levels of IRF7 can lead IFN" expression because of its 
preferential recruitment to the IFN" promoter (Yang et al, 2004). 
LPS treatment does not alter IRF3 protein expression level in both in the presence and 
absence of MyD88, so the activation of IRF3 is a posttranslational effect and is 
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required for its transcriptional activity (Kawai, 2001). IRF3 activation occurs through 
opening of inhibited state closed structure subsequent to multiple phosphorylation of 
C-terminal serine/ threonine residues (Qin et al., 2003; Honda et al., 2005). 
Phosphorylation begins at Serine 396 side and proceeds through Ser-404, Ser-405, 
Ser-386 or 385. Ser-339 and Ser-396 has compensatory mechanism and both have 
redundant roles on IRF3 transcriptional activity (Clement et al., 2008). While mutation 
of Serine 396 can cause constitutively active IRF3 , Clement et al. (2008), mutation at 
Ser 386 prevent IRF3 dimerization in the cytoplasm (Mori et al., 2004; McCoy et al., 
2008). IRF3 phosphorylation does not only function in positive regulation; it is also 
needed for negative regulation (McCoy et al., 2008). After virus invasion into cell, 
IRF3 degrade rapidly (Wathelet  et al., 1998; Marie et al., 1998). The transportation of 
IRF3 through nucleus is regulated via the nuclear localization and nuclear export 
amino acid sequences. Even though both sequences are constitutively active, prior to 
the infection nuclear export is dominate nuclear inport, thus IRF3 accumulates at 
cytoplasm. Serine/threonine phosphorylation effects the ability of IRF3 association 
with CBP/p300 in the nucleus, which inverts previous balance in the direction of IRF3 
nuclear accumulation (Kumar  et al., 2000). 
Although presence of either IRF3 or IRF7 is necessary, it is not enough for IFNbeta 
expression. The other three transcriptional factors which take part in the transcriptional 
activation are AP-1 (ATF-2-c-Jun), NF-"B , and the architectural protein HMG-I(Y) 
(Thanos  and Maniatis  1995; Thanos and Maniatis ,1992; Agalioti et. al, 2000; Merika 
and Thanos, 2001). For IFN" induction by infection, these four proteins need to form 
an ensemble called as enhanceosome (Thanos and Maniatis, 1995; Yie et al., 1999).  It 
was shown that rather than protein-protein interactions, conformational changes 
following sequential interactions with DNA are the source of cooperative binding of 
these activators (Panne et al., 2004). 
The main factors in the TLR4 pathway is depicted in the schematics given in 
Figure1.1 and their main characteristics can be summarized as: 
IRAK (IL-1 receptor associated kinese): 
• Among four members of vertebrates IRAK family, namely IRAK-1, IRAK-2, 
IRAK-4, IRAK-M, IRAK-M is the only one not having a kinase activity (Kawagoe et 
al, 2008; Gosu et al., 2012). IRAK-4 compires a central kinase and an N-terminal 
death domain (Suzuki et al., 2002). 
•  MyD88 activates IRAK4 through its dead domain and concomitantly leads 
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activation of IRAK1 by phosphorylation (Kawai and  Akira, 2007). 
 
 
                   Figure 1.1: The schematics of the TLR4 and IFN" pathway.  
•  IRAK-4 deficiency results with resistance to most viruses. Among 28 known 
IRAK-4-deficient patients, Ku et al. (2007), no one suffered from severe viral disease 
and resist normally to most viruses independent of whether the event occurs by means 
of TLR3-dependent but IRAK-4-independent responses to dsRNA, TLR3- and IRAK-
4-independent responses to dsRNA or responses to other viral intermediates through 
IRAK-4-independent pathways (Zhang et al., 2007).  
• Mouse and human IRAK is 84% identical and 87% similar to each other (Li et 
al., 2002).  
• IRAK-M prevents the dissociation of IRAKs and inhibits signaling through MyD88 
(Lu, Yeh, Ohashi, 2008; Kobayashi et al., 2002)  
• IRAK2 function is unknown (Kawai and Akira, 2007). 
TRAF6 (TNF receptor-associated factor 6): 
• It is in the structure of ring-domain E3 ubiquitin ligase (Kawai and Akira, 2007). 
 • TRIF binds TRAF6 by its N terminal region TRAF6-binding motifs and without 
these motifs, TRIF is not be able to activate NF!B (Kawai and Akira, 2007).  
• Normally the absence of TRAF6 in TLR3 pathway results in a decrease in NF!B 
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expression, Kawai and Akira (2007), however, in macrophages this is not the case, 
which indicates cell specific contribution of TRAF6 (Gohda et al., 2004). 
TAK1: 
•  Distinct regions of TRIF interact with TRAF6 and RIP1 and result in 
polyubiquitinated RIP1 and TRAF6 complex, activating TAK1. Such a cooperative 
functioning of TRAF6 and RIP1 in a complex causes robustness in NF!B expression 
(Kawai and Akira S., 2007). 
• TAK1 deficiency in TLR3 pathway results in impaired cell response (Sato et al., 
2005) 
TLR4 and TRAM: 
•  TRAM and TLR4 exist both at cell membrane and on true endosomes (Kagan et 
al., 2008) . 
•  In contrast to TLR4, independence of the localization of TRAM to dynamin 
illustrates that TRAM can target endosomes via different channel than plasma 
membrane (Kagan et al., 2008) . 
• The action of TLR4 and TRAM via different mechanism can be sign of not 
transporting together after internalization (Kagan et al., 2008) . 
Comparison of TIRAP and TRAM functioning. 
• Both TIRAP and TRAM act as a sorting adaptor controlling the initiation stage 
of the TRIF-dependent signaling pathway from the endosomal compartment (Kagan et 
al., 2008) . 
• TRAM exist at both plasma membrane and early endosomes, but TIRAP are not 
observed at endosomes ( Kagan et al., 2008). 
• Both TIRAP and TRAM has polybasic domains which are common motifs 
found in proteins having binding ability to acidic phospholipids. While TRAM and  
many acidic phospholipids binds to each other in detectable amounts, TIRAP rather 
bind with Ptdlns(4,5)P2 (Kagan and Medzhitov, 2006). Possibly myristate group 
provide a nonspecific binding ability to TRAM, so it does not require specific 
phospholipids binding domain on it. 
• Both TRAP-MyD88 and TRAM-TRIF adaptor pair can bind to the same site on 
the TIR domain of TLR4 , Nuez et al. (2007), but bind sequentially (Figure 1.2). 
TRAM: 
•       TRAM is expressed both in early endosomal compartments and at the plasma 
membrane (Kagan et al., 2008). 
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•       Mutant cells having no TRAM at the plasma surface can also produce type I 
interferon (Kagan et al., 2008). 
•      Disruption of TLR4 endocytosis by dynasore (inhibitor of dynamin) interrupts 
the TRAM-TRIF-dependent phosphorylation of IRF3 and so IFN-" (Kagan et al., 
2008). 
 
 
        Figure 1.2: TIRAP-MyD88 and TRAM-TRIF interaction with TLR4 receptor1.  
•    TRAM-TRIF-dependent signaling pathway is induced consequent to the 
endosomal localization of TLR4 (Figure 1.2) and from the endosome (Kagan et al., 
2008). 
• TRAM has bipartite motif (composed of myristate group subsequent to 
polybasic domain), both of which is essential for plasma membrane targeting but for 
endosomal localization only myristoylation is required (Kagan et al., 2008). 
TRIF: 
• Leads to chemokines such as IP-10 (Doyle et al, 2002) 
• Downstream is common both in TLR4 and TLR3 cascades (Yamamoto et al., 
2003).  
• Responsible for late NF!B activation (Sato et al., 2003).  
• Associates with TRAF6 via its TRAF6-binding motifs in its N terminal region 
and lack of this region hinders TRIF dependent NF!B activation (Sato et al., 2003). 
 
_____________________________________________________________________ 
1Figure is drawn to summarize the receptor metabolism reported by Kagan et al., (2008). 
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RIP: 
In TLR3 pathway it is shown that RIP1 combine with TRAF6 and TAK1 by 
polyubiquitination than their complex cooperatively facilitate TAK1 and result in 
robust NF!B activation (Kawai and Akira, 2007). 
TRAF3: 
• TRAF3 is only common component in TLR7, TLR9 (signals via MyD88-dependent 
IRF7 activation, Honda et al. (2005); Kawai et al. (2004)), TLR3 and TLR4 (signals 
via TRIF-dependent IRF3 activation (Doyle et al., 2002; Oshiumi et al., 2003)). 
MyD88 independent pathway includes TRAF3 and its downstream. 
• Dissimilar to the TRIP and TRAM, it is rather localized in the intra cellular 
compartments and it can not involved the cell surface as a part of TLRs pathway 
(Kagan et al., 2008). 
• It can act at plasma membrane by engaging with CD40. TLRs and CD40  
downstream are different (Xu, Cheng and Baltimore, 1996; Hostager, Catlett and 
Bishop, 2000). 
•To interact with TRAF3, endosomal internalization of TLR4 is required (Kagan et al., 
2008). 
•Production of type one interferons via TRAF3 can only be triggered by internal TLRs 
(Kagan et al., 2008). 
• Despite endosome located TLR3, TLR4 signaling is mediated by TRAM for the 
activation of TRIF-TRAF3 (Kagan et al., 2008). 
• TRAF3 form a connection between TRIF and TBK1 (Hacker et al., 2006; Oganesyan 
et al., 2006; Kawai and Akira 2007) 
TANK-TBK-IKKi Complex: 
TBK1 and IKKi is required for IFN" activation, Kawai and Akira (2007), but not for 
NF-"B in TLR mediated activation (Hemmi et al., 2004; Kawai and Akira, 2007). 
TBK1 and IKKi role in MyD88 independent pathway is phosphorylation of IRF3. 
IKKi deficiency does not alter IRF3 and IFN activity in the presence of TBK1, Hemmi 
et al. (2004), but increase the effect of TBK1 absence and ceases  IRF3 and IFN" 
activity (Hemmi et al., 2004; Kawai and Akira, 2007). 
IRFs: 
The IRFs are protein families having extremely important roles in infections and the 
host responses (Barnes, Lubyova and Pitha, 2002). IRF1 acts as transcriptional 
activator and IRF2 as repressor (Katze et al., 2002). IRF 1, IRF3, IRF5 and IRF7 are 
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transducers of immune response to viruses. (Katze et al., 2002). IRF3 has an important 
role in LPS stimulation. IRF3 activation is controlled by TRIF dependent pathway and 
not by MyD88 (Kawai et al., 2001). Before bacterial and viral stimulation, IRF3 is 
present in cytoplasm in an active form. Infection trigger TBK1 and IKKi to 
phosphorylate C- terminal region of IRF3 and phosphorylated IRF3s form a 
homodimers than goes to nucleus (Kawai and Akira, 2007). Over there IRF3 combine 
with NF-!B and ATF2/c-Jun to form a complex namely enhanceosome and target the 
promoter-enhancer side of the IFN" gene (Honda et al., 2006). In general IRFs that 
enter the nucleus can either take role in activation or repression of the IFNs/IFN-
regulated genes (Katze et al., 2002). 
There are numerous other factors regulating the TLR4 pathway (Lu et al, 2008). But 
from the computational aspect, constitutive activity of these regulators can be ignored 
in the case of either not being induced or showing no change by induction originating 
from the activity of pathways that we concern. 
Inhibitory proteins like A20, IRAK-M, I!B# can be induced by the effect of LPS. A20 
can inhibit ubiquitination of TRAF6, in turn down stream signaling (Lu, Yeh, Ohashi, 
2008). Targeting of RIP1 by A20 in TNF signaling pathway, Wertz et al. (2004), 
indicates a similar possibility for RIP1 in TLR4 signaling (Lu, Yeh, Ohashi, 2008). A 
recent study indicates induced expression is critical for the functioning of I!B# in 
NF!B expression but not for that of A20 (Werner et al., 2008). 
IRAK-M inhibits MyD88 downstream by preserving IRAKs-MyD88 complex 
(Kobayashi et al., 2002; Janssens and Beyaert, 2003).  
1.2.2  Interferon beta pathway 
IFNs are mainly classified in to three groups as Type I, Type II and Type III IFNs 
(Katze et al., 2002; Gad et al., 2009). Inspired from their induction in response to viral 
products like double stranded RNA, Type I IFNs also called as viral IFNs (Katze et al., 
2002) and they play active role in mucosal immunity to viral infection (Smieja et al., 
2008). Especially IFN" is very important among type I IFN because of being secreted 
by epithelial cells first encountering with viruses. IFN" discovered in chick cells after 
infection of heat inactivated influenza virus (Isaacs and Lindenmann, 1957). 
After the detection by their cell-surface specific receptors (IFNAR1/2), Type I 
Interferons result a signaling cascade through the IFNAR associated tyrosine kinases 
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phosphorylation of the signal transducers and activators of transcription (STATs) via 
Janus kinases (JAKs) (Katze et al., 2002). Phosphorylated STAT1–STAT2 forms 
homo and heterodimers and heterodimmers are recruited to ISRE, Taniguchi and 
Takaoka (2001), sequences together with IFN-regulatory factor 9 (IRF9) by forming 
ISGF3. STAT1 dimers and ISGF3 function as active transcription factors upon their 
transport into the nucleus (Smieja et al., 2008). Most of the STAT1-STAT2 
heterodimers form the ISGF3 complex, thus the contribution of the isolated 
heterodimers to the signaling pathway can be neglected (Smieja et al., 2008). STATs 
dephosphorylation occurs both in the nucleus and cytoplasm. Dephosphorylation 
causes destruction of the complex and removal of STATs from the nucleus, STATs in 
the cytoplasm are again available for phosphorylation and process goes so on so forth 
(Smieja et al., 2008). In our model we represent this process simply by activation and 
deactivation of ISGF3 both in the cytoplasm and nucleus. In the model increase in the 
phosphorylation after IFN" treatment correlated with the higher internalization rate 
introduced by IFN#. Even constitutively active phosphate exists, additional phosphates 
induced by IFN# function in the regulation of STAT1 homodimers (Smieja et al., 
2008). Such a change can also be a matter of fact for STAT1-STAT2 heterodimer and 
so ISGF3 regulation, but in this preliminary model it is kept out of concern.  
To prevent overshooting endogenous regulation of Type I IFN includes negative 
feedbacks at multiple points provided by suppressors of cytokine signaling (SOCS), 
Schmitz et al. (2000);  Qin et al. (2008); Song and Shuai (1998); Pauli et al. (2008); 
Starr et al. (1997); Endo et al. (1997); Yasukawa et al. (1999); Yamamoto et al. 
(2003); Dalpke et al. (2008); Giordanetto and Kroemer (2003), protein inhibitor of 
activated STATs (PIAS) and SH2 containing phosphates (SHP) proteins (Wormald 
and Hilton, 2004). SOCS-1 and SOCS-3 are important in Stat 1 and STAT 3 
regulation and act on different nodes (Schmitz et al., 2000; Qin et al, 2008; Song and 
Shuai, 1998; Pauli et al., 2008). SOCS-1 and SOCS-3 are also suppressors of TLR 
mediated responses and can be triggered by signals from TAM -Tyro3, Axl, and Mer -
receptors (Kawai and Akira et al., 2009; Starr et. al, 1997). While SOCS-1 exerts 
negative feedback on the tyrosine kinase activity of JAKs and concomitantly suppress 
activation of STATs, Starr et al. (1997); Endo et al. (1997); Yasukawa et al. (1999), 
SOCS-3 can also act at the cytokine receptor level regulating JAK-STAT pathway 
activation (Schmitz et al., 2000; Yamamoto et al., 2003). SOCS1 is a critical factor in 
the downstream of TLR4 pathway, its deficiency leads mice to be very vulnerable to 
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LPS mediated septic shock (Nakagawa et. al., 2002; Kinjyo et al., 2002). TLRs 
directly induce SOCS but SOCS proteins interfere with IFN-" signaling and prevent 
TLR dependent overshooting in an indirect way (Dalpke et al., 2008). SOCS-1 exerts 
negative feedback on JAK2 either by protruding toward the catalytic region and 
inhibiting kinesis activity or by letting proteasomal degradation (Giordanetto and 
Kroemer, 2003). Some experiments indicated that SOCS1 is not induced in IFN# 
stimulated cells (Smieja et al., 2008). Despite SOCS1, SOCS-3 transcribed at early 
stages of virus attack in a type I IFN independent manner. SOCS-3 deficient cells 
show a prolonged STAT1 activity resulting with increased levels of corresponding 
genes. Thus early response of SOCS3 has a possible role in suppression of the 
antiviral response (Rothlin et al. 2007; Kinjyo et al., 2002). Many of PIASs can 
sumoylate STATs and upon this sumoylation block its transcriptional activity 
(Schmitz et al., 2000). SHP1 can also be a limiting factor in JAK1 and STAT1 
activation restricting both the amount and duration. SHP1 have also role in basal level 
regulation of JAKs (David et al., 1995). 
While TLR4 pathways trigger interferon pathway via IRFs activation and concomitant 
IFN-" production, induction of IRFs by IFNs also enhances the response of IFN-
stimulated cells to TLRs (Smieja et al., 2008; Sato et al. 1998).  
ISGF3 acts on ISRE side of promoter region and function in transcription of PKR 
(Taniguchi and Takaoka, 2001).  
Early and late genes in this pathway evolve distinctly and are controlled by distinct 
transcription factor. Binding of STAT1 homodimers to the GAS site of the promoter 
region and the resulting expression of IRF1 gene form the early response of the system 
(Smieja et al., 2008). Primary transcription factor for IRF1 gene is STAT1 
homodimers and STAT1 homodimers mainly affect late system response trough IRF1 
gene. The heterodimers has weaker affinity to GAS region and if it binds, block the 
functioning of GAS. However, amount of free the heterodimers is very restricted in 
the nucleus (Smieja et al., 2008). This mechanism negatively regulated by 
dephosphorylation of the homodimers in the nucleus and the control mechanism on the 
early gene expression is independent to the blocking of STATs dephosphorylation at 
the level of IFNAR (Smieja et al., 2008). 
Upon its synthesis, IRF1 enters to the nucleus and consequently controls late gene 
expression such as TAP1/LMP2 and STAT1 (Smieja et al., 2008). There is a 
significant delay, about two hours, between the peak of IRF1 in the nucleus and that of 
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transcription of genes (Smieja et al., 2008). IRF2 have a negative regulator role in 
IRF1 gene transcription, Harada et al. (1994); Kroeger et al. (2002), and as a 
transcriptional attenuator by interfering with ISGF3 mediated ISGE activation, 
Taniguchi and Takaoka (2001); Hida et al. (2000), which in turn affects ISGF3 
dependent PKR activity. Induction of IRFs by IFNs also enhances the response of 
IFN-stimulated cells to TLR and RIG-I pathways (Sato et al., 1998; Smieja et al., 
2008). In the late response of this signaling pathway IRF1 transportation to the nucleus 
is blocked (Smieja et al., 2008).  
1.2.3 NF-!B circulatory network  
An important cellular signaling network is that of the nuclear factor-!B (NF-!B). The 
NF-"B family of transcription factors and signaling components exist in almost every 
differentiated cell types (Hoffmann and Baltimore, 2006; O’Dea and Hoffmann, 2009; 
Oeckinghaus and Ghosh, 2009). They have important roles in regulation of cellular 
survival signals, immunity, i.e., immune cell differentiation, organogenesis, 
inflammation and is subject to multilevel control mechanism (Li and Verma, 2002; 
Hoffmann and Baltimore, 2006). In response to the triggering signals, NF-!B targets 
over 150 genes (Pahl, 1999). NF-"B mediates cellular responses to lipopolysaccharide 
(LPS), interleukin IL and Tumor necrosis factor # (TNF') stimulation in different 
ways. Activation of NF-"B dimer is induced by phosphorylation of the inhibitor 
protein canonical I"B isoforms, namely, I"B', -#, and –( and the precursor proteins 
p105 and p100, thereby destruption of NF-"B-I"B complex (Ghosh et al., 1998, 
Hoffmann and Baltimore, 2006). Five different proteins form NF-"B family. i.e., cRel, 
RelA, RelB, p50, and p52 (Figure1.3A) (Ghosh et al., 1998; Hoffmann and Baltimore, 
2006). Functionally they form dimers and the confirmation, in turn binding ability to 
DNA is determined by binding partner (Hoffmann and Baltimore, 2006). The 
conformational change introduced by I"B effect the DNA-binding activity of NF-"B 
(Hoffmann and Baltimore, 2006; Kearns et al, 2006). NF-"B nuclear accumulation is 
also controlled by I"B isoforms (Ghosh et al., 1998). 
Hoffmann et al., (2002) developed a heuristic mathematical model based on ordinary 
differential equations and the role of I"B protein family feedback mechanisms in the 
fine tuning of time-varying NF-"B expression, due to the harmony in their activation 
and degradation mechanisms (Cho et al., 2003; Hoffmann 2002). The model supplied 
precious information about the roles of I"B isoforms, the bimodal nature of NF-"B 
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signal, and the gene expression specificity (Cho et al., 2003). Another ODEs model for 
TNF' was performed by complementing the enzyme kinetics to map the whole stages 
in retrieving concentration of reaction species at the steady state into a graphical form 
and transforming each stages into mathematical language via bunch of ODEs. 
Ensemble of the kinetic ODEs finally was resulted in a computable model explaining 
the signaling cascade regulating NF-"B through TNF' (Cho et al., 2003). Utilization 
of this kind of methodology for the LPS mediated NF- "B signaling can also result in 
well-designed and easliy traceable  mathematical models for TLR4 pathway.  
 
Figure 1.3: NF-"B combinatorial structure, NF-"B, I"B genes, polypeptides and 
dimmers (Hoffmann and Baltimore, 2006). Among 15 transcription 
factors (B) formed by hetero- and homo-dimerization of five different 
NF-"B polypeptides (A), only nine dimers at the top four rows can act as 
transcriptional activators in addition to having DNA binding ability. The 
fifth row represents dimers not having domains for transcriptional 
activation and the last row for dimers without DNA binding ability. The 
light blue boxes indicates Rel homology domains of NF-"B monomers 
that function in NF- "B dimerization and in binding to DNA and I"B 
proteins. (Hoffmann and Baltimore, 2006). 
Despite its damped oscillatory nature in response to TNF', NF-"B expresses stable 
behaviour to LPS stimuli in wild-type cells. LPS triggers immune signals through 
TLR4 and downstream comprises two branches of signaling cascade both resulting in 
TNF' type damped oscillatory NF-"B activity through the canonical pathway of NF-
"B, namely MyD88-dependent and MyD88 independent pathways (Covert et.al, 
2005). TNF' triggers the canonical pathway of NF-"B only once, however, LPS 
activates it once directly through MyD88 and once as secondary response following 
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the transcription of TNF' through MyD88 independent pathway (Covert et.al, 2005; 
Lee et al., 2009). A computational model elucidated that coupling of two antiphase 
oscillatory signals coming through MyD88-dependent and MyD88 independent 
pathways with a 30 min time lag is the one of the sources of LPS dependent stable 
early NF-"B activity. The delay originates from the time elapses to induce TNF# 
through MyD88-independent pathway (Covert et.al, 2005). 
In a recent study, it is shown that another reason behind the stable behavior of NF"B 
in LPS stimulated pathway hides in the delay of induced activation of I"B( with 
respect to that of I"B'. This late negative feedback on NF-"B activation prevents the 
long term oscillations in the system and regulates the cell type specific NF-"B activity 
(Kearns et. al, 2006). 
NF-"B is a vital transcription factor and such a critical immunoregulator naturally 
needs to be controlled by complex network of interactions to sustain a robust innate 
immunity. The following schematic (Figure 1.4) represents such a network of 
interaction regulating NF-"B (p50, p65) between cascades triggered by LPS, IL,IFN" 
and TNF# stimulations. 
 
                                  Figure 1.4 :  NF"B (p50, p65) regulation. 
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As previously mentioned, the characteristic of NF!B response strongly depends on the 
duration of stimuli, even very brief signal leads to significant amount of transient NF"
!B and if the stimulus is longer than one hour, NF"!B is sustained in an extent 
proportional to the duration of stimulus (Hoffman et al, 2002). This characteristic is 
not only restricted to NF"!B expression but it also can be observed in various gene 
expressions (Hoffman et al, 2002).  
1.2.4 PKR connection between IFN"  and TLR4 pathway 
There is some evidence indicating TLR4 and IFNAR pathways are connected through 
dsRNA-activated protein kinase (PKR) activity, Horng, Barton and Medzhitov (2001), 
and in turn through the translational inhibition of I"B (Levy and Garcia-Sastre, 2001; 
O’Dea et al., 2008). It is known that LPS activates IFN" transcription through the 
TRIF dependent pathway, Kawai et al. (2001);  Yamamoto et al. (2003), and PKR is a 
crucial factor in the antiproliferative effects and antiviral defense regulated by 
interferon (Katze, 1995; Balachandran et al., 2000). PKR impinge on upstream of 
IKK, Zamanian-Daryoush et al. (2000), and activates NF-!B by binding IKK# 
irrespective of its kinase activity (Chu et al, 1999; Bonnet et al, 2000). A justification 
for NF-"B activation under the influence of PKR is the induction NF-"B dependent 
survival genes (Wang et al, 1998; Karin and Lin, 2002). Induction of NF-"B as 
concomitance of eIF-2a phosphorylation cause a delay in PKR induced apoptosis 
(Donze et al., 2004). 
Viruses utilize the host defense system against itself by producing cellular stress 
response that blocking PKR activation and resisting initiate IFN response (Katze et al., 
2002). It is indicated that PKR is also a mediator in cell differentiation and growth 
control, Koromilas et al. (1992); Donze )et al. (1995); furtheremore, since its 
overexpression causes apoptosis, Balachandran et al. (1998); Donze et al. (1999), it 
can be effective in tumor suppression (Meurs et al, 1993; Barber et al, 1995; Donze et 
al., 2004). 
In summary PKR works as a molecular clock in two distinct and opposite phase in 
sequential manner, Donze O. (2004); namely an early enhancement of cell survival by 
acting on IKK#, Zamanian-Daryoush et al. (2000); Bonnet et al. (2000), and inducing 
NF"B, Chu et al. (1999); Bonet et al. (2000), and as a result of viral replication cycle a 
late induction of apoptosis by its kinase activity (Lee et al, 1997; Donze ) et al, 1999; 
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Donze O., 2004). 
One striking example that forms the basis of our research for PKR expression is the 
translational inhibition of I"B as a result of stress responses induced by UV radiation 
and ribotoxic agents. According to the existing evidence, translational inhibition of 
I"B in response to the UV radiation results from the phosphorylation of eukaryotic 
initiation factor-2# (eIF2#) by the effect of eIF2# kinase (PERK) (Jiang and Wek, 
2005; Wu et al., 2004). Similarly protein kinase PKR activity induced by IFN" results 
the phosphorylation of eIF2#, which indicate a possible translational inhibition 
process of I"B and so increased NF"B activity (Figure 1.5).  
Although the study first performed for UV radiation, it is also shown that the presence 
of other ribotoxic agents can also have similar effects and the surplus I"B synthesis 
and degradation seems to be evolved so that I"B provides resistance of NF"B 
signaling module to such kind of agents (O’Dea et al., 2008). 
 
                            Figure 1.5: LPS and IFN" stimulated pathways. 
It has been in silico demonstrated that the change in the NF"B level according to 
translational inhibition depends also on the I"B degradation rate. When the turnover 
rate of I"B increases, sensitivity of NF"B activation to the translational inhibition of 
I"B increases. In addition this sensitivity also depends on IKK activity, if IKK is not 
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activated there is no such sensitivity and increasing activity rate of IKK increase the 
sensitivity further. So while the maximum level of NF"B activity is determined by 
IKK activity, it is fine tuned by both I"B degradation and translational inhibition rates, 
O’Dea et al., 2008, which can be depended up on to PKR activity. 
p53 cause induction of PKR, Yoon et al. (2009), and PKR activates NF"B (Donze et 
al., 2004). While the previously mentioned sequential program on cell survival 
triggered through NF"B and planned cell death by phosphorylation of elf-2' is 
regulated by PKR, PKR is regulated by outcomes of this sequential activity. 
DNA damage cause p53 induction and p53 leads cell apoptosis, so tumor-suppression 
(Amundson et al., 1998; Yoon et al., 2008). Genotoxic stress dependent p53 activation 
results with a significant level of PKR synthesis though the cis-acting element (ISRE) 
(Yoon et al., 2008). p53 induced PKR resulting from the stress of DNA damage is 
significant in the intracellular network part of the tumor-suppressor function of p53 
(Yoon  et al., 2009). A resistance to apoptosis arises in the absence of p53 target genes 
(Villunger, et al 2003). 
 
Figure 1.6: Under the DNA damage PKR expression induced by P53 and concomitant                           
tumor inhibition mechanisms (Yoon et al., 2000). Redrawn based on the   
original figure. 
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As a homeostatic control mechanism PKR exerts a negative feedback on p53. Under 
genotoxic conditions this negative feedback may not be enough to overwhelm p53- 
induced apoptosis (Yoon et al., 2009). Knocking out PKR results with cells faster 
growing cells both in vivo and in vitro. Human tumor tissues having undetectable 
levels of P53 usually have lower PKR expression relative to normal ones (Yoon et al., 
2009). Figure 1.6 summarises the mechanisms under the DNA damage how PKR 
expressed and tumor suppression. 
1.2.5 Biologically important mechanisms 
1.2.5.1 Feedbacks 
Many natural biological systems utilized feedbacks. Without feedbacks, control 
systems are highly sensitive to disturbances and parameter changes of the processes or 
transfer functions. Continuous response, following the decay of transient response 
suffers from errors called as steady state errors. Closed loop feedback systems reduce 
the steady state error by continuously monitoring it and applying actuating signal. 
They are also used in the adjustment of transient response (Dorf and Bishop, 2008). 
A single negative feedback loop (Figure 1.10) can function as basal homeostat, 
adaptation, transient generator and output limiter (Brandman and Meyer, 2008). These 
four different function are consequences of its the initial conditions and characteristics 
(Brandman and Meyer, 2008). Depending on same reasons a single positive feedback 
motif can function as signal amplifier, bistable switches creator, and timing adjuster of 
a signaling response (Brandman and Meyer, 2008). Mixed feedback motifs  containing 
both positive and negative feedbacks can provide systems with oscillations or 
polarization (Brandman and Meyer, 2008). 
 
            Figure 1.10: An equivalent transfer function of single feedback system. 
Even though, adding feedback to the control systems provides several advantages, it 
also brings some cost like increasing the number of components and complexity. In 
addition, it can result with instability in the system. One handicap arose from the loss 
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of gain by a factor of 1/(1+Gc(s)G(s)), which is exactly corresponding to previously 
mentioned sensitivity decrease to parameter changes and disturbances. However, 
mostly utilities provided by feedbacks overweight these disadvantages (Dorf  and 
Bishop, 2008). 
1.2.5.2 Oscillation 
The mechanisms of regulatory and signal transduction networks do not only rely on 
shifts in protein concentration between steady states, temporal variation propagating 
through networks in a complex manner also carries information (Tina et al., 2007). 
There can be many roles of oscillating signals in biological network so it is important 
to find answers to question like: how cellular processes utilize temporally varying 
signals? how are oscillations genetared through the network? (Tina et al., 2007), why 
does oscillations start up in response to some agent or damage and what are the 
sufficient conditions? (Tina et al., 2007), are oscillations only a by product of adoption 
or has evolutionary significance? (Cheong and Levchenko, 2010), is there an 
information decoded in oscillations or a non-oscillating system can work equally well? 
(Cheong and Levchenko, 2010). 
As mentioned before I!B has isoforms inactivating NF-!B both in the nucleus as well 
as in the cytoplasm. These isoforms have different profiles and differently function on 
expression. Some of them transcriptionally activated by NF-!B and provide a negative 
feedback. A simple sketch of the feedback loops controlling the concentration NF-#!B 
is given in Figure 1.7. 
 
Figure 1.7: A sketch of the feedback loops controlling the concentration NF-!B 
(Tiana et al., 2007). Redrawn based on original figure. 
Experiments on wild-type cells and knockouts expressing only I!B$# (knockout I!B$ 
mutants are not viable)#"#$%!damped oscillatory behavior (Figure1.8) # illustrated the 
potency of this feedback loop in generating oscillations  in the nuclear import and 
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export of NF-!B (Hoffmann et al., 2002; Tiana et al., 2007). These results suggest that 
the NF-!B oscillations arise due to the the fast activation and regulation with the 
intense negative feedback (Hoffmann et al., 2002). 
The effect of I!B! deficiency observed as non-oscillatory NF-!B behaviour. I!B" and 
I!B( give slower response to IKK. During the long term stimulations they function to 
suppress the oscillations. Different behaviors of I!B!, I!B" and I!B( let them act 
together to give substantially fast response to sudden changes in triggering signal such 
as start up or end of IKK activity and lead to stable NF-!B concentrations in the case 
of  long-lasting stimili (Hoffmann et al., 2002). 
 
 
Figure 1.8: NF-!B nuclear localization predicted by a computational model.                                                                                
(Hoffmann et al., 2002) 
In monotone two variable systems having negative feedback loops, either explicit time 
delay or giving up monotonicity is necessary condition on the oscillations (Tiana et al., 
2007). Requirement for explicit time delay can be compensated by introducing a finite 
minimum time for processes and by introducing intermediate steps (Tiana et al., 
2007). If such a system is resolved by rate equations, the time ellapsed between two 
binding reaction assumed to obey Poisson distribution, in other words it is less than 
the average time seperating the reactions (Tiana et al., 2007). On the other hand, 
molecular processes can require some time and before this time is reached output can 
be taken as 0 and after 1 (Tiana et al., 2007). In addition to that a constraint restricting 
the degradation rate of one species with an upper limit, namely saturated degradation, 
can produce an effective time delay in the system. These kinds of mechanisms are 
widespread in biological systems and a good example is NF-!B regulation (Tiana et 
al., 2007). If there exist a positive feedback of a molecule on its own production 
a) wild type cell response 
b) mutants exhibiting the effects of I!B" 
isoform 
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(autocatalysis), oscillations can also occur. Autocatalysis is a necessary condition for 
oscillations in two variable systems having no explicit time delay (Guantes and 
Poyatos, 2006; Conrad, 1999; Tiana et al., 2007). Presence of autocatalysis results in 
non-monotonic system behavior (Tiana et al., 2007). Moreover, a nonlinearity in the 
reaction equations allows some of the variables to give sharper response to changes 
than that in linear fashion and in turn can leads oscillations (Tiana et al., 2007).  
Negative feedbacks are one of the prominent way in adaptation to persistent 
environmental signals, response time to adapt depends on the strength of the feedback 
and according to which either an overshooting or oscillation can occur (Cheong and 
Levchenko, 2010). 
An oscillating signal can transmit more information than a steady signal, and 
oscillations, particularly spiky oscillations, have many useful properties to ameliorate 
the efficiency and to increase the speed of signaling and response systems (Tiana et 
al., 2007). A prominent example to the networks exhibiting spiky oscillations is NF-
!B network given in Figure 1.9. Despite the views on the effect of NF-!B oscillations 
characteristics on consecutive cell responses, Nelson et al. (2004), many aspect of 
these effects still not clear (Barken et al., 2005). Many ubiquitous eukaryotic signaling 
molecules also demonstrate spiky behavior (Tiana et al., 2007). Being continuously 
subjected to a high constant level of hormones and other chemicals might  have 
undesirable results for the biological system and such a constant level can lead a 
saturation of a common receptor that also used by other signals. However, this 
problem can be overwhelmed in the case of spikes and oscillations (Tiana et al., 2007).  
The oscillatory activation of a gene expression can initiate different cascades 
depending on the sensitivity of the gene to the oscillations. For example, it is possible 
for a single downstream gene to have a role as low-pass filter (Tiana et al. 2007; 
Krishna et al. 2006). There can be interaction between different oscillators and one of 
them can entrain the other as in the case of day-night periodicity and circadian rhythm 
(Cheong and Levchenko, 2010). 
In biological systems, with the same logic of Fourier transform, a particular frequency 
response can be attained by regulatory circuits with suitable number of multiple 
components.  
Figure 1.9 illustrates the some of the important interactions in the NF-&B system 
,Tiana et al. (2007), which can be summarized as: 
??I!B forms a complex with NF-!B both in cytoplasm and nucleus. 
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??The NF!B-I!B complex cannot be transported into, but can go out from the nucleus. 
?? IKK cause proteolytic degradation of the cytoplasmic NF!B-I!B. Only I!B 
degradate as a result of this process (this degradation does not occur for free I!B) and 
NF-!B releases. 
????ree NF-!B transposted in to the nucleus via an active transport process, however, 
wise verse is not true. 
??NF-!B in the nucleus, stimulate transcription of the I!B$#gene which is the source of 
the I!B mRNA in the cytoplasm. 
??The I!B protein is synthesized by translation of the I!B mRNA in the cytoplasm. 
??The I!B protein transportation can be in both directions from the membrane of the 
nucleus. 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.9:  Some of the important part of the NF-"B regulatory system. Transcription  
and translation represented by green arrows, transport processes by blue, 
complex formation purple, and degradation of I"B from NF"B-I"B 
complex by red dashed ones (Tiana et al., 2007).  
Other important characteristics for the singnaling module can be summurized as: 
• Even short stimulations cause substantial NF-!B responses; correspondence of 
initial NF-!B response to duration and dose is very low (Cheong et al., 2006). 
• NF-!B activation shows high sensitivity in response to an extremely wide 
range of TNF concentrations (Cheong et al., 2006).  
• IKK activity can both induce and reduce (via the the phosphorylation of RelA 
by IKK itself) NF-!B expression (Hoffmann and Baltimore, 2006; Lawrence et 
al., 2005). 
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• NF-!B has ‘bimodal signaling characteristic’; while showing only one peak for 
stimulations shorter than one hour, activity of it directly proportional to the 
duration of a longer stimulus (Hoffmann et al., 2002). 
• I!B# exerts negative feedback on NF-!B expression (Hoffmann et al., 2002). 
• I!B" insert a positive feedback in NF-!B activity inside nucleus, by 
preventing nuclear export (Suyang et al.,1996; Phillips and Ghosh, 1997). 
• I!B$ produce late feedback on NF!B expression and a negative deviation in 
I"B( level allow prolonged activity of NF-"B but this not valid in presence of 
over expressed I"B' (Hoffmann et al., 2006). 
• Substantial amount of NF-!B is activated even in the case of very short 
stimulus (Hoffmann et al., 2002). 
• One of the reasons behind stable behavior of NF!B in LPS stimulated pathway 
hide in the about 45 minute delay of induced activation of I!B$ with respect to 
that of I!B# (Hoffmann et al., 2006). 
• Different behaviors of I!B#, I!B" and I!B$ let them act together to reply 
substantially fast to changes in the amount of IKK and let to stabilization in 
NF-!B activity in long-term (Hoffmann et al., 2002). 
• Feedback mechanisms controlled by NF-!B, A20 and IRF3 in the whole LPS 
and TNFR signaling pathway, let time dependents expression of IKK activity 
characteristic to the stimulus and to the pathway, which result in NF-!B 
activities and gene expressions specific to each particular case (Hoffmann et 
al., 2005). 
• Binding ability of NF-kB shows variation according to the constituting dimers 
and this can change transcriptional activity (May and Ghosh, 1998; Udalova et 
al., 2000; Li and Verma, 2002). 
• Amplitude of initial IKK activity does not have an influence on NF-"B 
concentration and duration (Hoffmann et al., 2005). 
• The duration of the initial peak in IKK activity changes NF-!B activity profiles 
(Hoffmann et al., 2005).  
• IKK activation rates alter that of NF-!B. Deactivation rates has little influences 
on NF-!B activation and only become apprehend by increasing towards the 
late activity of the NF-!B profile and leads no change in initial peak 
(Hoffmann et al., 2005). 
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• Sudden sharp impulses of IKK lead only little NF-!B activity. The effect of 
such a short but high increase is very similar to that of a long in duration but a 
small in amplitude. Both result in an NF-!B activity profile that persists much 
longer than the duration of the transient pulse of IKK activity (Hoffmann et al., 
2005). 
• The level of NF-!B concentration at late activity is mainly determined by that 
of IKK and presence of a second plateau in IKK activity has an important role 
in the late NF-!B activity and biphasic nature of it (Hoffmann et al., 2005). 
Experiments indicate such a two altered level of activity behavior for IKK 
(Cheong et al., 2006). 
• The free NF-!B leads transcription of the ubiquitination enzyme A20 which 
act as catalyzer inhibiting IKK transformation to an inactive form (Lee et al., 
2000; Lipniacki et al., 2004). 
1.2.5.3 Delay times 
In biological systems delay times can be originated by time necessary for transport of 
mass or energy and by the addition of time lags to each other due to the series 
connection of many low-order systems (Normey-Rico, 2007). In standard feedback 
controllers introduction of dead or delay times to the process brings difficulties in the 
control. Until considerable time has passed concomitance of disturbances can not be 
felt and errors caused by a previous situation is tried to be corrected at a later time 
after losing its validity. Delay time leads further decrease in the phase of system and 
so that of transfer function gains margin and in return results in instability (Normey-
Rico, 2007). 
1.2.6 Tools of system biology 
Before proceeding further inside into methods that will utilized in this study, it worth 
to overview different methods used in computational system biology. They can be 
summarized as (Materi and Wishart, 2007): 
• ODEs: In this method sets of ordinary differential equation type reaction rate 
equation are numarically solved. The advantages of this technique are its 
having well-defined formalism, its speed, deterministic and mathematically 
robust nature. The disadvantages are being brittle and restricted to temporal 
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modeling, presuming high concentrations and uniform distribution (Materi and 
Wishart, 2007).  
• Stochastic Modelings: Stochastic time evolution of a system is Modeled by an 
algorithm (Gillespie algorithm), Gillespie (1977), including a numerical 
approach to traditional stochastic differential equation formalism of chemical 
kinetics called as “master equation” (McQuarri, 1967). The algorithm based on 
Monte Carlo type methodology and utilizes random number generators. It is 
fast and robust method effective in modeling trace amounts of reaction 
members. On the other hand it is nondeterministic and restricted to time 
dependent modeling (Materi and Wishart, 2007). 
• S-system formalism or power law equations: It utilizes Taylor approximation 
to recast non-linear ODEs model and deciphers the biological systems by 
transforming the related steady state DEs to easily solvable linear equations 
with considirable simplifications. It is fast and allows rapid parameter testing. 
It is circumscribed to events and processes pertaining to time (Materi and 
Wishart, 2007). 
• PDE or molecular dynamics: It represents a system on spatiotemporal basis by 
means of solving partial derivatives with numerical approaches. The outputs 
are in numaric form given as concentrations and cartesian coordinates. It has a 
clear formalism, can be fast, robust in mathematical aspect and let the system 
model in a dimension of both space and time. However, it is complex, 
generalization is difficult, also tough to put into practice and brittle. It is not 
suitable for discontinous state transitions (Materi and Wishart, 2007). 
• Petri nets: It is executable graphical alternative of ODEs for modeling time-
dependent and discrete processes based on flowcharting technique between 
places (states), transitions (actions) and directional connections (D’Angelo, 
1983; David and Alla, 2005; Materi and Wishart, 2007). There exist also 
continous and hybrid versions of them (David and Alla, 2005). In the case of 
multiple inputs, signals from different branch of input weigthed to activate the 
down stream of events. It is a promising tool for asynchronous occasions, 
operation synchronization, concurrent operations, resource allocation and 
conflicts (Zurawski and Zhou, 1994). It has subclasses as colored petri nets, 
hybrid Petri nets, stochastic petri nets and timed Petri nets. It immiates 
telephone switchboard or load management in power-grids. It is suitable for 
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implementing nonmathematical and allows both qualitative and quantitative 
models. It also has the same problem of limiting to temporal modeling as 
previously mentioned ones. In addition to being less developed than ODEs, is 
widely applied in non linearization (Materi and Wishart, 2007). 
• Cellular automata (CA): This technique models time and space processes on a 
grid based approach in which simple Boolean logic rules out the neighboring 
objects interactions. It gives animated and numerical results. It permits both 
qualitative and quantitave modeling of time and space processes, simple to 
implement, and non mathematical but has the disadvantage of computational 
cost for large number of objects and having no basic conversion from rate 
constants. It is not as mature technique as ODEs and PDEs (Materi and 
Wishart, 2007). 
• Agent based models (ABM): Each model member, i.e., proteins, drugs, cells, 
designed as agents that can spatiotemporaly interact with each other according 
to some predetermining rules. While the rules can have either physical or 
complex knowledge basis, agents can have Brownian type or directed motions. 
It has similar properties with CA methodology but with a difference of not 
having formally essential spatial grids or synchronized time steps. However, in 
terms of practical aspects these constraints are widely employed in coding 
stage (Materi and Wishart, 2007). 
•  Pi calculus: It examines concurrent computational processes interacting with 
transfer of synchronized messages and having dynamical interconnections 
evolving with the interactions. In origin, it has algebraic form but can also be 
designed with graphical syntax. This method is less developed than all other 
modeling schemas (Materi and Wishart, 2007). 
• Hybrid models: Let to utilize the advantage of different techniques in a single 
model. One of the primary benefits is the ability to integrate processes that 
happens on different time scales, e.g., integrating diffusion (a fast process) and 
tumor growth, metastasis (relatively slow and can take days) (Materi and 
Wishart, 2007).  
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1.3 Theory 
1.3.1 Reaction ordinary differential equations 
Since our models will rely on reaction kinetics and ordinary differential equations, in 
this text emphasizes will be given on the ODEs techniques in the following part of the 
text.  
As mentioned before ODEs represents chemical reactions. If they are simple enough 
ODEs can have exact solutions; in other case must be solved numerically. For the 
computation of reactant concentrations numerical methods utilize linear 
approximations via smooth curves having small time intervals based on methods first 
derived by Newton and Gauss (Materi and Wishart, 2007). To improve the 
computational accuracy of it, several algorithms like Runge–Kutta are developed. 
The main reaction ODEs, Materi and Wishart (2007), can be given as : 
         
 
(1.1) 
 
         
 
(1.2) 
 
       
 
(1.3) 
 
         
 
(1.4) 
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 (1.5) 
            
        
 
(1.6) 
and for enzamatic reactions  
     
   
 
 
(1.7) 
1.3.2 Modeling with transfer functions 
 
The transfer functions firstly used as an elementary component of classical control 
engineering and nowadays widely used in nearly all fields of engineering. A transfer 
function can be used to recapitulate the way of how a signal evolves through the 
system. Having a known transfer function makes it possible to predict the output under 
a certain stimuli and vice versa. X(s) and Y(s) is usually represents the input and 
output of the system, respectively. G(s) and H(s) often indicate transfer functions 
(Figure 1.11). These are Laplace transforms of corresponding time-dependent 
functions x(t), y(t). 
 
 
 
Figure 1.11: A block representation of transfer function X(s) refers input, Y(s) is  
output. 
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In mathematical terms, if x(t) and y(t) are input and outputs in phase space 
respectively, the linear mapping to s domain (the Laplace transform) basically given as 
(Ogata, 1990): 
           (1.8) 
The general form of the transfer function for first order systems, which refers to 
systems modeled by first order differential equations are given by G(s)=K/('s+1) 
where K is gain, ' is the time constant for G(s). Transfer functions of second order 
system are G(s)=K&n2/(s2+2(&ns+&n2), where K, , &n represents gain, damping 
parameter and undamped natural frequency, respectively (Ogata, 1990; Oppenheim, 
Willsky and Nawab, 1997). Higher order systems usually can be modeled as the 
combination of first and second order systems (Oppenheim, Willsky and Nawab, 
1997). 
For K=1 and a unit step input X(s) = 1/s, by taking the inverse Laplace Transform of a 
second order transfer function one can obtain unit step response as (Ogata, 1990): 
         (1.9) 
In the equation unit step response  is defined as transient oscillations 
frequency. Both percentage over shoot and transient equation can be obtained from 
step response as given in Figure 1.12 at the next page. For K=1, one can determine 
transfer function from this quantities.  
The other important parameters which can be obtained by step response are the rise 
time and settling time. The interval that step responses undergo the most significant 
changes is called as rise time which can be in the range %0 to %100,%5 to %95, %10 
to %90 according to the application, Ogata (1990), and the length of time that takes 
the system to reach and settle in the vicinity of final value is called the settling time 
(Ogata, 1990). 
In spite of single cell stochastic nature, in average a population can have predictable 
behaviour that can be explained by simple linear rules (Selvarajoo, Tomita and 
Tsuchiya, 2009). According to this view, perturbations in first order mass action 
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response equations can help to resolve network structure of this kind of complex 
systems by linear principles (Selvarajoo, Tomita and Tsuchiya, 2009). Based on the 
evindences indicating the resemblance to linear systems and some previous 
applications, Covert et al. (2005),  we used transfer functions to apply the methods of 
control theory to model the system by representing the systems in frequency domain. 
 
Figure 1.12: Graphic illustrates the parameters used for determination of transfer 
function and second order systems. 
 
The transfer function of the graph is . Overshoot, settling time and    
rise time is demonstrated on it. 
For example in Figure 1.13 a transfer function produces a signal very close to the 
previously given graph of NF-!B activity for I!B# over expressed mutants. The 
related model illustrated below the graphs. As can be seen from the model, the source 
is a step function. 
Transfer function method was also used to model TLR4 mediated NF!B-I!B 
regulatory network, Covert et al. (2005), and provided clues about time delay in the 
Trif part of the pathway.  
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Figure 1.13: The graph given in the left part of the figure, Hoffmann et al., (2002), is 
the simulation output for I!B# over expressed NF!B activation. The 
right graph indicates the step response of the transfer function given by 
the yellow box in the below part of the figure.  
1.3.3 Optimization 
To solve most of the real-world problems, optimization of multiple objectives is 
required. Here optimization refers to just obtaining solutions such that all objective 
functions have values in acceptable limits, because of exact achievements of each 
objectives are almost impossible. These kinds of problems requiring the achivement of 
multiple goals are in general named as multi-objective, multi-criteria, or multi-
performance optimization problems and many heuristic search algorithms including 
artificial immune systems, memetic algorithms, simulated annealing, scatter search, 
tabu search, particle swarm optimization, and evolutionary algorithms are employed to 
solve them (Carlos, Gary, and David, 2007; Hamidreza and Christopher, 2008). 
Among all these optimization strategies, evolutionary approaches have been applied as 
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the primary tool during the last decades and several variations of multi-objective 
evolutionary algorithms are developed. In this study we also have a multi-objective 
problem and we mainly utilize genetic algorithms to minimize our cost functions 
serving these different objectives. By concerning the need of further refinement of the 
results, pattern search and Nelder –Mead algorithm are used as a hybrid function in the 
optimization process.   
The approaches to optimize multiple-objective problems can be separated in two 
general classes namely as Pareto techniques or non-Pareto techniques also known as 
classical, traditional techniques (Konak, Coit and Smith, 2006):   
The traditional approaches work by adding the multiple objectives into a single scalar 
one, by assigning a weight to each normalized objective function or by moving the 
objectives into constraint sets (Srinivas and Deb, 1994; Konak, Coit and Smith, 2006). 
The weights are expected to be supplied by users and only a single solution can be 
obtained by these weights. If the problem is solved repeatatively by using different 
combinations of the weights, than multiple solutions attained (Konak, Coit and Smith, 
2006). Automation of this process and achieving multiple solutions in a single trial is 
also possible by use of genetic algorithms if the related weights are placed in each 
chromosome (Hajela and Lin, 1992). Other possibility is the generation of normalized 
weight vectors randomly. While it makes possible to search for multiple directions in 
single run and having the advantage of computational efficiency, it may not work 
when the solutions distributed uniformly over concave (convex for maximization 
problems) trade off surface. (Zitzler et al., 2000; Konak, Coit and Smith, 2006). In 
addition, if the variable space is discontinuous, traditional approaches may fuction 
inadequately (Hamidreza and Christopher, 2008). 
In the general other class, it is possible to solve the multi objective problem without 
reducing it to a single objective one, by only finding the all feasible non-dominating 
solution set, also known as non-inferior, Pareto efficient or Pareto optimal set, or a 
representative subset of it. A Pareto optimal, Pareto (1896), is a solution such that 
further improvement in the objectives can not be performed without making at least 
one of them worse off. The name of non-dominated is originated from the property 
that the Pareto optimal solution can not be dominated by the other solutions in the 
search space. In mathematical terms: 
For a minimization multi objective problem let two decision variable vectors in the 
space Rm are given such that a=a1,a2,…am  and b=b1,b2,…bm
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Two objective variable vectors in the solution space Rn is represented by  
f(a)=(f1(a), f2(a), f3(a), f3(a), ..., fn(a)) and 
    f(b)=(f1(b), f2(b), f3(b), f3(b), ..., fn(b)) 
    a dominate b <=>  fi(b) * fi(a)  )i*{1, 2, 3,...,m}  
    fj(a) >fj(b)  +j*{1, 2, 3,...,m},  
(1.10) 
In other words a dominate b, if the solution a is not worser than b for all objective 
functions and for at least one solution a there is an objective function better than b. If 
there is no b solution such that b dominates a, than a is called as Pareto optimal 
solution (Srinivas and Deb, 1994; Zitzler et al., 2000). 
The values in objective space corresponding to values of Pareto optimum set form an 
image (for two dimension simply a curve) called as the Pareto frontier.  
Depending on the number of objectives, the size of Pareto optimal sets usually shows 
variation and obtaining whole Pareto optimal set for many problems is practically 
impossible on account of its size. Most of the time proof of solution optimality is not 
computationally cost efficient and to get rid of size problems one frequently applied 
method is investigating a good representative set of solutions (Zitzler et al., 2000; 
Konak, Coit and Smith, 2006). A proper set should be equally spaced in Pareto 
frontier and should reflect the entire trade off, especially at extreme ends (Zitzler et al., 
2000; Konak, Coit and Smith, 2006). 
Evolutionary algorithms are well tailored to solve multi-objective optimization 
problems, because they simultaneously handle a set of possible good solutions rather 
than a single solution (Deb, 2001; Srinivas and Deb, 1994). Dealing with sets of 
solutions has advantage of exploring the search space within a smaller number of runs, 
by determining several members of the Pareto optimal set in a single trial and also 
makes them faster relative to point to point local search procedures like tabu search or 
simulated annealing (April et al., 2003). Evolutionary algorithms can cope with non-
convex and discontinuous Pareto fronts because of being less sensitive to the shape 
and continuity of it (Ikonen et al., 1997; Coello Coello, Lamont, and Veldhuisen, 
2007). Moreover, dependence on initial conditions is lower and definition of 
neighborhood is not required in this kind of algorithm (April et al., 2003). 
1.3.3.1 Genetic algorithms 
Genetic algorithms (GA) are widespread meta-heuristics also applicable to 
multiobjective optimization problems by mimicking the natural process of genetic 
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duplication (Jones et al., 2002; Konak et al., 2006). Like in the nature better adopted 
members have more chance to survive and mate. In GA environmental conditions to 
be adopted are provided by fitness criteria. Population in each generation represents 
candidate solutions and members of this solution sets (chromosomes) selected to 
reproduce according to their fitness values. There are two reproduction mechanisms to 
evolve through new generations called as crossover and mutation. The crossover 
operator enables transfer and fuse of two parents’ best genes in the offsprings and the 
mutation operator facilitates the population diversity by providing random changes 
generally at the gene level and so into characteristics of chromosomes. Without 
mutation, repetition of crossover multiple times results with convergence of 
population members with indistinguishable chromosomes and one possible 
concomitant handicap of this is getting stuck in to local minima (Konak et al., 2006). 
In reproduction, the fitness of an individual determines its likelihood to be inherited to 
the next generation. Some of the best members of the population can be transferred to 
the next generation not to lose already found good solutions. The number of good 
parents kept from previous generations is called as elite count. How fitness of genes is 
used for selection is determined by different selection mechanisms and most popular 
mechanisms are proportional selection, tournament selection and ranking (Konak et 
al., 2006). In the current study we obtained our best results with fitness scaling 
function of rank, crossover function of two points, pattern search as hybrid function 
and with the MATLAB default values for all the other functions.  
1.3.3.2 Pattern search 
Pattern search methods do not use derivatives or approximations of them for 
optimization as in the case of other direct search algorithms (Kolda et.al, 2003). For 
this reason they are appropriate for non-smooth, discontinuous systems and for the 
system including stochastic noise. In many case they are more efficient and 
deterministic than genetic algorithm but it is needed to provide a right starting point 
for convergence. 
A pattern search algorithm repetitively scan the region around existing best point by 
evaluating the objective functions in each iteration, to get closer to the desired optimal 
value. All of points in this search region called as mesh. Size of the region is 
determined by multiplying a fixed set of vectors known as pattern with a scalar named 
as mesh size (Url-1). An example of pattern in two dimension is the set of unit vector 
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of four direction: [1 0], [0 1], [-1 0] and [0 -1]. As soon as algorithm finds a point 
fitting better to the criteria, the search continues around that new one and this type of 
search algorithm called as polling. As a next step mesh size is increased. If the results 
of trial are positive the process goes so on, otherwise mesh size decreased. If the mesh 
sizes less than a tolerance value, the process is ended. Other standard stopping criteria 
can also be applied. 
 
 
Figure 1.15: A comparison of derivative based algorithm and pattern search in finding 
the minima when a rough surface or when a stochastic noise present (Url-
2).  
Pattern search methods are quite appropriate for the incorporation of heuristic 
procedures. With heuristic algorithms (such as genetic algorithm), very fast 
achievement of a point near to optimum is possible. On the other hand desired 
convergence requires many more evaluations. Pattern search alone suffer from 
convergence to stationary point with polling but the flexible step size let to escape 
from local minimums. Incorporation with appropriate heuristics makes them well in 
determination of global minimums (Wetter and Wright, 2003; Ismail, Vaz  and 
Vicente, 2007). Thus, by using the near optimum output from genetic algorithm as 
input for a pattern search, it is possible to utilize pattern search as a efficient local 
search tool to refine the results. Figure 1.15 indicates a comparison of derivative based 
 
40 
algorithm and pattern search in finding the minima when a rough surface or when a 
stochastic noise is present. 
1.3.3.3 Nelder –Mead algorithm 
The Nelder-Mead algorithm, Nelder and Mead (1965), or simplex search is also an 
optimization method in the class of direct search methods. It suits very well to N 
dimensional space and especially designed for unconstrained optimization. This 
method is one of the oldest one and works well if a function alters smoothly. In an N 
dimensional space a simplex is determined by N+1 distinct vectors forming the 
vertices between N+1 points, Lagarias et al., (1998), and is in the shape of a polytope, 
basically a triangle in two dimensions and a polyhedron in three, a polycrone for four 
dimension and so forth. There are four main parameters for a simplex algorithm, 
namely expansion, contraction, shrinkage and reflection (Lagarias et al., 1998). Their 
default values are standard for most of the algorithms and are 1, 2, 1/2, 1/ 2 
respectively (Lagarias et al., 1998). 
To converge to desired simplex, the algorithm first determines a new point near to or 
in the existing one. If this new point has a better score in objectives than another 
current point of the simplex, then the old worse one is discarded (Lagarias et al., 
1998).  One of the methods to form a new candidate polytype is reflecting the worst 
point from the centroid of the vertices of other points (Lagarias et al., 1998). 
According to the fitness of new point, either it is stretched exponentially along the 
vertices connecting this point or an shrinkage in the direction of the best point is 
provided.  
One of the main problems related with the algorithm is getting stuck in rut, thus 
initialization with a right simplex is important. Restarting the algorithm from existing 
best value with a new simplex is one option that works in many circumstances. 
1.3.3.4 Stochastic Modeling 
In the deterministic ODE approach, dependences on spatial positioning other than 
being compartmentaly seperated (i.e. being in cytoplasm or in nucleus) are ignored 
(Hayot and Jayaprakash, 2008). This method usually works well for large number of 
molecules allowing the occurrence of any two reaction at the same time and changes 
in number of molecules can be solved differentially. But this approach breaks down 
for small amount of molecules, in which case reactions happens randomly with 
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temporal separation  rather than simultaneous occurance (Hayot and Jayaprakash, 
2008).  
For small number of molecules, like in single cell applications, a method based on 
probability of states for each given time function much better and mostly inevitable, 
especially in determining oscillations in the single cell experiments which are poorly 
occurs in reaction ODES method and in determining role of noise. One of the well-
known methods to implement the probabilistic, stochastic Modeling techniques is 
Gillespie’s algorithm (Gillespie, 1997). This approach converges to ordinary 
differential equation method when the results are avaraged over population (Hayot and 
Jayaprakash, 2008).  
1.3.3.5 Gillespie’s algorithm 
The Gillespie’s algorithm simply try to represent the collision of molecules within a 
reaction vessel with randomly generated reaction and time steps. In this aspect, 
Gillespies algorithms is a diversification of dynamical Monte Carlo algorithm. Despite 
well mixed enviroment with many collisions, the collisions leading reactions are rare, 
thus are assumed to merely take place between two molucules and can be modeled as 
collection of binary reactions.  
The algorithm basically includes four step as given below: 
 Initialization: Initialization of system parameters (i.e. the number of molecules, 
reactions constants).  
 Monte Carlo step: random number generation to pick the time interval and the next 
reaction.  
 Update: The number of molecules and time step are updated according to the 
reaction that occur and the randomly generated time interval, respectively.  
    Iterate: First three steps are repetitively applied until go beyond  simulation time or 
number of the reactants ceases. 
Figure 1.16, Hayot and Jayaprakash (2006), illustrates results of an application of 
Gillespie’s algorithm on a simplified version of the NF-"B model proposed by 
Hoffmann et al. (2002). The solid curve represents an average NF-"B expression in 
response TNF# over 1000 single cell for initial amount of IKK having a Gaussian 
distribution with average number 30,000 and width (,) equal to 5000. The dashed 
lines are for single cell with 25,000 and 35,000 IKK molecules. As this study 
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illustrates, average over many cells inadequately describe the single cell behaviour in 
terms of oscillations and phase. 
Depending on how strong the transcription rate and fluctuations on IKK molecules, 
this study also indicates that population average either can represent oscillations like in 
Hofmann 2002 model or oscillations can be sweep out in average because of the extent 
of variability in single cell behaviour (Nelson at al. 2004; Hayot and Jayaprakash, 
2006). 
 
                  Figure 1.16: NF-!B oscillations (Hayot and Jayaprakash, 2006). 
According to recent findings, Tay et al. (2009), it is possible to reproduce many single 
cell NF-"B profile in response to TNF# data obtained by micro fluidic studies by 
utilizing an upgraded version of previously developed stochastic model (Lipniacki at 
al., 2007). The new model differs from previous one according to some model 
parameters. These models include stochasticity at the level of receptor and at the 
transcription of A20 and I"B# genes by NF-"B. Stocasticity at the level of receptor 
supports the assumption that activation of single TNF# ligand complex is sufficient to 
induce  substantial amount of  NF-"B translocation to nucleus and activation of related 
genes. 
In another recent study on LPS stimulated NF-"B activation, Lee et al. (2009), to 
recapitulate single cell data, stochasticity is introduced by application of a set reaction 
rates to the reported NF-"B model (Covert et al., 2005). In the study while %50 of 
single cells show a late phase activity, the rest of the population do not. As a source 
of this behaviour, paracrine TNF# activation in response to MYD88 dependent 
pathway and resultant secondary NF-"B activation is indicated. It seems there are still 
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missing points in explaining this late phase activity because the computational results 
and experimental data difference in the late phase which is posibbly due to ignoring 
other crosstalk mechanism in between interferon and LPS pathway via PKR activity. 
Deterministic model is more effective at the initial stage for such a model examining 
the crosstalk mechanisms. But after indicating such an affect, utilization of stochastic 
Modeling approaches is important to be able to explain some single cell data. 
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2. METHODS 
2.1 Method I-Transfer Functions and Simulink 
The biochemical signaling networks of nuclear factor "B (NF-"B) family of proteins 
have important functions in immune response, inflammation, development and cell 
survival. This family of transcription factors is subject to multilevel control 
mechanism. In this part of the study we proposed a computational model relying on 
control theory and demonstrating the role of NF-"B inhibitor proteins (I"B isoforms) 
in NF- "B regulation. I"B#, I"B" and I"B( (the isoforms) act differently in NF- "B 
regulation and this difference allow rapid response to changes in the stimulus and 
long term moderate concentration of NF- "B. We calculated transfer functions for 
each isoforms and for the overall effect to reproduce the temporal damped oscillation 
profiles given by the models of Hoffmann’s group in literature. By utilizing direct 
search algorithms the multi-objective optimization problem of fitting the parameters 
in transfer functions, gains and delays are solved in 15 dimensional search space. Our 
preliminary optimization works on a simplified model of the system performed by 
MATLAB genetic algorithm toolbox with pattern search as hybrid method. We 
attained the main attributes of the reference signals, then refined the results by 
Nealder- Mead Algorithm. The resultant best profiles for the total effect of the I"B 
isoforms fit around eighty percent in amplitude to the reference signal for the initial 
peak and almost exactly in the later two peaks without any phase shift. 
Procedure: 
• After gathering the data from the reference model, we determined the transfer 
functions for each I!B isoforms (Figure 2.1 and Figure 2.2) 
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Figure 2.1: Transfer functions giving the NF"B activity profile for I"B isoforms 
isolated effects and for wild type cells. 
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      Figure 2.2: The output of transfer functions for the Model having real time scale. 
• By using the experimental results in literature we selected the possible 
feedback relations between I!B isoforms and NF!B (Figure 2.3 and Figure 
2.4). 
• We constructed several models in Simulink including these possible 
interactions and let 15 parameters free to fit the reference data. 
• These parameters are optimized by minimizing the least mean square error 
between reference signals of each isoform+their total affect and signals that 
we produced. In first stage of the optimization process Matlab Genetic 
algorithm toolbox is used. 
• Pattern search is utilized as hybrid algorithm in genetic algorithm to refine 
our results. 
• The best result is obtained from this hybrid search transfered to pattern search 
toolbox for further refinement with hybrid Nelder-Mead algorithm.  
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a) 
 
 
    
 
b) 
 
 
 
Figure 2.3: Some of the possible models that suits to existing experimental  
knowledge. a) signal coming from I!B site induces negative feedback, 
b) signal coming from I!B site induces positive feedback. 
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                   Figure 2.4: Some of the possible models planned to analyze. 
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2.2 Method II- Modeling with Ordinary Differential Equations 
The attempts to explain LPS stimulated pathways and late phase activity of LPS 
stimulated NF!B expression resulted in a few mathematical models of the system.  
While some of them were based on only one method like reaction ODEs or agent 
based approaches, An (2009), hybrid methods utilizing both transfer functions and 
reaction ODEs were also applied on the system. The main difficulty in these models 
is the lack of knowledge especially for the upstream MyD88 pathway and in 
determining the source of required delays. To achieve the expected NF!B profiles 
either intermediates were introduced, Selvarajoo (2006), by just predicting the 
number of steps for required outcome or in place intermediates mediating signal 
through the upstream, a transfer function recapitulating this part of the system by an 
output in conjunction with experiments were used (Covert et al., 2005). Assigning 
such transfer function for upstream of MyD88 dependent and independent pathways 
were not enough to explain the experimental results. By bringing stochasticity to the 
system with a probabilistic approach at the stage of Triff dependent TNF# 
production, it was possible to obtain NF!B late phase expression within relatively 
feasible limits (Lee et al., 2009). The other approach to estimate the number of 
intermediates in between receptor and downstream was not supported by the 
experiments indicating the receptor internalization as the source of the events in that 
region of the signaling cascade (Kagan et al., 2008). A rule-based model with crude 
estimate of reaction rates suggested various dose response curves and tolerance 
dynamics for LPS stimulated A20 and TNF# expression profiles (An and Feader, 
2009). This study also indicated the requirement of dual feedback mechanism 
exerted by both A20 at the TRAF6 and IKK level and I!B at the NF!B level and 
claimed A20 as an important source for providing delay and I!B as the source of 
tolerance (An and Faeder, 2009). Rather than negative crosstalk interactions, 
signaling flux redistribution is suggested as a possible regulatory mechanism by 
another ODEs model and competition, conformational changes and physical 
blocking are proposed as the source of flux redistribution. This model utilized to 
evaluate the flux distribution at the different nodes after introducing perturbation to 
input. However especially at the receptor level proposed flux redistribution is not 
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validated by the subsequent experiments clarifying sequential occurrence of reactions 
at this level (Selvarajoo et al., 2008). 
The only comprehensive IFN" pathway ODEs model in the literature was developed 
to enlighten the early and late responses of the system in the epithelial cells. In the 
study, while main emphasis was on the transcription from the GAS site like IRF1 
regulation and STAT1 homodimers were taken as the primary transcription factor in 
this process, detailed analysis of the part acting through ISGF3, ISRE and dependent 
gene expressions were left to later studies. It mainly concentrated on the mechanisms 
of STATs (STAT1, STAT2) phosphorylation, STATs homo and hetorodimer 
regulation, IRF1 regulation and tested several negative feedback mechanisms 
including SOCS1, PIAS, activation of dormant phosphatases, hypothetical molecules 
producing results commensurate with experiments (Smieja et al., 2008). One kind of 
these hypothetical molecules is supposed to be present at the nucleus, activated by 
ISGF3 and acts on STATs dimers and the other one is present in the cytoplasm and 
acts on IRF1. The system responses at the early stages were explained by phosphates 
activity and the late ones were based on IRF1 deactivation and accumulation at 
cytoplasm (Smieja et al., 2008). To determine the transcription factor behaviour, in 
this study we also tested the feedback mechanism, but we realised that receptor 
metabolism, i.e., degradation, complex formation and internalization, is the 
determining factor on the general tendency (Figure 3.5). In the previous study, it was 
claimed that transcription rate can be simply proportional to transcriptional factor 
concentration, however for the cases blocking the nuclear export with concomitant 
accumulation of transcription factors in the nucleus, they suggested to insert a 
nonlinearity, limiting the transcription by a function having a peak at the theoretical 
maximum transcription rate and given as: (Theoretical maximum transcription rate) x 
(Transcriptional factor concentration) / (parameter to be determined +Transcriptional 
factor concentration) (Smieja et al., 2008). 
2.3 Method III-Modeling of the Interferon Transcription  
In this study, to limit transcription at a certain extent we employed an alternative 
method based on the probability of desired states that is widespread in statistical 
physics and also recently well described for the transcription event (Bintu et al., 
2005). The binding probability to specific site can be written as the number of the 
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possible states that allow desired transcription divided by the number of all possible 
states of the system. Main assumptions of this approach are that transcription 
becomes possible if one of the RNA polymerase bound to specific side, the 
remaining ones distributed among the nonspecific sides on DNA and nonspecific 
sides act as the reservoir (Bintu et al., 2005). In our system the presence of both type 
of transcription factor at the same time enhances the transcription, in other words, 
NF!B and IRF3 act as AND gate for the transcription.  The enhancement of 
transcription factors appears as a multiplier in the probability equation and is called 
as the regulatory factor (Bintu et al., 2005). The measure of transcription factors’ 
effects on gene expression relative to the absence of transcription factors is given by 
fold change and it is approximately equal to the regulatory factor in the case of weak 
promoters controlling the transcription (Bintu et al., 2005). By using these definitions 
and the methodology, we derived the equations matching with the AND gate 
property of the transcription factors in our system. 
To determine the probability of the statistical weights for the cases at which the 
promoter occupied are added up after the weight of each case is calculated by 
multiplying the number of arrangements and the Boltzmann factor for each state and 
the result is divided by the total statistical weight of all the possible states of the 
system, namely the partition function of the system. For this part of the model, just 
for simplification we ignored the whole mechanism of the enhanceosome formation 
and mainly concentrated on the effect of transcription factors and according to this 
assumption there are four possible cases for the binding of the polymerase molecules 
to specific sides: 1) only the polymerase bind to promoter and activator site is 
unoccupied, 2) only RNA polymerase and NF!B bind to specific sites 3) only the 
polymerase and IRF3 bind to specific sites 4) both of the activator sites and the 
promoter site are occupied. In addition to these four eventualities, the partition 
function includes four other cases very similar to the above but with versions in 
which the promoter is unoccupied so transcription is not an issue. In the direction of 
these descriptions, the partition function for the system in our concern can be written 
as follows: 
 (2.1) 
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where P represents the number of RNA polymerases, A and B represent the number 
of transcription factor molecules. The Boltzmann weights are denoted as:  
        
 
  
(2.2) 
and  binding probability is: 
           (2.3) 
where 
            (2.4) 
Before the infection the IFN" secretion is very low and because of the fact that both 
the presence of IRF3 and NF!B is required for the transcription of IFN" in 
remarkable amounts, Yie et al. (1999), we assumed that although IRF3 and NF!B 
can bind to specific site, the adhesive energies, "ap, "bp between only one kind of 
transcription factor and the polymerase on the promoter is very low, close to zero, so 
the resultant fA, fB can be approximated as 1. In addition, we  assumed  the 
enhanceosome including IRF3 (A) and NF!B (B) has a binding energy $(ab)p  and 
resultant Boltzmann weights is denoted by fAB . We also accepted that this two 
transcription factor can not be on their specific sites without interacting with each 
other in enhanceosome ensemble based on reported data indicating completion of 
enhanceosome formation only become possible by the protein-protein interactions 
between IFN" activators (Yie et al., 1999). 
Simply: 
                 (2.5) 
In explicit form Zbound can be written as: 
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     (2.6) 
 
and in explicit form Ztotal  is : 
 
      
 (2.7) 
and the bounding probability is found to be 
           
 (2.8) 
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 (2.8) 
simplification results with 
         (2.9) 
and 
         
(2.10) 
by rearrangements 
         
 
(2.11) 
 
                     
 (2.12) 
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after simplifications, the equation reduces to the form, 
               
(2.13) 
and  is obtained as 
                (2.14) 
or 
                (2.15) 
, KA=[A]/a 
where [A], [B] are the concentrations and KA, KB are the effective equilibrium 
dissociation constants of the transcription factors, fAB is a factor which represents 
adhesive interactions in between union  of transcription factors and RNA polymerase 
on the promoter and & is the interaction between two transcription factors. 
In our model we utilize the regulatory factor in the reaction ODE for transcription as 
in the following equation: 
                   (2.16) 
 
 
                     Figure 2.5 :  Dependence of Fregulartory on fAB and & values. 
This equation gives one in the absence of one of the transcription factors. Either 
NF!B or IRF3 is not present in the system, to obtain zero production rate, we need to 
subtract one from the regulatory factor value. Figure 2. 5 depicts the how how & and 
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f values effect the  Fregulatory factor value for a change in between 0 and 15 and and  
Figure 2.6 indicates the dependecies of IFNmRNA values to these factors with w and 
fAB  values ranging between 0 and 6 with an interval of 0.5. 
At the transcription level epigenetic is another factor determining IFN" regulation 
(Génin et al., 2009). Histone modifications at local sides, chromatin remodeling 
complexes and so DNA folding can be also introduced in a more advanced statistical 
transcriptional model than the one used in this work. Unfortunately histone modifiers 
recruited by IRF3 and IRF7 are not known, Génin et al. (2009), and so are not 
involved in our model. 
2.4 Method IV-Modeling of the Signaling Cascades 
For the remaining part of the problem we formulated reaction ODEs for the each 
form of the reaction species represented in the Figure 2.8 and solved these equations 
with Matlab ode15s solver. Based on reaction ODEs method, I design two models for 
IFN pathway one taking account of IFNAR internalization and PKR feedback 
(Figure 2.8) and one assumes constant amount of total receptor but includes negative 
feedbacks like SOCs1 and SOCs3 to obtain required decrease of ISGF3 (Figure 2.7). 
Despite the model including the receptor metabolism stages, the model including the 
SOCs feedbacks have a single phase not involving a stage to reach basal values. 
                Figure 2.6 :  Dependence of IFNmRNA on fAB and & values. 
.  
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     Figure 2.7: The schematics of model structure based on feedback mechanisms. 
If sinks and sources are included, the models consist of 22, 12 species and 15, 9 ODE 
sets for the two interferon models, respectively. In the validation stage of these 
models, we observe that receptor internalization is very important in ISGF3 
expression and down regulation. As a result we eliminated the second model that 
assumes the total amount of receptor on the cell surface as constant.  
Because of the receptor internalization is a very important stage in IFN" pathway 
and by considering the number of the possible steps for the metabolism mechanism 
at the receptor level, we proposed a modified model based upon the TFNAR part of a 
reported TNF#-NF!B model, Werner et al. (2008), including receptor complex 
formation, internalization and degradation steps. This approach brought a very 
favourable reduction in the number of reaction kinetic rates needed to be determined, 
either by directly employing the same value or setting a reference point in search 
space. We also made use of the reference model’s two phases working principle, 
Werner et al. (2008); before ligand equilibrium basal levels of reactants are achieved 
and than by the ligand application time course data of the species are obtained. For 
the interferon pathway the reaction in the receptor level separated in to two parts for 
IFN" bound and unbound forms of receptor. The combined model includes 65 
parameter and 28 ODE equations in total. While most of the parameter values are 
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taken from the data in the literature some of them adjusted to fit the published IFN" 
and IRF3 profile in the reference experimental study (The parameter list and their 
sources are in the supplementary materials). 
From 37 parameters of the Interferon model, 8 of them are inherited directly from the 
reported TNF#-NF!B model. Very similar to interferon pathway receptor 
metabolism is also characteristic part of the TLR4-MyD88 independent pathway 
determining the timing of end products (Figure 3.5). For this part of the model we 
tried a rather reduced model and ignored the many steps assumed to spontaneously 
occur without ligand, which are involved at left part of the IFN" receptor level. As a 
result the TLR4 pathway model in this study involves 28 parameters 2 of which 
originated from the reference TNF#-NF!B model. After TLR4 forms dimmer in the 
presence of LPS, MyD88 and Triff bind to the complex sequentially and before Triff, 
MyD88 leaves the TIR domain (Kagan et al., 2008). This simplified model was also 
very efficient to produce similar results with the more comprehensive one including 
the unbound receptor steps. In the model Triff receptor complex activate TRAF3 and 
concomitantly TBK1-IKK$ complex, IRF3 and IRF7 activated in sequential manner. 
Since the activation of IRF3 is a posttranslational effect and responsible for 
transcriptional activity, in the model IRF3 represented in four different forms given 
as: inactive, active cytoplasmic and nuclear forms, while the dimerization ignored in 
the nucleus, Kumar et al. (2000); Tsuchida et al. (2009), causes transcription of IFN" 
in collaboration with NF!B (Thanos  and Maniatis , 1995; Yie et al., 1999).  
Resultant IFN" triggers Type I interferon receptor. 
The equations in two models can be given as:  
d[IFN"]/dt =          -K1.[IFN"]+0.51. K50.[IFNmRNA1]  
    -K15.[IFNAR].[IFN"]  
    -K16.[IFNAR2].[IFN"] 
    +K17.[ IFNAR2IFN"]  
    +K27.[IFNAR2JAKIFN"] 
     - K28.[IFNAR2JAK].[IFN"] 
            + K29.[ IFNAR2JAKIFN" a] 
                                      - K30.[ IFNAR2JAKa].[IFN"]; 
(2.17) 
While [IFNAR2JAKIFN"]  indicates concentration of dimerized IFNAR, JAK and 
IFN" molecules’ inactive complex, [IFNAR2JAKIFN" a] indicates active form of 
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this complex. [IFNAR2JAK], [IFNAR2JAKa]  are assingned for inactive form of 
two IFNAR molecule, JAK complex  and active form of the same complex, 
respectively. Similary [IFNAR2IFN"] represents dimerized IFNAR and JAK 
complex and [IFNmRNA1] refers to IFN" mRNA concentration. 
  d[IFNAR]/ dt    =                     +K2 - K3.[ IFNAR] + 2.K4.[ IFNAR]  
                                                   +2.K5.[ IFNAR2] 
                                                   -2.K15.[IFNAR].[IFN"]; 
(2.18) 
[IFNAR] is IFNAR receptor concentration, 
d[IFNAR2]/ dt =                    + K4.[ IFNAR] - K5.[ IFNAR2] 
                          - K6.[IFNAR2]-K7.[IFNAR2] 
                                                   + K8.[ IFNAR2JAK ]  
                                                   + K9.[IFNAR2JAK]; 
 
(2.19) 
[IFNAR2] is dimerized IFNAR receptor concentration, 
d[IFNAR2IFN" ]/ dt  =             - K18.[ IFNAR2IFN"]  
                         + K16.[IFNAR2].[IFN"]  
                          - K17.[ IFNAR2IFN"] 
                 + K15.[ IFNAR ].[IFN"] 
                  - K19.[IFNAR2IFN"]  
                  + K20.[ IFNAR2JAKIFN"]; 
(2.20) 
 
d[IFNAR2JAK]/dt =     +K7.[IFNAR2] - K8.[IFNAR2JAK]  
          -K9. [ IFNAR2JAK] 
          +K11.[IFNAR2JAKa ].[SOCS3] 
          +K11.[IFNAR2JAKa].[ SOCS1]  
             + K10 . [ IFNAR2JAKa]  
          + K27.[ IFNAR2JAKIFN"]  
          - K28 .[IFNAR2JAK] .[IFN"]; 
(2.21) 
 
d[IFNAR2JAKa]/dt   =          - K12.[IFNAR2JAK]  
            + K9.[IFNAR2JAK]  
             - K10.[ IFNAR2JAKa]  
             - K11.[ IFNAR2JAKa].[SOCS3] 
(2.22) 
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             - K11.[ IFNAR2JAKa].[SOCS1]  
             - K14.[ IFNAR2JAKa]  
             + K29.[IFNAR2JAKIFN" a]  
             - K30.[ IFNAR2JAKa].[IFN"] ; 
 
d [ IFNAR2JAKIFN" a] / dt=  - K24.[IFNAR2JAKIFN"]  
                         +K21.[IFNAR2JAKIFN"]  
                                  - K22.[IFNAR2JAKIFN" a] 
                 - K23.[IFNAR2JAKIFN" a].[SOCS3]  
                 - K23.[IFNAR2JAKIFN" a].[SOCS1]  
                 - K26.[IFNAR2JAKIFN" a] 
                 - K29.[IFNAR2JAKIFN" a] 
                                 + K30.[IFNAR2JAKa].[IFN"]; 
(2.23) 
 
d [IFNAR2JAKIFN"] / dt  =   + K19.[IFNAR2IFN"] 
                - K20.[ IFNAR2JAKIFN"] 
                - K21. [IFNAR2JAKIFN"]  
                + K22.[IFNAR2JAKIFN" a]  
                +K23.[IFNAR2JAKIFN" a].[SOCS3]  
                +K23.[IFNAR2JAKIFN" a].[SOCS1]  
                        - K25. [ IFNAR2JAKIFN"]  
                        - K27.[IFNAR2JAKIFN"] 
                        + K28.[IFNAR2JAK].[IFN"]; 
(2.24) 
 
d[ISGF3]/dt  =                +K33.[ISGF3a]  
              +K37.[ISGF3N] 
                      - K31.[ISGF3].[IFNAR2JAKa]  
              - K32.[ISGF3].[IFNAR2JAKIFN" a]  
                                               - K38.[ISGF3]; 
(2.25) 
[ISGF3] and [ISGF3a] is inactive and active ISGF3 concentration, respectively, 
d[ISGF3a]/dt =                 +K35.[ISGF3Na]  
              + K31.[ISGF3].[IFNAR2JAKa]  
(2.26) 
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                                               +K32.[ISGF3].[IFNAR2JAKIFN" a]  
                                               - K33.[ISGF3a] - K36.[ISGF3a]; 
[ISGF3N],  [ISGF3Na] are inactive and active ISGF3 concentration in the nucleus,   
d[ISGF3N]/dt =          +K34.[ISGF3Na] 
             +K38.[ISGF3] 
              -K37.[ISGF3N]; 
(2.27) 
 
d[ISGF3Na]/dt  =                -K34.[ISGF3Na]            
              -K35.[ISGF3Na]  
              +K36.[ISGF3a] 
(2.28) 
For TLR4 pathway the equations are: 
d[LPS]/dt  =          -K51.[LPS] 
             -K57.[TLR4].[LPS]; 
(2.29) 
[LPS] is the ligand (LPS) concentration, 
d[TLR4]/dt =                -K53.[TLR4] 
             +K52- 2.K57.[TLR4].[LPS]; 
(2.30) 
[TLR4] is TLR4 receptor monomer concentration, 
d [LPS2TLR4] / dt=               -K58 .[LPS2TLR4] 
     +K57.[TLR4].[LPS]  
     +K64.[ LPS2TLR4TRIF]  
     + K60.[ LPS2TLR4TRAM] 
             -K59.[LPS2TLR4]; 
(2.31) 
[LPS2TLR4] is concentration of LPS and dimerized TLR4 receptor complex,  
d [ LPS2TLR4TRIF ]/dt=    + K61.[LPS2TLR4TRAM] 
              - K62.[ LPS2TLR4TRIF] 
              - K66.[LPS2TLR4TRIF] 
                                                - K64.[ LPS2TLR4TRIF]; 
(2.32) 
[ LPS2TLR4TRAM] is concentration of LPS, TRAM and dimerized TLR4 receptor 
complex, 
d [ LPS2TLR4TRAM ] / dt  =   -K61 . [ LPS2TLR4TRAM ]  
                                                   + K62  . [ LPS2TLR4TRIF]  
                                           -K65  . [ LPS2TLR4TRAM]   
                                                   + K59   . [LPS2TLR4] 
                                                   - K60.[ LPS2TLR4TRAM]; 
(2.33) 
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d[TRAF3]/dt  =          - K69  . [TRAF3] . [LPS2TLR4TRIF]  
                                                  + K70 .  [TRAF3a] ; 
 
(2.34) 
[TRAF3] is TRAF3 concentration, 
d[TRAF3a]/dt  =           + K69  . [TRAF3] . [LPS2TLR4TRIF]  
                                                   - K70 .  [TRAF3a] ; 
(2.35) 
[TRAF3] is active TRAF3 concentration, 
d[TBK]/dt   =            - K69  . [TBK] . [TRAF3a]  
                                                    + K70 . [TBKa] ; 
(2.36) 
[TBK] is TBK concentration, 
d[TBKa]/dt    =           +K69.[TBK].[TRAF3a] 
                                                      -K70 . [TBKa]; 
(2.37) 
[TBKa] is active TBK concentration, 
d[IRF3a]/dt  =              +K74.[IRF3Na] 
                    +K71.[IRF3].[TBKa] 
                    -K72.[IRF3a]-K73.[IRF3a]; 
(2.38) 
[IRF3a] is active IRF3 concentration, 
d[IRF3]/dt    =            - K71.[IRF3].[TBKa] 
            - K76.[IRF3]+K72.[IRF3a] 
                    + K77.[IRF3N]; 
(2.39) 
[IRF3] is IRF3 concentration, 
d[IRF3Na]/dt  =       +K73.[IRF3a] 
           - K74.[IRF3Na] 
           - K75.[IRF3Na]; 
(2.40) 
[IRF3Na] is active IRF3 concentration in the nucleus, 
d[IRF3N]/dt  =       +K75 .  [IRF3Na] 
           +K76 .  [IRF3] 
                    -K77  .  [IRF3N]; 
(2.41) 
[IRF3N] is IRF3 concentration in the nucleus,  
d[IFNmRNA1]/dt =   (K82.F1-K82) 
     -K83.[IFNmRNA1]; 
(2.42) 
[IFNmRNA1] is IFN" mRNA concentration,  
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d [ IFNbeta ] / dt            =   - K1 . [ IFNbeta ]  
                                            + 0.51 . K50 . [ IFNmRNA1 ] 
- K15  . [ IFNAR ] . [ IFNbeta ] 
- -K16 . [ IFNAR2 ].[ IFN" ] 
                                    +  K17 .  [ IFNAR2IFNbeta ]  
                                            + K27 . [IFNAR2JAKIFNbeta ]   
                                            - K28  .  [ IFNAR2JAK ] . [ IFNbeta ] 
                                            + K29 . [ IFNAR2JAKIFNbeta a]  
                                    -  K30  .  [ IFNAR2JAK a ] . [IFNbeta]; 
(2.43) 
[LPS2TLR4] is LPS and dimerized TLR4 receptor concenteration.   
To model the events at the receptor level, one first needs to clarify how the different 
parts of the receptor function and how they interact with the ligand. All Type I 
interferons act through the same receptor complex called as IFNARs composed of 
two subunits IFNAR1 and IFNAR2. They and the ligand form ternary complex with 
stoichiometry 1:1:1 (Jaks et al., 2007). These receptor subunits differ in length of 
their extensions though cytoplasm and on the cell surface. They have different 
affinities to IFNs, basal turnover and internalization rates. In addition to general idea 
of accepting IFNAR receptor down-regulation as a means of signal attenuation 
(Kalie et al., 2008) recently internalization suggested as essential step for full and 
fast IFN signal transduction (Marchetti et al., 2006). Surface IFNAR2 decay slower 
and much less dynamic than IFNAR1. Type I interferons can produce 
immunomodulatory, antiviral and antiproliferative activities (Baig and Fish, 2008). 
The extent of ISGF3 and antiviral activity are in parallel with the relative affinities of 
ligands towards IFNAR2 (Jaks et al., 2007). On the other hand the differential 
antiproliferative potency correlated with relative affinities towards the different 
receptor subtypes, Jaks et al. (2007), and prolonged IFNAR1 down regulation. 
According to other findings, while low concentrations, transient activity and weak 
binding of interferon’s cause antiviral activity, prolonged signals with high 
concentrations and strong binding results with antiproliferative activity (Kalie et al., 
2008). In this view total binding affinity to receptor subunits determines occurrence 
of antiproliferative activity. A broader description of antiproliferative factors is 
ternary complex stability and rate of complex formation (Kalie et al., 2008). 
Nonlinearity in pSTAT1 activation and binding affinity dependent nonlinear effects 
of the antiviral response is strongly correlated with the ternary complex stabilization 
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on the membrane and the deactivation rate of the signaling complex (Kalie et al., 
2008). The specific activity of interferons is a consequence of ternary complex 
binding affinity rather than its components. By considering these later perspectives, 
in the model IFNAR1 and IFNARII are taken to be identical for the sake of 
simplicity and their different internalizalition rates and affinities are ignored. 
Antipolifirative activity utilizes pSTAT-independent pathway.  
The other main steps in the interferon model are represented by schematics given in 
Figure2.6 and can be summarized as: the interferon receptor dimerized either in the 
presence and in the absence of the ligand, than transformed to JAK bound receptor 
complex. The activation of the complex yields active ISGF3. Both active and 
inactive forms of ISGF3 are transported in and out from the nucleus. 
 
 
Figure 2.8:  The schematics of the TLR4 and IFN" model. The purple arrows 
indicate direction of the transformation processes, the blue arrows are 
reserved for reactions, and yellow arrows for activation processes, 
green arrows indicate internalization, degradation to sink without 
leading a signaling cascade or synthesis of the complexes. - indicates 
sources and sinks.  
2.5 The PKR Connection 
By concerning that only one of the transcription factor seems to function in early and 
late responses of PKR, we utilized following formulas for PKR synthesis facilitated 
by either p53 or ISGF3. 
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(2.44) 
Where [p53] indicates the concentration, fp is the binding affinity to DNA and Kp is 
the effective equilibrium dissociation constant.  
                         
 (2.45) 
Where [ISGF3] indicates the concentration, fpkr is the binding affinity to DNA and 
Kpkr is the effective equilibrium dissociation constant. 
To trace the concentration profile, all the factors involved in the concentration 
changes included in an ODE as given below: 
                        
 
(2.46) 
 
                       
 
(2.47) 
where Kd, Kd1 indicates the degradation rate. 
To obtain these equation we utilized previously mentioned statistical physics 
approach based on the binding probability of these molecules, with a difference that 
only one transcription factor is required in this case. As previously mentioned 
regulatory factor is obtained by utilizing: 
 (2.48) 
where P represents number of RNA polymerases,  
 is the Boltzmann weight (Bintu et al., 2005).  
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2.6 Method V-Stochastic Modeling of Interferon Pathway  
For interferon pathway only reported stochastic models is designed for transcription 
part of the process, Hu et al. (2007), and there is a need to develop a model for the 
whole pathway to recapitulate single cell behviour. Since the role of transcriptional 
noise in regulation of the IFNB1 in human dendritic cells is investigated and 
because of the applied approach, it is worth to summarize the reported study here. 
The idea behind the model is based on that the observed noise is a result of 
stochasticity in the time onset of transcription and enchanceoseme formation is very 
likely the source of dominant part to the stochastic behavior. In the model, four 
proteins bind DNA by just causing conformational change without interacting with 
each other, Panne et al., 2004, and so bind in sequential manner. The four proteins 
are the transcriptional activators NF-"B and AP-1(ATF-2-c-Jun), interferon 
regulatory factor IRF and the architectural protein  HMG-I(Y) (Yie et al., 1999; 
Munshi et al., 1999; Munshi  et al., 2001; Agalioti et al., 2000; Thanos D. and 
Munshi, 1992). Since it provides reasonable approximation for sequential, 
cooperative assembly and consequent stochasticity in the time of transcriptional 
initiation, for the sake of simplicity possible requirement of more than one IRF and 
necessity of HMGI-(Y) are ignored. As a result,  just four reactions given below are 
involved in transcription: 
 (2.49) 
represent promoter region, Ds13 the bound form of enchosome     
  
and the transcription is represented by : 
                           (2.50) 
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                      Figure 2.9 : Schematics of  interferon mRNA production.  
The results obtained by applying Gilespies algorithm on these reactions and the 
experiments indicate that indeed the source of the intrinsic and extrinsic noise mainly 
arise form variations in the formation time of the enhanceosemes. 
To match with my previous interferon model utilizing regulation factor in 
transcription stage, based on the study mentioned above, I decided to develop rather 
simplified version of stochastic transcription model including the two molecules but 
with a difference of functioning together as AND gate at transcription as illustrates in 
Figure 2.9. 
 (2.51) 
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The reaction for mRNA: 
        (2.52) 
For this purpose I used the following procedures of Gilespie algorithm: 
If one considers the present state of a chemical system as an ensamble of X1, 
X2…Xn, to determine how system evolves, the time and kind of the next reaction are 
needed.  When the number of molecules is low, these questions are answerable only 
in probabilistic sense because of the stochastic nature of reactions. 
According to Gillespie’s algorithm, Gillespie (1977), in such calculations reaction 
probability density function is give by: 
                    (2.53) 
Where , 
 number of distinct molecular combinations  in the state (X1, X2…Xn),  
probability of reaction to occur in between  this particular combination of molecules. 
cµ. cµ is related to deterministic reaction rate constant with   k1 = V.c1 /X1.X20 / / X10 
/ X20 for the reaction R1 and V is the volume of the reaction occur. 
Since there is no difference in between /X1.X20 and /X10 /X20 in deterministic 
approach (the reaction rate constants contains, the equation can simply written as  
k1 = V.c1  and  
                   (2.54) 
As  the main step of the algorithm described above, first initial values cµ, hµ are 
assigned to calculate aµ and accordingly  is calculated. Two random numbers r1 and 
r2 are used to obtain 
                 (2.55) 
and to determine an integer µ as follows: 
                 (2.56) 
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Then, ' and µ are utilized to update time and molecular population levels and these 
steps are repeatedly applied to obtain a transcription profile. Reaction kinetic rates 
of the previously mentioned enchanceoseme model were used. 
Based on this theory, the olgarithm and  related folmulas for the two transcription 
factor can be given as: 
to trace the  active IRF3 in the nucleus   
            (2.57) 
and  for  NF!B in the nucleus 
           (2.58) 
The mRNA sythesis is modeled by: 
           (2.59) 
and  mRNA degradation is: 
           (2.60) 
where the probability of which reaction will occur is given by 
          (2.61) 
and the parameters are: 
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w= 5; 
Developing a stochastic model were not among the initial objective of this PhD 
thesis at 2008, however, devolopments in the field was toward the direction of 
single cell and stochastic studies. I had chance to iniate the study in UCSD Center 
of Theoretical Biology and presented here because of the link between the subjects 
and just to examplify stochastic approach on the system. Rest of the study is 
reserved for a later model that I am planing to conduct following the PhD degree 
due to some documentation (i.e., document no: 30.2. ITU. 0.10.10.00-772.02/221) 
and related permisions issues necessary to visit expert groups during the PhD.  
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3.  RESULTS and DISCUSSION 
3.1 Results for the NF!B-I!B module 
An approach based on the control theory and transfer functions is used to model the 
NF"B-I"B signaling. I attempted to identify model topologies and parameter sets that 
reproduce the dynamic behaviour of the NF!B signaling which is seen 
experimentally and in the ODE models.  
After obtaining each transfer function via curve fitting, I have tried to optimize each 
function as a part of the whole system by minimizing least mean square difference of 
the each function with its parameterized version. To do so the total value of this 
difference of all three transfer functions is minimized by use of genetic algorithms. 
By this way even though the total NF"B profile of the whole system is attained, the 
existence of feedbacks and parameterized values of each transfer function in the 
same model cause the large deviations in individual profiles of the NF"B that 
produced only when one of the I"B isoform is present (Figure  2.1, Figure 2.2 and 
Figure 3.1-a).  
To prevent this I decided to optimize only delays and gains in the system and 
followed a similar strategy of minimizing the least mean square error, but in this case 
for just total NF"B expression level (Figure 3.1). The best result obtained till now is 
demonstrated in Figure 3.1 b, c. There is a small attenuation in the last peak of the 
total NF"B expression. The lower amplitude of the first peak does not necessarily fit 
since the different cells in a culture can respond with different strength. The most 
crucial thing is obtaining the main trend in the overall profile matching with realistic 
values of the parameters.  This optimization is performed for the transfer function 
that scales the over all expression in between 10 second time interval, so I do not 
expect linear proportionality between these delays with that of real time scaled ones 
but at least they seems to have similar trends as the real values.  
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Figure 3.1: Results of optimization for the total NF!B profile, gains and delay in the  
system. 
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Transfer functions for real scales were also determined. Troughout this study I have 
observed that the transfer function methodology is not efficient to apply large 
systems, if real profile of each system is not well defined for different initial 
conditions. A function having a right profile for a specific case may not produce the 
expected one when many conditions change in the system. The determination of right 
transfer functions requires a well-defined system for different sets of conditions and 
sometimes it is not possible. On the other hand solving a set of ODEs for system 
provide flexibility of changing solution for different inputs. Even if the profile of a 
species can not be known under some conditions, solution of the system ODEs can 
provide it. If knowledge about some part of the system is very restricted, in place of 
specific transfer function for each species, sometimes its effective to represent that 
part by a single transfer function. Such Modeling methods can be very effective to 
represent vague processes in between two steps at a certain dose of stimuli, 
especially at the beginning of the pathway. This provides a chance to model the 
whole system without worrying what is going on in this part. A good example to this 
is the model developed by Covert et al. in 2005 for LPS stimulated pathway 
performed by assigning one transfer function for each MyD88 depended and 
independent pathways to obtain desired profiles of IKK.  
In summary, to resolve the whole pathway with transfer functions and guest dose 
response characteristic of system require a library of data for many species under 
these circumstances, for many case these kind of empirical data sets not available 
and hybrid approaches need to be applied. In spite of some progress in these NF!B-
I!B models, because of not considering this problem scientifically effective any 
longer, due to the restrictions of the methodology detailed above and having already 
some models for the systems based on ODEs, I mainly concentrated on ODEs model. 
We may still use transfer function method to define unknown parts of the systems in 
single step like Covert et al. did in 2005. According to these developments my model 
for large system is based on reaction kinetics ODEs.  
3.2 Modeling of TLR4 and IFN"  Pathways with Ordinary Differential Equation 
Based Method 
Despite the extensive literature on IRF3 and IFN", the time course expression levels 
of these species applicable for Modeling purposes are very restricted. We tested the 
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model based on data that covers the longest time span for these two molecules. IFN" 
protein production is observed after 2 hours of the treatment in the RAW264.7 cells 
subjected to 10 ng/mL LPS for up to 12 hours (Qin  et al., 2005). The IRF3 profile 
was obtained from the gel shift assays, Qin et al. (2005), for RAW264.7 cells 
incubated within 10 ng/mL LPS up to 4 hours (Figure 3.2a, b). To obtain LPS molar 
concentration, we assumed an average weight of 100kDa for endotoxin (typically 
endotoxin weight range of between 10kDa and 1000kDa) (Rietschel et al., 1994; 
Roth et al., 1993). In that case 10 ng/mL endotoxin corresponds to 0.1nM of LPS. 
The in slico experiments were initiated by LPS stimulation of TLR4 receptor and the 
signal propagating through the down stream cascade of MyD88 independent pathway 
(Figure 2.8 left) results with IRF3 and IFN" expression profiles. These profiles were 
tuned by modulating the parameters to fit the reference empirical data. The list of the 
parameters and their sources are provided in Table 1 at the end of the section. Figure 
3a represents the simulation and empirical results in comparison. According to these 
data, while IFN" protein peaks at 8 hours with 4ng/mL concentration and then 
declined to 2ng/mL at 12 hours (the molecular weight of interferon 1a and 
interferon1b reported by their manufacturers are used in the conversion to molar 
concentration), IRF3 activation is observed during the first hour and reaches a peak 
at the second hour (Figure 3.2a). The blue line represents the empirical IRF3 profile, 
Qin  et al. (2005), gathered by Image J program. The red line in the same graph 
indicates simulations results for IRF3. Having no data about the amplitude of IRF3 
expression, it is assumed that active IRF3 in the nucleus have a peak around 0.012 
µM. The peak of the profiles represented with blue and red lines are normalized to 
one (Figure 3a). The IFN" transcription rate (parameter 50) is highly linked to the 
parameter IRF3 activation constant (parameter 71). To have more precise values for 
these parameters we need to have information about the concentration of the IRF3 
expression. We have only experimental results for the four time points so the empiric 
results are discontinuous. Even though the similar tendencies are attained up to 4 
hours, the lack of data after that point prevents us from understanding the whole 
profile. The main trends in the simulation such as having a pick around 2 hours and 
having a considerable decrease at four hour match with the IRF3 profile estimate 
calculated by the network component analysis (NCA) (Seok et al., 2009).  Our 
findings and the gel shift data that we used also have similar trends. In accordance 
 
77 
with this IRF3 profile, we suggest the possible IRF3 expressions for different doses 
of the ligand (Figure 3.2b). These profiles need to be tested by experiments. 
Interferon production changes with LPS  level as shown in Figure 3.2c.  Figure 3.2d 
provides insight to understand how LPS level modulates IRF3 concentration. The 
colour gradient reflects different IFN" (Figure 3.2c) and IRF3 levels (Figure 3.2d).  
 
Figure 3.2: In silico simulations of the IRF3 expression profile and dose response 
curves. a) In silico IRF3 activation profile (red line) in comparison with 
empirical results (blue line), the results normalized to one because of 
the lock of knowledge about amplitude b) IRF3 dose response curves 
for different concentrations of LPS treatment. The colour code in the 
left part indicates the LPS doses. c) Colour-plots for IFN" profiles for 
different doses of LPS treatment, colours represent IRF3 concentration. 
d) IRF3 expression for doses of LPS, colours indicate IRF3. 
The application of reported empirical IRF3 profile represented as in Figure 3.2a and 
NF!B expression level shown in Figure 3.3a resulted in the interferon profile 
represented by the red line in Figure 3.3b. Figure 3.3a depicts LPS induced NF!B 
profiles, from literature we have time course data up to 4 hour of LPS treatment for 
mouse embryonic fibroblast (MEFs), Covert et al., (2005); Lee et al., (2009), and the 
data from Th1 cells indicate that NF!B activity persist at high level for the first 12 
hours after stimulation and being lost entirely after 24 hours (Sharif, 2007). Figure 
3.3b also includes interferon beta time course expression in the same cell line up to 
12 hours (Qin et al., 2005). Even though we attain very close profile with the 
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empirical one (Figure 3.3 b), the deviation in the graph can be an indication of other 
missed mechanisms such as presence or a lack of time lag between two-transcription 
factors (resulting from the different sources of NF!B and IRF3 profile data), possible 
other intermediates and/or feedbacks. Also one needs to concern differences in 
between cell cultures and individual cells in a given population.  To have an idea 
about how single cells behave, a stochastic Modeling approach should be employed.  
 
Figure 3.3: The simulation results for IFN" in comparison with experimental values. 
a) Population average of LPS stimulated NF!B profile (Lee et al., 2009) 
(The amplitude is changed to 0.045µM as given in Covert et al, (2005) in 
place of 0.025 µM.) b) in silico IFN" expression results (red line) in 
comparison with the empirical IFN" profile (blue line). 
The regulation of IFN" is a result of a sensitive balance of many mechanisms. In the 
graphs at Figure 3.3 both empirical and simulation results for interferon begin from 
zero level. This is based on the fact that IFN" gene expression is constitutively 
blocked in absence of infection, Nourbakhsh and Hauser (1999); Nourbakhsh et al. 
(2000), and infection causes a transient activity (Doly et al., 1998). For the different 
organs of normal human individuals, in vivo constitutive production of IFN" mRNA 
is less than 10-4 copy per cell (Tovey et al., 1987). One reason behind the low mRNA 
production rate is NF!B repression factor (NRF) (Nourbakhsh and Hauser, 1999; 
Nourbakhsh and Hauser , 1997). NRF exerts negative feedback on IFN"3 promoter 
after positioning on the negative regularity element (NRE). Infection breaks this 
feedback without the need of NRF removal from NRE (Nourbakhsh  et al., 2000). In 
response to high doses of LPS (250 µg/mouse), NRF knockout mice show same LPS 
induced shock symptoms as unmodified mice (Froese et al., 2006). The virus induced 
IFNbeta promoter activity are not only built on NRF but also other sensitive 
regulatory mechanisms like a protein called as Yin Yang1 (YY1) are involved. YY1 
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is a transcriptional factor, which can either function as activator or repressor, Lee et 
al., (1994), depending up on the way of how it interacts with cofactors, from where 
its acetylated, concomitant different DNA binding affinities, Yao et al. (2001), 
concentration of both cofactors and YY1 (Weill et al., 2003). Presence of histone 
deacetylase inhibitors can result with transcription from the IFN" promoter without a 
need of infection (Shestakova et al., 2001).  In addition, both simultaneous presence 
of IRF3 together with NF!B, Servant et al. (2002), and right timing and positioning 
of inducers allow the IFN" promoter to be active (Natoli et al., 2005). In general, 
location of target side on the nucleosome like being at peripheral part or inner 
regions is a factor determining transcriptional regulation (Andersaon and Widom, 
2000). 
It is important to determine biologically significant LPS and interferon doses in the 
analysis of these two pathways. An interferon concentration around 30 pM is very 
low for antipolifirative effects for either IFN' and IFN# in WISH cells. Despite 
IFN', 300 pM IFN# can produce antipolifirative in the same type of cells (Kalie et 
al., 2008). 100 pM IFN# application is enough to produce maximal ISGF3 activity in 
2fTGH and HL116, B2TB1 cells. For these cell types 1.5 pM IFN# cause half 
maximal ISGF3 activation and 10pM IFN# result with half maximal (Jaks et al., 
2007). By focusing on these data, in our simulations, either a 100pM interferon or the 
in silico interferon produced through TLR4 model with a peak of 180 pM directly 
applied on the IFN# beta pathway in Figure 3.3b. The LPS concentration determined 
from reference experimental study, Qin et al. (2005), utilized for interferon curve in 
Figure 3.4a and b. The amount of in silico interferon produced in our TLR4 model is 
180 pM and is enough to produce maximal ISGF3 activity, thus antiviral response.  
There are other data in literature shed light to the profile of our concern. For example 
LPS stimulation result with IRF3 Ser-396 phosphorylation at 30 min and show a 
peak at 60 min (McCoy et al., 2008). It was also reported that IRF3 activation could 
occur as early as within 7 min, Selvarajoo et al. (2008), or 15-30 min of the 
stimulation (Doyle et al., 2002). These experimental results appear to be in 
agreement with Figure 3.1 because IRF3 begins at very early stages of the 
stimulation and reaches a peak around one and half hour. The deviation from having 
a peak around 60 min to 90 min can result from the multiple steps in phosphorilation 
and from the difference in the cell type. Small amounts of TLR3/TLR4 agonists such 
as 1 ng/ml LPS/lipid treatment can results with an increase exceeding 50-fold in gene 
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expression (Doyle et al., 2002). A study conducted on murine bone marrow 
macrophages indicate that 100ng/ml LPS treatment cause IRF3 activation within first 
15–30 min of treatment and IFN" shows 100 times increase in concentration with a 
peak around one hour. During the next 5 hours, it decline more than ten times (Doyle 
et al., 2002). These data are also consistent with respect to the IRF3 simulation 
results but the point at where IFN" have a peak strongly deviates from our reference 
data, which probably results from cell type and organism difference. Application of 
1.0 µg/ml Escherichia coli-type synthetic lipid A on mice peritoneal macrophages, it 
was shown that mobility shift assay data of IRF3 taken by two hours time intervals of 
treatment indicated the presence phosporylated IRF3 at the second and at the fourth 
hours, with a relative decrease in the concentration at the forth hour (Kawai et al., 
2001). Treatment of human monocyte-derived macrophages with 0.5!µg/ml LPS 
points out 100 fold change in IFN" mRNA transcription at the first hour and 
transcription vanishes around six hour. In the same study western blot analysis 
indicate IRF3 activation both at 45 min and second hour of stimulus (Marson et al., 
2004). All these data indicate similar tendencies with our results, within feasable 
range since the sources are different organisms and cell lines. 
In the interferon pathway part of the simulation, the model utilizes the interferon 
outcome coming from TLR4 pathway and triggers signal transduction resulting the 
nuclear accumulation of active ISGF3. We tested that the receptor modules of both 
the interferon and TLR4 models almost have the same outcomes for the same 
parameter sets. As a result, concerning the number of intermediates up to IRF3 and 
ISGF3, similar profiles are expected for both transcription factors. We were not able 
to obtain a consistent ISGF3 time course profile from literature. We were not able to 
obtain a consistent ISGF3 time course profile from literature, however, we know that 
ISGF3 activation occurs in the very early stages of signal transduction just after 
stimulation of Type I interferon receptor (Fu et al., 1992; Levy et al., 1989). IFN# 
treatment results with ISGF3 localization at the nucleus just half an hour after the 
treatment, reaching a peak at 1 hour and restoring the basal level around 6,5 hour 
(Levy et al., 1989). Cytoplasmic extract of HeLa cells indicated the presence of 
ISGF3 in the first minutes of IFN# treatment before the translocation to the nucleus.  
In these cell lines ISGF3 begin to appear in the nucleus even just five minute after 
IFN# (Levy et al., 1989). IFN" application results with ISGF3 both in the nucleus 
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and cytoplasm of human epithelial cells even with in first 10 min of the treatment 
(Smieja  et al., 2008). All these data are in accord with our simulation results given in 
Figure 3.4. However the only EMSA data for a time span long enough, Smieja et al., 
(2008), the profiles seems to have a peak after five hour, which contradicts with our 
results and the empirical ones indicating a peak around one hour.  Therefore, based 
on the current data, we only proposed here how could the ISGF3 dose response curve 
looks like. The Figure 3.4 indicates the dose response profiles for different level of 
LPS and IFN" application. LPS doses are given in colour code in the upper right part 
of the graph. 
 
  Figure 3.4: The proposed LPS-ISGF3 dose response curves. a) ISGF3 dose 
response    curve for different levels of LPS-the colour codes represent 
LPS doses. b) IFN"-ISGF3 dose response curve-the colour-codes 
represent IFN" doses. c) LPS-ISGF3 dose response colour plots- the 
colours represent different ISGF3 levels indicated by the concentration 
next to the colour bar. d) IFN"-ISGF3 colour plots- the colours 
represent different ISGF3 levels indicated by the concentration next to 
the colour bar. 
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Figure 3.5: The effect of degradation and internalization rate on the   transcription 
factor profile. a) The effect of TLR4 internalization rate (causing the 
signaling cascade) on the transcription factor profiles.  The difference in 
the IRF3 and ISGF3 is because of the number of the steps in betwen 
ligand and the transcription factor,  the difference in the rate parameter 
between two pathways, the number of  reaection at the receptor level. 
b)The effect of TLR4 receptor degradation on the transcription factor 
profiles. c)The effect of IFN" receptor internalization (indicated as - 
and not leading signaling cascade)  on the transcription factor profiles.  
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To determine the effect of receptor metabolism on IRF3 and ISGF3 profiles, receptor 
internalization and degradation rates were changed. The results are illustrated in the 
Figure 3.5. While an increase in TLR4 internalization rate that result in the 
initialization of the signaling cascade cause an increase in the strength of both 
transcription factor (Figure 3.5a), the internalization resulted with direct degradation 
of receptor or in other words not triggering the signaling cascade cause considerable 
decrease in the profiles (Figure 3.5b). As easily can be observed from the graphs the 
receptor concentrations have an important role in the transcription factor activation. 
Figure 3.5c represent the effect of IFN" receptor degradation . 
        Figure 3.6: Expression profiles of some other reaction species in the model 
The expression profile of some other important species in the pathways are given in 
the Figure 3.6. The first graph indicates how free LPS level change in the in silico 
environment. The next two graphs indicate free TBKa and TBK profiles. We know 
experimentally that TBK1 has rapid response to LPS stimulations and TBK1 activity 
show remarkable increase at the first 15th min after LPS stimulation (Solis et al., 
2007). The second graph in the second row represents active and inactive IRF3 
profiles in the nucleus. Last two graphs represent the surface receptor concentration 
change for IFNAR and TLR4. While initially concentration decreases because of 
degradation and internalization, due to dicrease in the ligand, receptor synthesis rate 
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or recycling back to surface overcome the degradation or internalization rate and 
surface receptor concentration begins to be recovered by time. These results are in 
parallel with the experimental results indicating the recovery and recycling of 
interferon receptor to the surface (Kalie et al.,  2008). To obtain receptor 
concentration, either the number of the receptors can be divided by an average cell 
volume or titration curve and Kd values can be utilized. It is assumed that on average 
100-5000, Novick et al. (1995) and Uze et al. (2007), interferon receptor per cell 
exist. However for example in Daudi cell this number is around 1.1*104  (Cutrone 
and Langer, 1997). While the calculation for Daudi cells 5.5*10 -3 µM receptor, these 
values varies for different cell types and sizes.  A receptor concentration of 4*10-3 
µM fulfills the empirical IFN" profile, which remains in the feasible range. From the 
titration curve and so from Kd value, the concentration for TLR4 is around 1-1.2*10-
2µM obtained (Visintin et al, 2010). Simulations satisfy empirical values around 
5.6*10-3 with in viable limits concerning the differentiation in cell types with a value 
around 3*10-3 µM (Figure 3.6). 
The parameter values utilized at the model are in the Table 1 given below. 
Deterministic Modeling gives population average results, however, the behaviour of 
single cells can deviate drastically from the population average. Even though we may 
try to attain some empirical values, results from cell cultures can be deceptive, 
because of the immortalization process and duration of ex vivo cultivation. A similar 
problem also exists for in vitro studies because of a loss of natural surroundings, 
three-dimensional structure with numerous regulatory loops and feedback regulations 
exerted by extracellular factors or cell-cell signaling (Froese et al., 2006). Therefore, 
slight deviations from the parameters in the model to some extend can still lead to 
biologically feasible results for different cell types and cell environment. The model 
parameters and sources are listed in Table 1. 
Colour codes 
         Parameters fit, lighter yellows are the ones that we have some comparison or information. 
         Parameters very close to or same with the A20 model for TNFR (Werner et al., 2008). 
         The model is very sensitive to these parameters at least in some range. We have references for these values  
          from the literature. 
       These values are same with yellow ones, if we know yellows we know these values also 
         We know these values from the literature. 
          Not active 
          Insensitive to these parameters in a wide range. 
          We know one of these values for another system. 
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Table 3.1: The list of model parameters and sources.  
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Table 3.1 (continued): The list of model parameters and sources. 
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Table 3.1 (continued): The list of model parameters and sources. 
 
 
88 
Table 3.1 (continued): The list of model parameters and sources. 
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3.3 The Results for the PKR Connection 
The ISGF3 outcome and the model are tested for published PKR profiles (Donze et 
al., 2004; Hsu et al., 2004). PKR is one of the products of the pathway responsible 
for broad antiviral and anticellular actions and important because several cancer 
drugs target and modulate PKR action (García et al., 2006; Yoon et al., 2009). 
Assuming that the late phase activity of PKR arises only because of the synthesis 
from ISRE site, in silico ISGF3 dependent PKR profile and empirical data is 
compared in Figure 3.7.  
 
 Figure 3.7: a), b), d) NIH3T3 cell extracts immunoblotting results with an anti- 
PKR antibody (Donze et al., 2004) (The red line in the graph. The Data 
are normalized). PKR activation under the influence of 100 ng/ml LPS. 
PKR examined in lysed cells (illustrated by blue), Hsu et al., (2004), the 
outcome model (green line). c) the profile of proposed molecule 
inserting negative feedback on PKR. d) PKR negative feedback on its 
self by inhibiting the phosphorylation of STAT.  
Utilization of an empirical IFNbeta profile, Qin et al (2005), in the system resulted in 
a PKR expression reflecting similar characteristics in first incline and position of the 
peak for the late phase activity of PKR. The slight deviation in the position of first 
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incline is a result of reduction in the steps of ISGF3 production in the model. Since 
we do not have data about the amplitude of the expression, the highest peak of PKR 
is normalized to one. The data form NIH3T3 cell ,Donze et al. (2004), does not 
include the profile after 420 min and data from bone-marrow-derived macrophages, 
Hsu et al. (2006), have a sharper decline which can be a result of a negative feedback 
on PKR production (Figure 3.7-b and 3.7-d) such as a feedback on itself (Figure 3.7-
d), other feedback mechanisms effecting phosphorylated STAT dimmer profiles, 
Yamada et al. (2003), having a different IFN profile for this cell line, or having a 
higher receptor internalization rate for this cell type.  To determine which 
mechanisms are responsible for the decline we need to have more data for IFN, PKR 
data of single cell line. 
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4. CONCLUSIONS 
Notwithstanding the extensive number of experimental data for PAMPs, the 
correlations among them are unclear and many data are inconsistent. Computational 
modeling and system biology tools brings these data together and helps to analyse 
the whole picture for the system of the concern. In this study we utilized some of 
these methods to explain the mechanisms regulating the NF!B, and to model TLR4 
and IFN" pathways. 
The study was initialized with modeling of NF!B-I!B signaling module. To 
recapitulate the expression of each species,  corresponding transfer functions were 
obtained via  Matlab curve fiting algorithm. To observe the behavior of each species 
inside the system, each function was optimized as a part of the whole system by 
minimizing least mean square difference with their parameterized version. The 
model was constructed in a way that in addition to the parameters of the transfer 
function, also parameters related with delays and feedbacks can be optimized. The 
difference between each transfer function was minimized by use of genetic 
algorithms and results were refined by use of pattern search algorithm. Even though 
the first attempts were in the directions of resolving the feedback mechanisms of I!B 
isoforms, in spite of large search space and the feedback inputs causing a 
computationally infeasible model, the chosen method combining optimization 
techniques, control diagrams and feedbacks in Simulink enviroment appeared to be 
unproductive.  
ODEs expilicitly include many reaction kinetics rates. The direct comparison of 
these parameters with actual system rate data provides guidance to realize the model, 
however, the link between transfer function parameters  and  actual system is 
diffucult to interpret which makes transfer function models difficult to handle. In 
addition to these handicaps, a library of I!B isoforms for different doses of stimuli is 
a must for such a model, because of the fact that each transfer function is a specific 
solution of the system and in nonlinear systems, dose dependent attributes of 
individual species can demonstrate large variations under different conditions. 
Evaluating the efficiency of the method, problem reduced to the optimization of 
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some specific parameters and single feedback mechanism due to increased level of 
NF!B. This reduction let a simplified model of the system for a well-defined 
expression profile under some initial conditions. At the end of simulations we were 
able to attain a NF-!B profiles that match with the emperical data in main 
characteristics, except the amplitude of the initial peak within a feasible range caused 
by cell differentiation and with some deviation of the first peak position. The model 
can be enlarged to the previously proposed model including the other species only if 
we know the behaviour of the species under a set of different conditions, and only 
after that it can be used to determine the behaviour of the remaining other very 
restricted number of the species and mechanisms.  At this stage we are totally 
restricted by the lack of experimental data. On the other hand, as applied on LPS 
stimulated pathway, Covert et al., (2005), especially at the initial stage of the 
cascades, it is very effective tool just to represent a vague part of the signaling 
pathway and can be used as a link between signal and outcome of a specific step.  
As second stage of the study, to determine the mechanisms regulating the NF!B, we 
utilized reaction kinetics ODEs. In this context both TLR4 and Interferon Beta 
pathways are combined in an in silico model. Simulation results are validated by 
empirical expression profiles for IFN" and IRF3. ISGF3 responses for different 
doses of LPS and interferon treatment are proposed in parallel to the present data in 
literature. To explain the transcription factors and interferon profiles, receptor 
metabolism makes use of as an important and determining step as also validated by 
previous experimental studies (Kagan et al., 2008; Marchetti et al., 2006). In 
transcriptional regulation of IFN", to restrict the transcription with a limit, we 
utilized a hybrid method combining a statistical approach and ODEs. The resultant 
IFN" initiates IFNAR signaling cascade. The extension of the IFN" pathway in a 
way including the related gene expressions can enlighten other regulatory 
mechanisms between the two pathways. The concomitant ISGF3 profile needs to be 
validated by further experimental gel shift data but concerning the number of steps, 
similarity to IRF3 profile is an expected result. PKR transcribed by ISGF3 is 
presumed to have a role in NF!B regulation. Having a model for PKR production 
provides the opportunity to model other important factors regulated by PKR. There 
are published expression profiles for PKR for both early and late responses of the 
system. Our initial findings indicate very similar profiles with the late phase of 
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empirical ones. Having a PKR profile could allow us to refine the current NF!B 
models.  
In addition to being the first study combining the TLR4 and Interferon beta pathways 
in a single in silico model and analyzing how they communicate with each other, the 
content of this part of the study also can be evaluated and has a value as review of 
the literature for both pathways and their interactions. This model utilized the TLR4 
internalization and other receptor metabolism as important and determining steps in 
explaining the transcription factors and interferon profiles as already validated by the 
experimental studies (Kagan et al., 2008; Marchetti et al., 2006). Thus, in aspect and 
focus, it is different from other LPS models in the literature remaining the 
mechanism at this stage elusive and bringing about explanations either utilizing the 
transfer functions, Covert et al. (2005), or suggesting additional unidentified 
intermediate species (Selvarajoo, 2006). The model was designed to explain two vital 
pathogen activated pathways and at least it seems to bring about one of the best 
approaches for interferon beta production through LPS stimulation, both because of 
involving receptor internalization and because of its efficiency in recapitulation of 
empirical data. A reported statistical physics method, Bintu et al. (2005), is adopted 
to simulate the AND gate characteristic exhibited by NF"B and IRF3 at interferon 
transcription. This part of the study is also original because of the utilization way of 
the method in a pathogen activated pathway model to limit transcription and together 
with detailed model structure, this methodology provided the opportunity to mimic 
nonlinear dose response relation in the pathway. The same methodology is also 
applied for PKR transcription but this time for single transcription factor. Simulation 
results were validated by empirical expression profiles for IFN" and IRF3. ISGF3 
responses for different doses of LPS and interferon treatment are proposed in parallel 
to the present data in literature. The concomitant ISGF3 profile needs to be validated 
by further experimental gel shift data. At the down stream of ISGF3, PKR is 
responsible for broad antiviral, anticellular actions of the pathway and hence several 
cancer drugs target and modulates it activity. Concerning its importance, the model is 
tested for published PKR profiles. The model also provides a realistic approach in  
the timing of late phase in the PKR expression profile. While the simulation results 
are able to recapitulate the experimental expression profiles of IFN", IRF3, Qin et al. 
(2005) and PKR, Donze et al. (2004); Hsu et al. (2004), the model is also supported 
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by literature  data related with rate parameters .  
To shed light on the whole picture, epigenetics is another factor having a role in the 
differentiation of specialized immune cells for IFN" regulation. Concerning this 
factor, in addition to the statistical method used here at transcription level, factors 
like chromosome folding may be employed to refine the model as  a further study.  
The deterministic modeling approach in the case of ODEs only produces data about 
the behaviour of population average. Today it is possible to gather plenty of data 
from single cell experiments such as conducted by micro-fluidic devices. To explain 
single cell behaviour I designed a model (at UCSD Centre of Theoretical Biological 
Physics) and obtained first results for IFN" production. The insertion of this model 
in the large system is still on process. 
The attempts restricted in a single pathway can be possibly misleading because of 
extensive communication between the parts of immune system. This model 
developed as a part of a larger model involving other main pathogen activated 
pathways and the results are planed to be utilized in the regulation of other important 
transcription factor profiles such as NF!B. 
In addition to communication of Type I interferon and TLR4 pathways, TNF# 
pathway is important factor effecting the late phase of NF!B because of the fact that 
the induction of TNF# through Triff dependent part of TLR4 pathway introduce the 
system with extra IKK (Lee  et al, 2009). Even though insertion of this mechanism in 
probabilistic sense very effectively to handle the problem of the late phase regulation 
in a stochastic manner, Lee  et al. (2009), the presence of other mechanism effective 
through TNF# should be also concerned. For example in Multiple Sclerosis (MS) 
disease, IFN" medication results with a better prognose of the disease by reduction 
of the relapses (Gayo  et al., 1999). This is a result of a decrease in TNF# production 
under the drug (interferon 1b) treatment (Gayo et al., 1999). It is known that TNF# 
causes the lost of myelin sheets which is the source of MS. By involving the 
mechanisms of IFN" dependent TNF# synthesis reduction, I am about to bring in a 
more realistic approach for the rates of the reported stochastic model, Lee et al. 
(2009), and improve the model by combining linked TLR4 and IFN" with this 
system trough PKR. This combination will result with a large hybrid model including 
very important four pathway of innate immune system for the first time in literature 
and will result with a refinement of the current main well known models of the 
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distinct pathways.  
Even though this study begin by supposing and proposing the late phase activity of 
LPS stimulated pathway can be explained by defining the behaviour of the each 
intermediate by transfer functions and later it appears that this method is a not 
effective tool for such an system. However, with the ODEs model presented here two 
important pathways regulating to responses to bacterias (LPS-MyD88 pathway) and 
virus (IFN" pathway)  successfully modeled and new insights in to NF!B regulation 
are brought and suggested. 
Involvement of many cross talk and feedback mechanisms to deal with pathogens 
makes immune system highly challenging in Modeling aspects, but bacteria and 
viruses have very effective tools to cope with these complicated challenging 
mechanisms, mostly based on their easily adaptable basic structures, large numbers 
and sophisticated decision making strategies to survive. Resolving the mechanisms in 
both bacterial and immune system site could provide the chance for better 
therapeutics, but still we are far away to resolve whole mechanism of very primitive 
structures and many important parts of the immune system is still elusive. 
The bacterial decision making sometimes shows similarities with highly developed 
organisms and can be explained with game theory approaches more sophisticated 
than the classic game theory problem called as the Prisoner`s Dilemma (Schoultz et 
al., 2009). Under adverse stress conditions 10% of bacteria population chose a state 
called competence, while 50-70% of the population either die directly or commit to 
sporulation, which is a stage not able to validate immediate favourable conditions. 
The bacteria under competence stage can take the advantage of lysed other bacterial 
cells genetic material to repair itself (Schoultz et al., 2009). In some cases the 
population survival become only possible by the bacteria’s choosing competence 
mode. Similar rates are also valid in other life-forms. For example, to find food while 
the most of rats goes to known main food source, the other members of population 
search for other alternatives. In the cases of insufficieny in the main known food 
source, the members searching for alternatives can be only hope for the population. 
The behavioral observations of different life-forms indicating similar rates in 
searching alternatives can yeild a question: is it posibble use the renormalization 
methods to understand decision-making strategies of different life-forms regardless 
of their complexity level? Actually a more important question that can arise is: how 
logical for a population to prevent the members searching for alternatives or a better 
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one how logical to prevent young scientist searching for alternatives by isolating 
intellectualy or treat them with mobing methodologies? 
Pathogen life forms and immune systems evolves their own strategies in the battle 
between and the systems gained complex attributes challing the system biologist. 
Researches conducted in both type of of life forms have great value, to understand 
life and deal with human sicknesses. 
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APPENDIX A 
 
A1-)The Code Calling the File in Figure 3.1c 
----------------------------------------------------------------------------------------------------------------
- 
function z=yeniseri37u(x) 
global k1 k2 k3 a1 a3 K1%The global variables should also defined in 
command window. 
k1=x(1); 
k2=x(2); 
k3=x(3); 
a1=x(4); 
a3=x(5); 
K1=x(6); 
sim('yeniseri301u'); 
z= hata(101); 
 
A2-) The Optimization Code  
(this code calls the yeniseri37u and yeniseri37u calls yeniseri301u)  
----------------------------------------------------------------------------------------------------------------
- 
function [x,fval,exitflag,output,population,score] = 
yeniseri37u(nvars,lb,ub,PopulationSize_Data) 
% This is an auto generated M-file from Optimization Tool. 
% Start with the default options 
options = gaoptimset; 
% Modify options setting 
options = gaoptimset(options,'PopulationSize', 40); 
options = gaoptimset(options,'SelectionFcn', {  
@selectiontournament [] }); 
options = gaoptimset(options,'HybridFcn',     {  @patternsearch 
[] }); 
options = gaoptimset(options,'Display', 'off'); 
[x,fval,exitflag,output,population,score] = ... 
ga(@yeniseri37u,6,[],[],[],[],[],[0 0 0 0 0 0],[1 1 1 1 1 
1],options); 
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A3-) The Simulink Code in Figure 
3.1c
-------------------------------- 
Model { 
  Name 
 
"yeniseri301u" 
  Version 
 
   
7.4 
  MdlSubVersion 
 
    
0 
  GraphicalInterface     { 
    NumRootInports              0 
    NumRootOutports 
          
0 
    ParameterArgumentNames     "" 
    ComputedModelVersion     
"1.48" 
    NumModelReferences 
0 
    NumTestPointedSignals       0 
  } 
  SavedCharacterEncoding      
"windows-1254" 
  SaveDefaultBlockParams     
on 
  ScopeRefreshTime            
0.035000 
  OverrideScopeRefreshTime   
on 
  DisableAllScopes            
off 
  DataTypeOverride           
"UseLocalSettings" 
  MinMaxOverflowLogging 
"UseLocalSettings" 
  MinMaxOverflowArchiveMode  
"Overwrite" 
  MaxMDLFileLineLength 
120 
  Created 
 
  
"Thu Apr 17 11:39:25 2008" 
  Creator 
 
    
"REGAL" 
  UpdateHistory 
 
           "UpdateHistoryNever" 
  ModifiedByFormat              "%<Auto>" 
  LastModifiedBy 
              "aylingunel" 
  ModifiedDateFormat           
"%<Auto>" 
  LastModifiedDate        "Tue Dec 11 16:26:31 2012" 
  RTWModifiedTimeStamp 
 276895188 
  ModelVersionFormat          "1.%<AutoIncrement:48>" 
  ConfigurationManager 
     "None" 
  SampleTimeColors                       
off 
  SampleTimeAnnotations 
off 
  LibraryLinkDisplay                    "none" 
  WideLines 
 
                
off 
  ShowLineDimensions                 
off 
  ShowPortDataTypes 
                    off 
  ShowLoopsOnError                       
 on 
  IgnoreBidirectionalLines               off 
  ShowStorageClass                         off 
  ShowTestPointIcons                     on 
  ShowSignalResolutionIcons              on 
  ShowViewerIcons 
                       on 
  SortedOrder 
 
                    off 
  ExecutionContextIcon                   off 
  ShowLinearizationAnnotations           on 
  BlockNameDataTip                       off 
  BlockParametersDataTip                 off 
  BlockDescriptionStringDataTip     
off 
  ToolBar 
 
                 
on 
  StatusBar 
 
                 
on 
  BrowserShowLibraryLinks            
off 
  BrowserLookUnderMasks 
off 
  SimulationMode 
                     
"normal" 
  LinearizationMsg                      
"none" 
  Profile 
 
                
off 
  ParamWorkspaceSource          "MATLABWorkspace" 
  AccelSystemTargetFile         "accel.tlc" 
  AccelTemplateMakefile         "accel_default_tmf" 
  AccelMakeCommand               "make_rtw" 
  TryForcingSFcnDF                
off 
  RecordCoverage 
               
off 
  CovPath 
 
            
 
"/" 
  CovSaveName 
 
             "covdata" 
  CovMetricSettings 
             "dw" 
  CovNameIncrementing 
   off 
  CovHtmlReporting                 on 
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  CovForceBlockReductionOff    
   on 
  covSaveCumulativeToWorkspaceVar on 
  CovSaveSingleToWorkspaceVar     on 
  CovCumulativeVarName 
  "covCumulativeData" 
  CovCumulativeReport 
  off 
  CovReportOnPause                on 
  CovModelRefEnable 
            "Off" 
  CovExternalEMLEnable 
  off 
  ExtModeBatchMode                off 
  ExtModeEnableFloating 
  on 
  ExtModeTrigType 
               "manual" 
  ExtModeTrigMode 
               "normal" 
  ExtModeTrigPort 
               "1" 
  ExtModeTrigElement            "any" 
  ExtModeTrigDuration 
 1000 
  ExtModeTrigDurationFloating  "auto" 
  ExtModeTrigHoldOff              0 
  ExtModeTrigDelay                 0 
  ExtModeTrigDirection 
 "rising" 
  ExtModeTrigLevel                0 
  ExtModeArchiveMode             "off" 
  ExtModeAutoIncOneShot 
  off 
  ExtModeIncDirWhenArm 
  off 
  ExtModeAddSuffixToVar 
  off 
  ExtModeWriteAllDataToWs        off 
  ExtModeArmWhenConnect 
  on 
  ExtModeSkipDownloadWhenConnect  off 
  ExtModeLogAll 
 
             on 
  ExtModeAutoUpdateStatusClock    off 
  BufferReuse 
 
             on 
  ShowModelReferenceBlockVersion  off 
  ShowModelReferenceBlockIO       off 
  Array { 
    Type 
 
               "Handle" 
    Dimension 
 
               1 
    Simulink.ConfigSet { 
      $ObjectID 
 
               1 
      Version 
 
              "1.6.0" 
      Array { 
 
Type 
 
 
"Handle" 
 
Dimension 
 
9 
              Simulink.SolverCC { 
 
$ObjectID 
 
         2 
 
Version                     "1.6.0" 
 
StartTime                   "0.0" 
 
StopTime 
 
         "10.0" 
 
AbsTol                      "auto" 
 
      FixedStep 
 
        "auto" 
 
      InitialStep  
        "auto" 
 
      MaxNumMinSteps             "-1" 
 
      MaxOrder 
5 
 
      ZcThreshold  
        "auto" 
 
      ConsecutiveZCsStepRelTol   "10*128*eps" 
 
      MaxConsecutiveZCs 
        "1000" 
 
      ExtrapolationOrder    
  4 
 
      NumberNewtonIterations      1 
 
      MaxStep 
 
         "auto" 
 
      MinStep 
 
         "auto" 
 
      MaxConsecutiveMinStep 
   "1" 
 
      RelTol 
 
         "1e-3" 
 
      SolverMode                  "Auto" 
 
      Solver 
 
         "ode45" 
 
      SolverName                  "ode45" 
 
      ShapePreserveControl 
  "DisableAll" 
 
  ZeroCrossControl       "UseLocalSettings" 
 
  ZeroCrossAlgorithm     "Nonadaptive" 
 
  AlgebraicLoopSolver    "TrustRegion" 
 
  SolverResetMethod 
    "Fast" 
 
  PositivePriorityOrder   off 
 
  AutoInsertRateTranBlk   off 
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  SampleTimeConstraint   "Unconstrained" 
 
  InsertRTBMode 
   "Whenever possible" 
 
} 
 
Simulink.DataIOCC { 
 
  $ObjectID 
 
    3 
 
  Version                 "1.6.0" 
 
  Decimation 
 
   "1" 
 
  ExternalInput  
   "[t, u]" 
 
  FinalStateName 
   "xFinal" 
 
  InitialState 
 
   "xInitial" 
 
  LimitDataPoints         on 
 
  MaxDataPoints  
   "1000" 
 
  LoadExternalInput 
    off 
 
  LoadInitialState        off 
 
  SaveFinalState          off 
 
  SaveCompleteFinalSimState off 
 
  SaveFormat 
 
    "Array" 
 
  SaveOutput 
 
    on 
 
  SaveState 
 
    off 
 
  SignalLogging  
    on 
 
  InspectSignalLogs 
    off 
 
  SaveTime 
 
    on 
 
  ReturnWorkspaceOutputs   off 
 
  StateSaveName  
    "xout" 
 
  TimeSaveName 
 
    "tout" 
 
  OutputSaveName           "yout" 
 
  SignalLoggingName 
    "logsout" 
 
  OutputOption 
  "RefineOutputTimes" 
 
  OutputTimes 
 
     "[]" 
 
  ReturnWorkspaceOutputsName "out" 
 
  Refine  
            "1" 
 
} 
 
Simulink.OptimizationCC { 
 
  $ObjectID 
 
  4 
 
  Version  
  "1.6.0" 
 
  Array { 
 
    Type 
 
           "Cell" 
 
    Dimension                4 
 
    Cell 
"ZeroExternalMemoryAtStartup" 
 
    Cell 
"ZeroInternalMemoryAtStartup" 
 
    Cell 
"NoFixptDivByZeroProtection" 
 
    Cell 
"OptimizeModelRefInitCode" 
 
    PropName           "DisabledProps" 
 
  } 
 
  BlockReduction 
on 
 
  BooleanDataType           on 
 
  ConditionallyExecuteInputs  on 
 
  InlineParams 
off 
 
  UseIntDivNetSlope 
off 
 
  InlineInvariantSignals    off 
 
  OptimizeBlockIOStorage    on 
 
  BufferReuse 
on 
 
  EnhancedBackFolding 
off 
 
  StrengthReduction 
off 
 
  EnforceIntegerDowncast    on 
 
  ExpressionFolding 
on 
 
  BooleansAsBitfields 
off 
 
  EnableMemcpy              on 
 
  MemcpyThreshold 
64 
 
  PassReuseOutputArgsAs "Structure reference" 
 
  ExpressionDepthLimit     2147483647 
 
  FoldNonRolledExpr 
on 
 
  LocalBlockOutputs 
on 
 
  RollThreshold  
5 
 
  SystemCodeInlineAuto  
off 
 
  StateBitsets 
off 
 
  DataBitsets 
off 
 
  UseTempVars 
off 
 
  ZeroExternalMemoryAtStartup on 
                  ZeroInternalMemoryAtStartup  on 
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                  InitFltsAndDblsToZero        on 
                  NoFixptDivByZeroProtection   off 
                  EfficientFloat2IntCast       off 
                  EfficientMapNaN2IntZero      on 
                  OptimizeModelRefInitCode     off 
                  LifeSpan                    "inf" 
 
  BufferReusableBoundary       on 
 
  SimCompilerOptimization     "Off" 
 
  AccelVerboseBuild 
        off 
 
} 
 
Simulink.DebuggingCC { 
 
  $ObjectID 
 
         5 
 
  Version 
               "1.6.0" 
 
  RTPrefix 
               "error" 
 
  ConsistencyChecking 
        "none" 
 
  ArrayBoundsChecking 
        "none" 
 
  SignalInfNanChecking         "none" 
 
  SignalRangeChecking          "none" 
 
  ReadBeforeWriteMsg "UseLocalSettings" 
 
  WriteAfterWriteMsg "UseLocalSettings" 
 
  WriteAfterReadMsg  "UseLocalSettings" 
 
  AlgebraicLoopMsg 
      "warning" 
 
  ArtificialAlgebraicLoopMsg "warning" 
 
  SaveWithDisabledLinksMsg   "warning" 
 
  SaveWithParameterizedLinksMsg "none" 
 
  CheckSSInitialOutputMsg          on 
          UnderspecifiedInitializationDetection  "Classic" 
          MergeDetectMultiDrivingBlocksExec       "none" 
          CheckExecutionContextPreStartOutputMsg     off 
          CheckExecutionContextRuntimeOutputMsg      off 
          SignalResolutionControl       "UseLocalSettings" 
                    BlockPriorityViolationMsg  "warning" 
 
  MinStepSizeMsg 
      "warning" 
 
  TimeAdjustmentMsg             "none" 
 
  MaxConsecutiveZCsMsg         "error" 
 
  SolverPrmCheckMsg 
      "warning" 
 
      InheritedTsInSrcMsg        "warning" 
 
      DiscreteInheritContinuousMsg  "warning" 
 
        MultiTaskDSMMsg                "error" 
 
        MultiTaskCondExecSysMsg       "error" 
 
        MultiTaskRateTransMsg         "error" 
 
        SingleTaskRateTransMsg        "none" 
 
  TasksWithSamePriorityMsg      "warning" 
 
  SigSpecEnsureSampleTimeMsg    "warning" 
 
  CheckMatrixSingularityMsg     "none" 
 
  IntegerOverflowMsg 
          "warning" 
 
  Int32ToFloatConvMsg           "warning" 
 
  ParameterDowncastMsg           "error" 
 
  ParameterOverflowMsg           "error" 
 
  ParameterUnderflowMsg         "none" 
 
  ParameterPrecisionLossMsg     "warning" 
 
  ParameterTunabilityLossMsg    "warning" 
 
  FixptConstUnderflowMsg        "none" 
 
  FixptConstOverflowMsg 
   "none" 
 
  FixptConstPrecisionLossMsg    "none" 
 
  UnderSpecifiedDataTypeMsg     "none" 
 
  UnnecessaryDatatypeConvMsg    "none" 
 
  VectorMatrixConversionMsg     "none" 
 
  InvalidFcnCallConnMsg         "error" 
 
  FcnCallInpInsideContextMsg    "Use local settings" 
 
  SignalLabelMismatchMsg        "none" 
 
  UnconnectedInputMsg 
         "warning" 
 
  UnconnectedOutputMsg          "warning" 
 
  UnconnectedLineMsg 
         "warning" 
 
  SFcnCompatibilityMsg          "none" 
 
  UniqueDataStoreMsg 
          "none" 
 
  BusObjectLabelMismatch        "warning" 
 
  RootOutportRequireBusObject   "warning" 
 
  AssertControl                  "UseLocalSettings" 
 
  EnableOverflowDetection       off 
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  ModelReferenceIOMsg 
          "none" 
 
   ModelReferenceVersionMismatchMessage "none" 
 
        ModelReferenceIOMismatchMessage     "none" 
 
        ModelReferenceCSMismatchMessage     "none" 
 
        UnknownTsInhSupMsg 
             "warning" 
 
        ModelReferenceDataLoggingMessage  "warning" 
 
        ModelReferenceSymbolNameMessage  "warning" 
 
        ModelReferenceExtraNoncontSigs    "error" 
 
  StateNameClashWarn 
                  "warning" 
 
  SimStateInterfaceChecksumMismatchMsg  "warning" 
 
  StrictBusMsg 
 
                  "Warning" 
 
  LoggingUnavailableSignals           "error" 
 
  BlockIODiagnostic                   "none" 
 
} 
 
Simulink.HardwareCC { 
 
  $ObjectID 
 
                  6 
 
  Version 
 
                        "1.6.0" 
 
  ProdBitPerChar 
                  8 
 
  ProdBitPerShort 
                  16 
 
  ProdBitPerInt 
 
           32 
 
  ProdBitPerLong 
                  32 
 
  ProdIntDivRoundTo                   "Undefined" 
 
  ProdEndianess 
                "Unspecified" 
 
  ProdWordSize 
 
     32 
 
  ProdShiftRightIntArith   on 
 
  ProdHWDeviceType "32-bit Generic" 
 
  TargetBitPerChar         8 
 
  TargetBitPerShort 
    16 
 
  TargetBitPerInt 
    32 
 
  TargetBitPerLong 
    32 
 
  TargetShiftRightIntArith on 
 
  TargetIntDivRoundTo 
 "Undefined" 
 
  TargetEndianess 
 "Unspecified" 
 
  TargetWordSize 
 32 
 
  TargetTypeEmulationWarnSuppressLevel 0 
 
  TargetPreprocMaxBitsSint     32 
 
  TargetPreprocMaxBitsUint     32 
 
  TargetHWDeviceType 
   "Specified" 
 
  TargetUnknown  
                            off 
 
  ProdEqTarget 
 
 
                      } 
 
  Simulink.ModelReferenceCC                  { 
 
  $ObjectID 
 
                            7 
 
  Version  
                              "1.6.0" 
 
  UpdateModelReferenceTargets "IfOutOfDateOrStructuralChange" 
 
  CheckModelReferenceTargetMessage            "error" 
 
  ModelReferenceNumInstancesAllowed           "Multi" 
 
  ModelReferencePassRootInputsByReference     on 
 
  ModelReferenceMinAlgLoopOccurrences         off 
 
} 
 
Simulink.SFSimCC { 
 
  $ObjectID 
 
                           8 
 
  Version  
                            "1.6.0" 
 
  SFSimEnableDebug                           on 
 
  SFSimOverflowDetection                    on 
 
  SFSimEcho 
 
                          on 
 
  SimBlas  
                             on 
 
  SimCtrlC 
 
                          on 
 
  SimExtrinsic 
 
                          on 
 
  SimIntegrity 
 
                          on 
 
  SimUseLocalCustomCode 
                    off 
 
  SimBuildMode 
 
        "sf_incremental_build" 
 
} 
 
Simulink.RTWCC { 
 
  $BackupClass 
 
                "Simulink.RTWCC" 
 
  $ObjectID 
 
                 9 
 
  Version 
 
          "1.6.0" 
 
  Array { 
 
    Type 
 
            "Cell" 
 
    Dimension 
 
                 1 
 
    Cell "IncludeHyperlinkInReport" 
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    PropName 
"DisabledProps" 
 
  } 
 
  SystemTargetFile   "grt.tlc" 
 
  GenCodeOnly  
                 off 
 
  MakeCommand 
 
                 "make_rtw" 
 
  GenerateMakefile 
           on 
 
  TemplateMakefile 
          "grt_default_tmf" 
 
  GenerateReport                  off 
 
  SaveLog 
 
                 off 
 
  RTWVerbose 
 
                 on 
 
  RetainRTWFile 
 
           off 
 
  ProfileTLC 
 
                 off 
 
  TLCDebug 
 
                 off 
 
  TLCCoverage 
 
                 off 
 
  TLCAssert 
 
                 off 
 
  ProcessScriptMode 
          "Default" 
 
  ConfigurationMode 
          "Optimized" 
 
  ConfigAtBuild 
 
           off 
 
  RTWUseLocalCustomCode            off 
 
  RTWUseSimCustomCode 
           off 
 
  IncludeHyperlinkInReport        off 
 
  LaunchReport  
                 off 
 
  TargetLang 
 
                 "C" 
 
  IncludeBusHierarchyInRTWFileBlockHierarchyMap off 
      IncludeERTFirstTime                       off 
 
 GenerateTraceInfo 
                         off 
 
 GenerateTraceReport 
                  off 
 
 GenerateTraceReportSl                   off 
 
 GenerateTraceReportSf                   off 
 
 GenerateTraceReportEml                    off 
 
 GenerateCodeInfo 
                         off 
 
 RTWCompilerOptimization                  "Off" 
 
 CheckMdlBeforeBuild 
                 "Off" 
 
 Array { 
      Type 
 
                           "Handle" 
      Dimension 
 
            2 
      Simulink.CodeAppCC { 
      $ObjectID 
 
           10 
      Version 
 
        "1.6.0" 
      Array { 
 
 
 Type 
                              "Cell" 
 
 
 Dimension 
 
                       16 
 
 
 Cell 
        "IgnoreCustomStorageClasses" 
 
 
 Cell 
                   "InsertBlockDesc" 
 
 
 Cell 
 
 
       "SFDataObjDesc" 
 
  Cell 
 
 
        "SimulinkDataObjDesc" 
 
 Cell 
 
 
        "DefineNamingRule" 
 
 Cell 
 
 
        "SignalNamingRule" 
 
 Cell 
 
 
        "ParamNamingRule" 
 
 Cell 
 
 
        "InlinedPrmAccess" 
 
 Cell 
 
 
        "CustomSymbolStr" 
 
 Cell 
 
 
"CustomSymbolStrGlobalVar" 
 
 Cell 
 
 
     "CustomSymbolStrType" 
 
 Cell 
 
 
    "CustomSymbolStrField" 
 
 Cell 
 
 
    "CustomSymbolStrFcn" 
 
 Cell 
 
           "CustomSymbolStrBlkIO" 
 
 Cell 
 
 
    "CustomSymbolStrTmpVar" 
 
 Cell 
 
 
    "CustomSymbolStrMacro" 
 
 PropName 
 
          "DisabledProps" 
 
      } 
 
 ForceParamTrailComments              off 
 
 GenerateComments 
                 on 
 
 IgnoreCustomStorageClasses           on 
 
 IgnoreTestpoints 
                 off 
 
 IncHierarchyInIds 
                 off 
 
 MaxIdLength 
                        31 
 
 PreserveName                         off 
 
 PreserveNameWithParent               off 
 
 ShowEliminatedStatement              off 
 
 IncAutoGenComments                   off 
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 SimulinkDataObjDesc                  off 
 
 SFDataObjDesc                        off 
 
 IncDataTypeInIds 
                 off 
 
 MangleLength 
                        1 
 
 CustomSymbolStrGlobalVar       "$R$N$M" 
 
  CustomSymbolStrType                "$N$R$M" 
 
  CustomSymbolStrField               "$N$M" 
 
  CustomSymbolStrFcn                 "$R$N$M$F" 
 
  CustomSymbolStrFcnArg              "rt$I$N$M" 
 
  CustomSymbolStrBlkIO               "rtb_$N$M" 
 
  CustomSymbolStrTmpVar              "$N$M" 
 
  CustomSymbolStrMacro               "$R$N$M" 
 
      DefineNamingRule                    "None" 
 
      ParamNamingRule                    "None" 
 
      SignalNamingRule                    "None" 
 
      InsertBlockDesc                    off 
 
      SimulinkBlockComments              on 
 
      EnableCustomComments               off 
 
      InlinedPrmAccess                    "Literals" 
 
      ReqsInCode 
                   off 
 
      UseSimReservedNames                off 
 
    } 
 
    Simulink.GRTTargetCC { 
 
      $BackupClass 
     "Simulink.TargetCC" 
 
      $ObjectID  
                   11 
 
      Version  
                         "1.6.0" 
 
      Array { 
 
 
Type 
 
 
                  "Cell" 
 
 
Dimension 
 
                  15 
 
 
Cell 
 
 
       "IncludeMdlTerminateFcn" 
 
 
Cell 
 
 
       "CombineOutputUpdateFcns" 
 
     Cell 
 
 
"SuppressErrorStatus" 
 
     Cell 
 
 
"ERTCustomFileBanners" 
 
     Cell   
              "GenerateSampleERTMain" 
 
     Cell 
              "GenerateTestInterfaces" 
 
    Cell "ModelStepFunctionPrototypeControlCompliant" 
 
    Cell 
                "MultiInstanceERTCode" 
           Cell 
 
 
       "PurelyIntegerCode" 
           Cell 
 
 
       "SupportNonFinite" 
           Cell 
 
 
       "SupportComplex" 
           Cell 
 
 
       "SupportAbsoluteTime" 
           Cell 
"SupportContinuousTime" 
           Cell 
        "SupportNonInlinedSFcns" 
           Cell 
        "PortableWordSizes" 
 
 
     PropName  
"DisabledProps" 
 
      } 
 
      TargetFcnLib 
"ansi_tfl_tmw.mat" 
 
      TargetLibSuffix   "" 
 
      TargetPreCompLibLocation "" 
 
      TargetFunctionLibrary   "ANSI_C" 
 
      UtilityFuncGeneration    "Auto" 
 
      ERTMultiwordTypeDef      "System defined" 
 
      ERTMultiwordLength        256 
 
      MultiwordLength           2048 
 
      GenerateFullHeader        on 
 
      GenerateSampleERTMain     off 
 
      GenerateTestInterfaces    off 
 
      IsPILTarget 
          off 
 
      ModelReferenceCompliant   on 
 
      ParMdlRefBuildCompliant   on 
 
      CompOptLevelCompliant     on 
 
      IncludeMdlTerminateFcn    on 
 
      GeneratePreprocessorConditionals "Disable all" 
 
      CombineOutputUpdateFcns   off 
 
      SuppressErrorStatus       off 
 
      ERTFirstTimeCompliant     off 
 
      IncludeFileDelimiter     "Auto" 
 
      ERTCustomFileBanners      off 
 
      SupportAbsoluteTime       on 
 
      LogVarNameModifier        "rt_" 
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      MatFileLogging 
          on 
 
      MultiInstanceERTCode      off 
 
      SupportNonFinite           on 
 
      SupportComplex 
          on 
 
      PurelyIntegerCode 
   off 
 
      SupportContinuousTime     on 
 
      SupportNonInlinedSFcns    on 
 
      SupportVariableSizeSignals off 
 
       EnableShiftOperators          on 
 
       ParenthesesLevel       "Nominal" 
 
       PortableWordSizes 
            off 
 
      ModelStepFunctionPrototypeControlCompliant off 
 
      CPPClassGenCompliant         off 
 
      AutosarCompliant 
            off 
 
      UseMalloc 
 
            off 
 
      ExtMode 
 
            off 
 
      ExtModeStaticAlloc           off 
 
      ExtModeTesting 
            off 
 
      ExtModeStaticAllocSize   1000000 
 
      ExtModeTransport 
             0 
 
      ExtModeMexFile 
     "ext_comm" 
 
      ExtModeIntrfLevel       "Level1" 
 
      RTWCAPISignals 
          off 
 
      RTWCAPIParams 
          off 
 
      RTWCAPIStates 
          off 
 
      GenerateASAP2 
          off 
 
    } 
 
    PropName 
 
         "Components" 
 
  } 
 
} 
 
hdlcoderui.hdlcc { 
 
  $ObjectID 
 
                 12 
 
  Version 
 
                "1.6.0" 
 
  Description "HDL Coder custom configuration component" 
 
  Name 
 
 
         "HDL Coder" 
 
} 
 
PropName 
 
               "Components" 
      } 
      Name 
 
                    "Configuration" 
      CurrentDlgPage                     "Solver" 
      ConfigPrmDlgPosition    " [ 200, 74, 1080, 704 ] " 
    } 
    PropName 
 
               "ConfigurationSets" 
  } 
  Simulink.ConfigSet { 
    $PropName 
 
    "ActiveConfigurationSet" 
    $ObjectID 
 
    1 
  } 
  BlockDefaults { 
    ForegroundColor 
        "black" 
    BackgroundColor 
        "white" 
    DropShadow 
 
         off 
    NamePlacement 
           "normal" 
    FontName 
 
        "Arial" 
    FontSize 
 
        10 
    FontWeight 
 
        "normal" 
    FontAngle 
 
        "normal" 
    ShowName 
 
        on 
    BlockRotation 
           0 
    BlockMirror 
 
        off 
  } 
  AnnotationDefaults { 
    HorizontalAlignment 
    "center" 
    VerticalAlignment 
    "middle" 
    ForegroundColor 
          "black" 
    BackgroundColor 
          "white" 
    DropShadow 
 
           off 
    FontName 
 
          "Arial" 
    FontSize 
 
          10 
    FontWeight 
 
          "normal" 
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    FontAngle 
 
          "normal" 
    UseDisplayTextAsClickCallback off 
  } 
  LineDefaults { 
    FontName 
 
            "Arial" 
    FontSize 
 
            9 
    FontWeight 
 
           "normal" 
    FontAngle 
 
           "normal" 
  } 
  BlockParameterDefaults { 
    Block { 
      BlockType 
 
      Fcn 
      Expr 
 
      "sin(u[1])" 
      SampleTime 
           "-1" 
    } 
    Block { 
      BlockType 
 
      Gain 
      Gain 
 
      "1" 
      Multiplication       "Element-wise(K.*u)" 
      ParamMin 
 
      "[]" 
      ParamMax 
 
      "[]" 
      ParameterDataTypeMode         "Same as input" 
      ParameterDataType 
         "fixdt(1,16,0)" 
      ParameterScalingMode "Best Precision: Matrix-wise" 
      ParameterScaling 
               "[]" 
      ParamDataTypeStr 
    "Inherit: Same as input" 
      OutMin 
 
          "[]" 
      OutMax 
 
          "[]" 
      OutDataTypeMode 
    "Same as input" 
      OutDataType 
             "fixdt(1,16,0)" 
      OutScaling 
             "[]" 
      OutDataTypeStr           "Inherit: Same as input" 
      LockScale 
 
           off 
      RndMeth 
 
           "Floor" 
      SaturateOnIntegerOverflow 
on 
      SampleTime 
              "-1" 
    } 
    Block { 
      BlockType 
 
           Integrator 
      ExternalReset 
           "none" 
      InitialConditionSource    "internal" 
      InitialCondition 
    "0" 
      LimitOutput 
             off 
      UpperSaturationLimit     "inf" 
      LowerSaturationLimit     "-inf" 
      ShowSaturationPort        off 
      ShowStatePort 
                  off 
      AbsoluteTolerance 
            "auto" 
      IgnoreLimit 
                     off 
      ZeroCross 
 
                  on 
      ContinuousStateAttributes 
     "''" 
    } 
      Block { 
      BlockType 
 
     Mux 
      Inputs 
 
     "4" 
      DisplayOption 
     "none" 
      UseBusObject         off 
      BusObject 
 
     "BusObject" 
      NonVirtualBus 
     off 
    } 
    Block { 
      BlockType 
 
      Saturate 
      UpperLimit 
        "0.5" 
      LowerLimit 
         "-0.5" 
      LinearizeAsGain 
 on 
      ZeroCross 
 
       on 
      SampleTime 
          "-1" 
      OutMin 
 
       "[]" 
      OutMax 
 
       "[]" 
      OutDataTypeMode 
 "Same as input" 
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      OutDataType 
          "fixdt(1,16,0)" 
      OutScaling 
          "[]" 
      OutDataTypeStr        "Inherit: Same as input" 
      LockScale 
 
        off 
      RndMeth 
 
        "Floor" 
    } 
    Block { 
      BlockType 
 
        Scope 
      ModelBased 
           off 
      TickLabels 
           "OneTimeTick" 
      ZoomMode 
 
        "on" 
      Grid 
 
        "on" 
      TimeRange 
 
      "auto" 
      YMin 
 
       "-5" 
      YMax 
 
       "5" 
      SaveToWorkspace 
 off 
      SaveName 
 
      "ScopeData" 
      LimitDataPoints 
 on 
      MaxDataPoints 
       "5000" 
      Decimation 
          "1" 
      SampleInput 
          off 
      SampleTime 
          "-1" 
    } 
    Block { 
      BlockType 
 
      Step 
      Time 
 
      "1" 
      Before 
 
      "0" 
      After 
 
       "1" 
      SampleTime 
         "-1" 
      VectorParams1D        on 
      ZeroCross 
 
       on 
    } 
    Block { 
      BlockType 
 
       Sum 
      IconShape 
 
       "rectangular" 
      Inputs 
 
       "++" 
      CollapseMode           "All dimensions" 
      CollapseDim 
          "1" 
      InputSameDT 
          on 
      AccumDataTypeStr 
"Inherit: Inherit via 
internal rule" 
      OutMin 
 
     "[]" 
      OutMax 
 
     "[]" 
      OutDataTypeMode     "Same as first input" 
      OutDataType 
        "fixdt(1,16,0)" 
      OutScaling 
         "[]" 
      OutDataTypeStr       "Inherit: Same as first input" 
      LockScale 
 
      off 
      RndMeth 
 
      "Floor" 
      SaturateOnIntegerOverflow 
on 
      SampleTime 
           "-1" 
    } 
    Block { 
      BlockType 
 
       ToWorkspace 
      VariableName          "simulink_output" 
      MaxDataPoints 
       "1000" 
      Decimation 
          "1" 
      SampleTime 
          "0" 
      FixptAsFi 
 
       off 
    } 
    Block { 
      BlockType 
 
      TransferFcn 
      Numerator 
 
      "[1]" 
      Denominator 
         "[1 2 1]" 
      AbsoluteTolerance 
"auto" 
      ContinuousStateAttributes 
"''" 
      Realization 
          "auto" 
    } 
    Block { 
      BlockType 
 
        TransportDelay 
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      DelayTime 
 
        "1" 
      InitialOutput 
        "0" 
      BufferSize 
          "1024" 
      FixedBuffer 
            off 
      TransDelayFeedthrough   off 
      PadeOrder 
 
         "0" 
    } 
  } 
  System { 
    Name 
 
        "yeniseri301u" 
    Location 
 
         [-187, 477, 808, 1067] 
    Open 
 
         on 
    ModelBrowserVisibility    off 
    ModelBrowserWidth 
          200 
    ScreenColor 
 
          "white" 
    PaperOrientation          "landscape" 
    PaperPositionMode 
          "auto" 
    PaperType 
 
          "A4" 
    PaperUnits 
 
          "centimeters" 
  TiledPaperMargins  [0.500000, 0.500000, 0.500000, 
0.500000] 
    TiledPageScale            1 
    ShowPageBoundaries 
  off 
    ZoomFactor 
 
        "80" 
    ReportName 
 
        "simulink-default.rpt" 
    SIDHighWatermark         25 
    Block { 
      BlockType 
 
               TransferFcn 
      Name 
 
                       "1" 
      SID 
 
                         1 
      Position 
 
      [190, 129, 295, 191] 
      BackgroundColor 
           "yellow" 
      Numerator 
 
       "[39.89 216.318 516.102 0] " 
      Denominator 
                "[1 0.4784 12.938 0]" 
    } 
    Block { 
      BlockType 
 
              TransferFcn 
      Name 
 
             "2" 
      SID 
 
              2 
      Position 
 
       [190, 232, 295, 288] 
      BackgroundColor   "[0.501961, 0.501961, 1.000000]" 
      Numerator 
 
         "[16.52 393.71028 -10.44]" 
      Denominator 
                        " [1 4.086 0]" 
    } 
    Block { 
      BlockType 
 
                       TransferFcn 
      Name 
 
                              "3" 
      SID 
 
                               3 
      Position 
 
            [190, 329, 300, 381] 
      BackgroundColor 
             "cyan" 
      Numerator 
 
      "[-30.2 736]" 
      Denominator 
                  "[1 8]" 
    } 
    Block { 
      BlockType 
 
               Fcn 
      Name 
 
              "Fcn" 
      SID 
 
                 4 
      Position 
 
        [620, 240, 680, 270] 
      Expr 
 
              "u^2" 
    } 
    Block { 
      BlockType 
 
               Gain 
      Name 
 
              "Gain1" 
      SID 
 
               5 
      Position 
 
       [425, 145, 450, 175] 
      BackgroundColor  "[0.501961, 1.000000, 0.501961]" 
      Gain 
 
               "k1" 
      ParameterDataTypeMode  "Inherit via internal rule" 
      ParameterDataType 
               "sfix(16)" 
      ParameterScaling 
               "2^0" 
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      ParamDataTypeStr "Inherit: Inherit via internal rule" 
      OutDataTypeMode 
 "Inherit via internal rule" 
      OutDataType 
            "sfix(16)" 
      OutScaling 
            "2^0" 
      OutDataTypeStr             "Inherit: Inherit via 
internal rule" 
      SaturateOnIntegerOverflow 
off 
    } 
    Block { 
      BlockType 
 
         Gain 
      Name 
 
        "Gain2" 
      SID 
 
               6 
      Position 
 
               [425, 245, 455, 275] 
      BackgroundColor   "[0.501961, 1.000000, 0.501961]" 
      Gain 
 
               "k2" 
    ParameterDataTypeMode   "Inherit via internal rule" 
    ParameterDataType 
                  "sfix(16)" 
    ParameterScaling                  "2^0" 
  ParamDataTypeStr "Inherit: Inherit via internal rule" 
     OutDataTypeMode    "Inherit via internal rule" 
     OutDataType 
                      "sfix(16)" 
  OutScaling 
                                  "2^0" 
  OutDataTypeStr 
"Inherit: Inherit via internal rule" 
      SaturateOnIntegerOverflow 
off 
    } 
    Block { 
      BlockType 
 
       Gain 
      Name 
 
             "Gain3" 
      SID 
 
              7 
      Position 
              [425, 340, 455, 370] 
      BackgroundColor   "[0.501961, 1.000000, 0.501961]" 
      Gain 
 
             "k3" 
      ParameterDataTypeMode "Inherit via internal rule" 
      ParameterDataType 
      "sfix(16)" 
      ParameterScaling 
      "2^0" 
      ParamDataTypeStr "Inherit: Inherit via internal rule" 
      OutDataTypeMode 
     "Inherit via internal rule" 
      OutDataType 
            "sfix(16)" 
      OutScaling 
            "2^0" 
      OutDataTypeStr  "Inherit: Inherit via internal rule" 
      SaturateOnIntegerOverflow 
off 
    } 
    Block { 
      BlockType 
 
      Gain 
      Name 
 
      "Gain4" 
      SID 
 
      8 
      Position 
 
      [445, 428, 495, 472] 
      BlockMirror 
         on 
      BackgroundColor 
"cyan" 
      Gain 
 
      "K1" 
      ParameterDataTypeMode  "Inherit via internal rule" 
      ParameterDataType 
        "sfix(16)" 
      ParameterScaling 
          "2^0" 
  ParamDataTypeStr "Inherit: Inherit via internal rule" 
      OutDataTypeMode   "Inherit via internal rule" 
      OutDataType 
           "sfix(16)" 
      OutScaling 
           "2^0" 
  OutDataTypeStr 
  "Inherit: Inherit via internal rule" 
      SaturateOnIntegerOverflow 
off 
    } 
    Block { 
      BlockType 
 
      Integrator 
      Name 
 
      "Integrator" 
      SID 
 
      9 
      Ports 
 
      [1, 1] 
      Position 
 
      [785, 240, 815, 270] 
    } 
    Block { 
      BlockType 
 
      Mux 
      Name 
 
      "Mux" 
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      SID 
 
      10 
      Ports 
 
      [2, 1] 
      Position 
 
      [620, 441, 625, 479] 
      ShowName 
 
      off 
      Inputs 
 
      "2" 
      DisplayOption 
      "bar" 
    } 
    Block { 
      BlockType 
 
      Saturate 
      Name 
 
      "Saturation2" 
      SID 
 
      11 
      Position 
 
      [700, 240, 730, 270] 
      UpperLimit 
         "10" 
      LowerLimit 
         "0" 
    } 
    Block { 
      BlockType 
 
      Scope 
      Name 
 
      "Scope" 
      SID 
 
      12 
      Ports 
 
      [1] 
      Position 
 
      [700, 529, 730, 561] 
      Floating 
 
      off 
      Location 
 
      [552, 421, 1172, 708] 
      Open 
 
      off 
      NumInputPorts 
      "1" 
      List { 
 
ListType  
AxesTitles 
 
axes1 
 
 
"%<SignalLabel>" 
      } 
      TimeRange 
 
      "10" 
      YMin 
 
      "0" 
      YMax 
 
      "120" 
      DataFormat 
         "StructureWithTime" 
      SampleTime 
         "0" 
    } 
    Block { 
      BlockType 
 
      Scope 
      Name 
 
      "Scope1" 
      SID 
 
      13 
      Ports 
 
      [1] 
      Position 
 
      [875, 264, 905, 296] 
      Floating 
 
      off 
      Location 
 
      [695, 91, 1019, 331] 
      Open 
 
      off 
      NumInputPorts 
      "1" 
      List { 
 
ListType  
AxesTitles 
 
axes1 
      "%<SignalLabel>" 
      } 
      TimeRange 
 
             "10" 
      YMin 
 
             "0" 
      YMax 
 
             "0.025" 
      SaveName 
 
        "ScopeData1" 
      DataFormat 
           "StructureWithTime" 
      SampleTime 
           "0" 
    } 
    Block { 
      BlockType 
 
      Scope 
      Name 
 
      "Scope2" 
      SID 
 
      14 
      Ports 
 
      [1] 
      Position 
 
      [430, 589, 460, 621] 
      Floating 
 
      off 
      Location 
 
      [410, 533, 734, 772] 
      Open 
 
      off 
      NumInputPorts 
      "1" 
      List { 
 
ListType  
AxesTitles 
 
axes1 
 
 
"%<SignalLabel>" 
      } 
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      TimeRange 
 
      "10" 
      YMin 
 
      "0" 
      YMax 
 
      "100" 
      SaveName 
 
      "ScopeData2" 
      DataFormat 
         "StructureWithTime" 
      SampleTime 
         "0" 
    } 
    Block { 
      BlockType 
 
      Step 
      Name 
 
      "Step1" 
      SID 
 
      15 
      Position 
 
      [50, 500, 80, 530] 
      BackgroundColor "[0.607843, 0.443137, 0.756863]" 
      Time 
 
      "0" 
      SampleTime 
           "0" 
    } 
    Block { 
      BlockType 
 
      Step 
      Name 
 
      "Step2" 
      SID 
 
      16 
      Position 
 
      [50, 245, 80, 275] 
      BackgroundColor "[0.607843, 0.443137, 0.756863]" 
      Time 
 
      "0" 
      SampleTime 
         "0" 
    } 
    Block { 
      BlockType 
 
      Sum 
      Name 
 
      "Sum" 
      SID 
 
      17 
      Ports 
 
      [2, 1] 
      Position 
 
      [580, 245, 600, 265] 
      BackgroundColor 
          "cyan" 
      ShowName 
 
                 off 
      IconShape 
 
                 "round" 
      Inputs 
 
                 "|+-" 
      InputSameDT 
                    off 
      OutDataTypeMode 
"Inherit via internal rule" 
      OutDataType 
         "fixdt(1, 16)" 
      OutScaling 
         "2^0" 
      OutDataTypeStr "Inherit: Inherit via internal rule" 
      SaturateOnIntegerOverflow 
off 
    } 
    Block { 
      BlockType 
 
      Sum 
      Name 
 
      "Sum2" 
      SID 
 
      18 
      Ports 
 
      [2, 1] 
      Position 
 
      [105, 245, 135, 275] 
      BackgroundColor 
          "lightBlue" 
      ShowName 
 
                 off 
      IconShape 
 
                "round" 
      Inputs 
 
                 "|+-" 
      InputSameDT 
                    off 
      OutDataTypeMode "Inherit via internal rule" 
      OutDataType 
           "sfix(16)" 
      OutScaling 
           "2^0" 
      OutDataTypeStr "Inherit: Inherit via internal rule" 
      SaturateOnIntegerOverflow 
off 
    } 
    Block { 
      BlockType 
 
      Sum 
      Name 
 
      "Sum3" 
      SID 
 
      19 
      Ports 
 
      [3, 1] 
      Position 
 
      [515, 235, 555, 275] 
      BackgroundColor 
          "lightBlue" 
      ShowName 
 
      off 
      IconShape 
 
      "round" 
      Inputs 
 
      "|+++" 
      InputSameDT 
         off 
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      OutDataTypeMode 
"Inherit via internal rule" 
      OutDataType 
         "sfix(16)" 
      OutScaling 
         "2^0" 
      OutDataTypeStr "Inherit: Inherit via internal rule" 
      SaturateOnIntegerOverflow 
off 
    } 
    Block { 
      BlockType 
 
      ToWorkspace 
      Name 
 
      "To Workspace" 
      SID 
 
      20 
      Ports 
 
      [1] 
      Position 
 
      [860, 195, 920, 225] 
      VariableName         "hata" 
      MaxDataPoints 
      "inf" 
      SampleTime 
         "0.1" 
      SaveFormat 
         "Array" 
    } 
    Block { 
      BlockType 
 
      TransportDelay 
      Name 
 
      "Transport\nDelay" 
      SID 
 
      21 
      Position 
 
      [345, 141, 385, 179] 
      DelayTime 
 
      "a1" 
    } 
    Block { 
      BlockType 
 
      TransportDelay 
      Name 
 
      "Transport\nDelay2" 
      SID 
 
      22 
      Position 
 
      [350, 245, 380, 275] 
      DelayTime 
 
      "0.5" 
    } 
    Block { 
      BlockType 
 
      TransportDelay 
      Name 
 
      "Transport\nDelay3" 
      SID 
 
      23 
      Position 
 
      [350, 340, 380, 370] 
      DelayTime 
 
      "a3" 
    } 
    Block { 
      BlockType 
 
      TransportDelay 
      Name 
 
      "Transport\nDelay4" 
      SID 
 
      24 
      Position 
 
      [385, 500, 415, 530] 
      DelayTime 
 
      "0.19" 
    } 
    Block { 
      BlockType 
 
      TransferFcn 
      Name 
 
      "referans sinyali" 
      SID 
 
      25 
      Position 
 
      [195, 492, 295, 538] 
      BackgroundColor 
           "orange" 
      Numerator 
 
      "[0.7268 24.8548 48.7423 0]" 
      Denominator 
        "[0.0471 0.1386 1.1019 0 ]" 
    } 
    Line { 
      SrcBlock 
 
      "Step1" 
      SrcPort 
 
      1 
      DstBlock 
 
      "referans sinyali" 
      DstPort 
 
      1 
    } 
    Line { 
      SrcBlock 
 
      "referans sinyali" 
      SrcPort 
 
      1 
      Points 
 
      [30, 0] 
      Branch { 
 
Points 
 
 
[0, 90] 
 
DstBlock  
       "Scope2" 
 
DstPort 
 
 
1 
      } 
      Branch { 
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DstBlock  
"Transport\nDelay4" 
 
DstPort 
 
1 
      } 
    } 
    Line { 
      SrcBlock 
 
      "Mux" 
      SrcPort 
 
      1 
      Points 
 
      [0, 85] 
      DstBlock 
 
      "Scope" 
      DstPort 
 
      1 
    } 
    Line { 
      SrcBlock 
 
      "3" 
      SrcPort 
 
      1 
      DstBlock 
 
      "Transport\nDelay3" 
      DstPort 
 
      1 
    } 
    Line { 
      SrcBlock 
 
      "Gain3" 
      SrcPort 
 
      1 
      Points 
 
      [75, 0] 
      Branch { 
 
Points 
 
 
[0, 95] 
 
DstBlock  
       "Gain4" 
 
DstPort 
 
 
1 
      } 
      Branch { 
 
DstBlock  
      "Sum3" 
 
DstPort 
 
 
3 
      } 
    } 
    Line { 
      SrcBlock 
 
      "Sum2" 
      SrcPort 
 
      1 
      Points 
 
      [10, 0] 
      Branch { 
 
Points 
 
         [5, 0] 
 
Branch { 
 
  DstBlock 
 
     "2" 
 
  DstPort 
 
      1 
 
} 
 
Branch { 
 
  Points  
  [-5, 0; 0, 95] 
 
  DstBlock 
 
      "3" 
 
  DstPort 
 
      1 
 
} 
      } 
      Branch { 
 
Points 
 
[-5, 0; 0, -100] 
 
DstBlock  
"1" 
 
DstPort 
 
1 
      } 
    } 
    Line { 
      SrcBlock 
 
      "Sum3" 
      SrcPort 
 
      1 
      Points 
 
      [-1, 1; 6, -1] 
      Branch { 
 
Points 
 
[5, 1; 0, 194] 
 
DstBlock  
"Mux" 
 
DstPort 
 
1 
      } 
      Branch { 
 
DstBlock  
"Sum" 
 
DstPort 
 
1 
      } 
    } 
    Line { 
      SrcBlock 
 
      "Transport\nDelay4" 
      SrcPort 
 
      1 
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      Points 
 
      [170, 0] 
      Branch { 
 
Points 
 
[15, 0] 
 
DstBlock  
"Mux" 
 
DstPort 
 
 
2 
      } 
      Branch { 
 
DstBlock  
"Sum" 
 
DstPort 
 
2 
      } 
    } 
    Line { 
      SrcBlock 
 
       "1" 
      SrcPort 
 
        1 
      DstBlock 
 
        "Transport\nDelay" 
      DstPort 
 
        1 
    } 
    Line { 
      SrcBlock 
 
      "Transport\nDelay" 
      SrcPort 
 
      1 
      DstBlock 
 
      "Gain1" 
      DstPort 
 
      1 
    } 
    Line { 
      SrcBlock 
 
      "Fcn" 
      SrcPort 
 
      1 
      DstBlock 
 
      "Saturation2" 
      DstPort 
 
      1 
    } 
    Line { 
      SrcBlock 
 
      "Integrator" 
      SrcPort 
 
      1 
      Points 
 
      [10, 0] 
      Branch { 
 
Points 
 
 
[0, -45] 
 
DstBlock  
      "To Workspace" 
 
DstPort 
 
 
1 
      } 
      Branch { 
 
Points 
 
 
[0, 25] 
 
DstBlock  
       "Scope1" 
 
DstPort 
 
 
1 
      } 
    } 
    Line { 
      SrcBlock 
 
      "Saturation2" 
      SrcPort 
 
      1 
      DstBlock 
 
      "Integrator" 
      DstPort 
 
      1 
    } 
    Line { 
      SrcBlock 
 
      "Transport\nDelay2" 
      SrcPort 
 
      1 
      DstBlock 
 
      "Gain2" 
      DstPort 
 
      1 
    } 
    Line { 
      SrcBlock 
 
      "2" 
      SrcPort 
 
      1 
      DstBlock 
 
      "Transport\nDelay2" 
      DstPort 
 
      1 
    } 
    Line { 
      SrcBlock 
 
      "Step2" 
      SrcPort 
 
      1 
      DstBlock 
 
      "Sum2" 
      DstPort 
 
      1 
    } 
    Line { 
      SrcBlock 
 
      "Gain4" 
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      SrcPort 
 
      1 
      Points 
 
      [-319, 0] 
      DstBlock 
 
      "Sum2" 
      DstPort 
 
      2 
    } 
    Line { 
      SrcBlock 
 
      "Gain1" 
      SrcPort 
 
      1 
      Points 
 
      [50, 0] 
      DstBlock 
 
      "Sum3" 
      DstPort 
 
      1 
    } 
    Line { 
      SrcBlock 
 
      "Gain2" 
      SrcPort 
 
      1 
      Points 
 
      [25, 0; 0, 12] 
      DstBlock 
 
      "Sum3" 
      DstPort 
 
      2 
    } 
    Line { 
      SrcBlock 
 
      "Transport\nDelay3" 
      SrcPort 
 
      1 
      DstBlock 
 
      "Gain3" 
      DstPort 
 
      1 
    } 
    Line { 
      SrcBlock 
 
      "Sum" 
      SrcPort 
 
      1 
      DstBlock 
 
      "Fcn" 
      DstPort 
 
      1 
    } 
    Annotation { 
      Position 
 
      [371, 559] 
    } 
  } 
}
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APPENDIX B 
IRF3 DATA 
0 2.76571428 x10-1 4.62628571 x10-1 9.92685714 x10-1 6.96685714285 x10-1 
0 min 30 min 60 min 120 min 240 min 
 
The IRF3 data are gathered by Image J program from IRF3 gel shift assay (Qin et al., 2005) 
and indicates relative amount of IRF3. The IRF3 data and the simulation results are given in  
normalized form in Figure 3. 
 
IFN! DATA 
0 µM 0.42 x10-4 µM 1.4 x10-4 µM 1.62 x10-4 µM 0.78 x10-4 µM 
0 min 120 min 240 min 480 min 720 min 
 
The Data obtained from by data capture (Figure 4d of Qin et al, 2005).  According to 
these data, while IFN! protein peaks at 8 hours with 4ng/mL concentration and then 
declined to 2ng/mL at 12 hours (the molecular weight of interferon 1a and 
interferon1b reported by their manufacturers are used in the conversion to molar 
concentration) 
 
PKR DATA 
PKR (NIH3T3 cell extracts 
immunobloting results (Donze 
et al, 2004))  
PKR (bone–morrow-derived 
macrophages  
(Hsu et al. 2004)) 
min normalized min normalized 
0 4.11600x10-2 0 1.39804875 x10-1 
180 5.4432x10-2 30 1.00 
240 2.6438126x10-1 60 5.769054375 x10-1 
300 4.0655009x10-1 120 4.34244125   x10-1 
x360 7.3498169x10-1 240 2.04262275   x10-1 
420 7.8272241x10-1 360 7.221298       x10-1 
  420 2.959473125 x10-1 
  600 2.930598125 x10-1 
 
The data are gathered by Image J program from gel shift assays (Donze et al, 2004; 
Hsu et al. 2004). The original data from gel shift assays only include data about 
relative amounts. All PKR data normalized and characteristics of profiles compared 
with each other. 
 
NF"B DATA 
NF"B value is obtained by fitting a function recapitulating experimental profile (Lee et 
al., 2009) up to 224 min plus extrapolation up to 720 min. for the time interval between 
0 and 223: 
 
360
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NF"B= NF"B* 
NF"B* = -0.17364 - 0.0348 . cos (0.01408 t) + 0.22 . cos (0.02816 t) 
                +  0.03934 . cos (0.04224 t)   +      0.3238 . sin (0.01408 t)   
                +  0.0512 . sin (0.02816 t)      -      0.11668 . sin (0.04224 t) 
                 -  0.04262 . cos (0.05632 t)    - 0.02422 . sin (0.05632 t) 
                 -  0.006856.cos (0.0704 t)     + 0.00658. sin (0.0704 t); 
 
to extrapolate the function up to 720 min, for the time interval between 223 and 720 it is 
defined as: 
 
NF"B = NF"B -0.45.10-5;  
 
The function given above can be directly applied to simulation but it includes a small 
oscillation between 0-25 minutes and does not exactly reflect the reported 
experimental profile. Even though this oscillation does not affect the simulation 
results, to obtain the function given in Figure 4 of the main text, we defined NF"B 
piecewise in the interval between 0 and 224 as given below: 
 
NF"B = 0.0018 + 0.000097272 . (t/20)2 in between 0 and 20 minutes,  
NF"B= NF"B* + 0.002 . (t-20)-0.5 in between 20 and 31 minutes,  
NF"B= NF"B* in between 31 and 223 minutes.  
 
In that function it is assumed that about 0.0018 µM basal level of NF"B exist to get 0 
basal value 0.0018 can be subtracted from the equations and this is also has no effect 
on the simulation results. 
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